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I GENERAL INTRODUCTION 
1 READY-TO-USE DRUG/DEVICE COMBINATION PRODUCTS 
(DDCP) 
Over the last decades, ready-to-use DDCPs have changed the perspectives of patients and health 
care professionals towards injectables. In-line with the success of therapeutic proteins to treat a 
wide range of severe oncology and immune disorders [1], the use of DDCPs for therapeutic 
proteins has considerably grown by 22 % from 2010 to 2015 compared to 11 % for other 
injectables [2]. It is forecasted that the market will grow from 2 billion sold pre-filled syringes 
(PFS) in 2009 to 6.83 billion units in 2025 [3]. While the glass PFS market was worth 
$3.59 billion in 2015, revenues are predicted to reach $5.51 billion in 2022 with Becton 
Dickinson, Schott, Nipro Glass, Nuova Ompi and Gerresheimer being the dominating syringe 
suppliers [4]. Likewise, advanced DDCPs such as auto-injectors pre-loaded with cartridges or 
syringes have evolved to further improve the ease of self-administration by automatic needle 
insertion and drug delivery (e.g., spring-controlled). Self-administration of DDCPs allows 
patients to take their medication with a high level of convenience at home or during travelling 
[5]. For health care professionals, DDCPs are the primary choice for immediate and safe 
medication (85% of health care professionals prefer DDCPs over other parenteral delivery 
systems) [6]. The expected market growth is primarily attributed to an increasing demand for 
injectable therapeutic proteins [4]. In addition, DDCPs are also used for the parenteral 
administration of small molecular drugs (Tab. I-1).  
Recently, large volume (up to 10 mL), wearable DDCPs, i.e., patch pumps such as SmartDose®, 
SteadyMed®, which are well-known in insulin therapy, have gained more attention within the 
highly competitive biopharmaceutical market [7,8]. These systems eliminate the need for 
multiple injections or infusions. 
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Tab. I-1. Selected medications available as DDCP modified from [2,6,7] (by May 6, 2016).  
Brand name INN 
a
 LM 
b
/SM 
c
 Indication/Disease (selection) DDCP 
Aranesp Darbepoetin alpha LM Anemia PFS 
APO-go Apomorphine HCl SM Parkinson´s disease PFS, injector 
Avonex Interferon β-1a LM Multiple sclerosis PFS, injector 
Clexane Enoxaparin sodium SM Deep vein thrombosis PFS 
Emerade Epinephrine tartrate SM Anaphylaxis Injector 
Enbrel Etanercept LM TNF blocker PFS, injector 
Engerix Hepatitis B (rDNA) vaccine LM Hepatitis B PFS 
Heparin-Calcium-
5000 ratiopharm 
Heparin calcium SM Anticoagulant PFS 
Humira Adalimumab LM Rheumatoid arthritis PFS, injector 
IntronA Interferon α-2b LM Chronic hepatitis B Injector 
Lantus SoloSTAR Insulin glargine LM Diabetes Pen 
Metex Methotrexat SM Rheumatoid arthritis PFS, injector 
Neupogen Filgrastim LM Neutropenia PFS 
Pegasys Peginterferon alpha-2a LM Chronic hepatitis B & C PFS 
RoActemra Tocilizumab LM Rheumatoid arthritis PFS 
Roferon Interferon α-2a LM Leukaemia PFS 
a International non-proprietary name 
b Large molecule 
c Small molecule 
 
The interest dedicated to DDCPs can be tracked back to several advantages for both industry and 
the intended user population. The main reasons include the following (modified from [4]): 
 increased sterility assurance 
 reduced handling requirements improve ease and speed of administration (no separate 
reconstitution or filling step from another container (vial, ampoule) to the syringe) 
 potential for self-administration by the patient 
 improved dosing accuracy  
 benefits for the safety of patients and health care professionals with regard to post-
administration needle-stick injuries, e.g., by integrated needle safety devices 
 brand differentiation in the course of life-cycle management 
 less overfill of costly therapeutics (2-3 % compared to 20-25 % for ampoules/vials [3]) 
and consequently reduced waste and costs 
General Introduction 
3 
 ease of manufacture by purchasing ready-to-fill (pre-washed, pre-sterilized, 
depyrogenated, siliconized) syringes   
However, significant variations in design, format, construction material, surface treatment (e.g., 
coating) and secondary components (plunger rod, tip, cap, rigid needle shield etc.) for most 
DDCPs also pose numerous technical challenges. These include selection of appropriate on-site 
filling and assembly technologies, functional performance, compatibility with the therapeutic 
protein during shelf life and matching user requirements [9,10]. 
2 SILICONIZATION PROCESSES FOR PRIMARY PACKAGING 
GLASS BARRELS 
Numerous parenteral packaging components are to some extent lubricated with silicone oil to 
improve functional performance and machinability. Rubber components such as vial stoppers and 
syringe pistons are less sticky after siliconization, which ensures discharging from stopper 
washing bowls, seamless feed from hoppers to machine paths as well as transfer through machine 
guides. Siliconization further reduces the force to insert vial stoppers [11]. In addition, siliconized 
vials show better drainage and less fogging after siliconization [12]. From a patient´s perspective, 
needle lubrication results in less injection pain due to lower frictional forces during skin 
penetration. Adequate siliconization of the inner syringe/cartridge glass barrel is essential for a 
smooth, easy and consistent injection of DDCPs [11]. Thus, among the different functional 
performance tests for DDCP, e.g., seal integrity testing, tip cap removal force, the forces to 
initiate (referred to as break-loose force) and to maintain the movement of the piston within the 
glass barrel (gliding force) are still the most important measurable outputs and are often 
somehow related to the degree of siliconization [3].  
In addition, silicone oil free systems are being promoted. These techniques include lubricious, 
biocompatible coatings for plunger stoppers, which enable adequate extrusion performance in 
silicone oil free syringes, e.g., fluoropolymer coatings (FluroTec®) or proprietary i-coating™, 
often in combination with polymer based syringes (Plajex™, CrystalZenith®) [13–15]. Studies 
suggest a great potential of these systems for highly sensitive protein therapeutics with low 
protein aggregate and subvisible particle levels, but suitability has still to be confirmed with more 
systematic investigations [16].  
Usually, siliconization of the inner glass barrel is performed by spraying-on either silicone oil 
(referred to as spray-on siliconization) without further treatment [17] or diluted silicone emulsion 
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that is baked-on the glass surface at approximately 300 °C for 10-30 min (referred to as bake-on 
siliconization) [18,19]. Automated siliconization units precisely regulate the spray amount, 
nozzle position, nozzle speed as well as the air atomization pressure and spray time [17,20]. Both 
processes are applicable for luer cone PFS and cartridges. In contrast, staked-in needle PFS need 
to be spray-on siliconized due to the low heat resistance of the glue used for embedding the 
needle into the fluid path of the syringe cone. Generally, siliconization can also be performed by 
wiping, dipping or washing the component in a solvent-based silicone solution or silicone 
emulsion followed by drying at room temperature or elevated temperature [21–24].  
The most widely applied silicone oil for spray-on siliconization is trimethylsiloxy-endcapped 
polydimethylsiloxane, e.g., silicone oil as lubricant [25] or dimethicone [26], with viscosities 
ranging from 1,000 cSt to 12,500 cSt [17,21]. The physical and chemical requirements for non-
parenteral use (i.e., as lubricant) are defined in the relevant monographs in the Ph. Eur., 
depending on the fluid viscosity [25,26].  
Silicone emulsion for bake-on siliconization, e.g., dimethicone emulsion, contains additional 
stabilizers such as preservatives (methyl paraben and propyl paraben), non-ionic surfactants 
(Tween 20 and Triton X-100) and co-solvents (propylene glycol) up to 5 % each and about 35 % 
dimethicone, 350 cSt, in water [27,28]. Even though diluted emulsions are applied and hence 
these stabilizers level-off, there might be concerns with respect to a potential interaction with the 
drug.  
Silicone oil has been safely used as lubricant over decades [25], for the treatment of retinal 
detachment and soft tissue augmentation due to its biological inertness [29]. However, certain 
low molecular weight siloxanes, which may be present in silicone oil as residues from polymer 
synthesis [30,31] have been associated with toxicological concerns [32,33]. These low molecular 
weight siloxanes may also appear as thermal decomposition products [34–36] during bake-on 
siliconization. Nevertheless, adequate heat-treatment is essential to remove the emulsion water 
and for concomitant sterilization and depyrogenation [9,17,19,28].  
Although bake-on siliconization is widely implemented in industry, there is currently a 
substantial gap in understanding the thermal impact on the applied silicone emulsion. A 
systematical evaluation of the change in the silicone level, extrusion performance and chemical 
composition upon bake-on may help to define an adequate processing window with regard to 
burn-in time and temperature.  
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For both siliconization processes, it is critical to target an adequate silicone level in order to meet 
the intended piston extrusion performance, also in context of long-term product storage, but at the 
same time keeping the overall silicone quantity as low as possible. Spray-on siliconization 
processes most commonly apply relatively high silicone levels of 0.2-1 mg/barrel due to 
limitations of the siliconization equipment to precisely spray lower amounts of viscous silicone 
oil [10,16,17,37–42]. In bake-on processes, silicone levels below 0.1 mg/barrel are achieved by 
adjusting the spray amount and/or concentration of the silicone emulsion [37,43,44].  
Likewise, a homogeneous distribution of the silicone within the glass barrel is challenging. An 
uneven silicone distribution may lead to a poor injection performance, stalling of the piston 
during injection or “chattering” with repetitive halting of the piston [10,45]. In this context, great 
effort is made by suppliers to optimize the silicone distribution using different static or dynamic 
spray nozzle positions [17,20], but technical aspects are rarely published and considered as 
proprietary know-how. Overall, siliconization processes are not well standardized and as such, 
there is a high variability in the silicone level, distribution and leaching from individual 
siliconized containers [43,46]. 
3 CHARACTERIZATION METHODS FOR SILICONIZED 
PRIMARY PACKAGING GLASS BARRELS 
Reliable analytical techniques are the prerequisites for the optimization of siliconization 
processes. Silicone levels of approximately 0.2-7.3 mg/barrel have been quantified using Fourier 
transform infrared (FTIR) spectroscopy or atomic absorption spectroscopy after solvent 
extraction [37,42,47]. For silicone levels between 0.2 mg and 1.0 mg/barrel, quantification has 
been performed simply gravimetrically by weighing the syringe before and after siliconization 
[17]. The functional performance of DDCPs is assessed by extrusion force measurements, which 
may serve as an indirect measure for siliconization quantity and distribution within the glass 
barrel.  
A rather subjective qualitative evaluation of the silicone distribution within the glass barrel can 
be performed by spreading glass or talcum dust or suspension, which adhere to the siliconized 
areas on the glass surface [17,48]. The relatively thick spray-on silicone layers usually exhibit 
individual plaque-like structures, which can be assessed by optical microscopy [41,42,45]. In 
addition, upon contact with aqueous media the silicone layer forms micro-droplet structures that 
can be tracked along the syringe barrel by schlieren visualization (e.g., Flex-Bench-Top 
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Lubricant Characterization System from Zebrasci, Inc.). Other spectroscopic techniques such as 
interferometry with white light (e.g., Layer Explorer from rap.ID Particle Systems GmbH) have 
been applied to determine silicone layer thicknesses up to approximately 1 µm with a lower limit 
of quantification of approximately 80 nm [39,41,42,45,48,49]. In addition, interferometric 
profilers that apply a red laser beam have been proposed to determine silicone layers as thin as 
20 nm [50], but no data have been published yet. 
A combination of these methods should enable the full characterization of siliconized syringes 
and cartridges in terms of silicone quantity, silicone layer thickness and distribution. 
Quantification limits as low as 0.2 µg/mL have been reported for FTIR. Together with easy 
sample preparation (e.g., solvent extraction) and fast measurement, this makes FTIR a promising 
technique to quantify baked-on silicone levels even below 0.1 mg/barrel. The relatively new 
spectroscopic methods based on schlieren visualization or interferometry have not been 
systematically investigated yet, which limits the applicability even for spray-on silicone layers. In 
particular for thin, baked-on silicone layers of less than 100 nm these methods lack sufficient 
sensitivity. Hence there is currently a gap in analytical methods to characterize very thin baked-
on silicone layers. 
4 DRUG PRODUCT COMPATIBILITY WITH SILICONIZED 
PRIMARY PACKAGING SYSTEMS 
Protein drugs are generally prone to both chemical instabilities, e.g., deamidation or oxidation, 
and physical instabilities such as particle formation and adsorption. These protein instabilities are 
induced by various factors including higher temperature, freezing and thawing and mechanical 
agitation by shaking or stirring [51–53]. Protein aggregates and particles have been associated 
with immunological concerns [54–57] and adverse clinical effects [58,59]. The topic is highly 
debated, since on the other hand, marketed products with some levels of particles have been 
safely used for years [46].  
The protein-inherent degradation pathways might also be triggered by various surfaces proteins 
encounter during formulation (filters), manufacturing (tanks, columns, tubing), shipping (bags), 
storage (DDCPs, bags) and delivery (infusion bags, DDCPs) [60,61]. DDCPs should offer 
protection of the drug product during storage and facilitate drug delivery during administration. 
However, the different component surfaces can interact with the drug product and may thus be 
critical for product quality. This includes siliconized surfaces or droplets that have leached into 
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the drug product formulation. Other product-related impurities for PFS formats have been traced 
back to tungsten/tungsten oxide as residues from tungsten pins used to form the syringe fluid path 
and to the adhesive process used to attach the needle in the syringe fluid path [4,62–64]. 
Leaching impurities from uncoated rubber materials may also play a critical role, e.g., the 
increased incidence of pure red cell aplasia in chronic kidney disease patients treated with Eprex 
(epoetin alfa) in a PFS format was postulated to be related to such impurities [65,66]. Also, the 
glass barrel adds to the impurity profile [9]. The following section focuses on silicone-protein 
interactions. Effects of other surfaces and leachable have been thoroughly reviewed in the 
referenced literature. 
Silicone can detach from the inner glass wall and appear as silicone droplets in the drug product 
formulation, which renders two potential problems. Firstly, silicone droplets increase the number 
of particles, for which limits are set by the pharmacopoeias [67–71]. Secondly, protein stability 
may be perturbed leading to homogeneous protein aggregates and particles or heterogeneous 
protein-silicone particles. Early studies observed particles and a loss of insulin activity associated 
with the release of silicone droplets [72]. In siliconized syringes and silicone-spiked formulations 
without surfactant, aggregation and particle formation was reported for several proteins upon 
agitation [16,22,40,73–76], at increased temperatures [38,77] or periodical rupture of the silicone 
oil-water interface [78]. However, in most of the performed spiking studies, the silicone 
concentrations were considerably higher than typically present in DDCPs. Furthermore, the 
addition of surfactant efficiently mitigated the observed protein instabilities [74,75,78–81]. 
Interestingly, minimal silicone migration was reported for baked-on siliconized containers as 
compared to spray-on siliconized containers with higher silicone levels [22,38,39,41]. Overall, it 
appears that in most cases, particle levels and turbidity increased due to silicone migration rather 
than compromised protein stability [19,40,82–85]. 
Due to their surface activity proteins readily adsorb to container materials. Since the adsorbed 
amounts of most proteins are considerably low, loss in protein content may be only of concern for 
diluted or low concentration protein therapeutics [86,87]. In contrast, structural alteration upon 
adsorption followed by exchange or desorption back into solution often receives more attention 
since these altered structures are considered as precursors for protein aggregation [88–90]. In the 
absence of polysorbate 80, a loss in protein content and structural alteration was reported for 
albinterferon α2b likely through protein adsorption to silicone droplets [74]. Silicone oil induced 
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protein loss was also observed for several other proteins, e.g., anti-SA IgG1, abatacept, lysozyme 
and trastuzumab, but the effect on protein stability was minimal [75,81].  
Given the cited reports in addition to optimized formulation approaches, optimized siliconization 
processes to reduce the silicone levels and the usage as lubricant for years, silicone oil does not 
seem to pose a serious risk for protein stability. However, the increased use of DDCPs as storage 
and delivery systems for therapeutic proteins makes a more thorough investigation of the extent 
of silicone leaching, the driving factors and concomitant protein adsorption and particle 
formation necessary. 
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5 ABBREVIATIONS 
DDCP Drug/device combination product 
FACS Fluorescence activated cell sorting 
FTIR Fourier transform infrared (spectroscopy) 
LM Large molecule 
PFS Pre-filled syringe 
SM Small molecule 
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II OBJECTIVES AND OUTLINE OF THE THESIS 
This thesis aimed at the optimization of the bake-on siliconization process for 5 mL cartridges 
and the investigation of silicone-associated interactions after cartridge-filling with drug product 
with regard to particle formation and protein adsorption. 
The first main objective was to establish novel analytical techniques for the characterization of 
thin baked-on silicone layers, which have not been accessible with standard techniques so far. 
Fourier transform infrared spectroscopy and 3D-laser scanning microscopy were introduced to 
quantify low, baked-on silicone levels after solvent extraction and to determine the thickness of 
these thin layers (chapter III). 
Although siliconization processes are widely implemented in industry, information is rarely 
published or still considered proprietary know-how. The application of the established, sensitive 
methods allowed a straightforward optimization of the bake-on siliconization process to fill this 
gap in process understanding. In chapter IV, the spray-on process of silicone emulsion was 
thoroughly evaluated. Important process parameters such as the spray quantity, spray nozzle 
position, spray pressure, time for pump dosing and the nozzle design were studied with focus on 
the impact on the baked-on silicone level, layer thickness and distribution within the cartridge 
barrel. The concentration of the silicone emulsion was adapted to challenge adequate, but limited 
silicone levels to ensure extrusion performance of the piston after long-term storage. Comparable 
to a commercial bake-on siliconization process, the sprayed-on silicone emulsion was baked-on 
in a heat-tunnel. In chapter V, the impact of different burn-in times and temperatures on the 
silicone layer characteristics was investigated. In addition, the focus was set on the thermal 
decomposition of silicone and pharmaceutically relevant stabilizers of the emulsion in terms of 
weight loss, formation of cyclic low molecular weight siloxanes and change in molecular weight 
distribution of the silicone polymer. The formation of covalent bonds between silicone and the 
glass surface upon bake-on, which is postulated in literature, was functionally addressed by 
contact angle measurements. In addition, a heat-oven was assessed as an experimental model to 
mimic the heat-tunnel. 
Subsequently, the effect of different baked-on silicone levels on the particle formation in 
cartridges filled with placebo and monoclonal antibody solution was investigated (chapter VI). 
For placebo, different stresses such as cartridge expelling, shaking or a combination of both 
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factors were applied to determine the most detrimental effect on silicone leaching from the 
siliconized container surface. A toolbox of methods was employed to cover a broad aggregate 
and particle size range. Overall, the results aimed to clarify a potential impact of silicone oil 
droplets from baked-on silicone layers on protein particle formation. 
In chapter VII, the focus was set on two novel methods to characterize protein adsorption to 
silicone surfaces. The adsorption behavior of a monoclonal antibody on silicone and heat-treated 
silicone was investigated using a quartz crystal microbalance to mimic spray-on and bake-on 
siliconized drug product containers. Furthermore, fluorescence activated cell sorting using 
fluorescently labeled monoclonal antibody was introduced as promising technique to monitor 
concentration and time-dependent adsorption processes. The fluorescence activated cell sorting 
method was further challenged with focus on limitations associated with the application of 
fluorescently labeled protein species. Electrostatic and hydrophobic interactions were evaluated 
as driving forces for protein adsorption using both techniques.  
Finally, the main results were summarized in chapter VIII.  
Overall, this thesis shall highlight the complex set of parameters during the development of 
siliconized drug/device combinations products from early siliconization process set-up to final 
challenges related to drug product quality. 
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III ANALYSIS OF THIN BAKED-ON SILICONE LAYERS BY 
FOURIER TRANSFORM INFRARED SPECTROSCOPY AND 
3D-LASER SCANNING MICROSCOPY  
The following chapter is published as research article in the European Journal of Pharmaceutics 
and Biopharmaceutics: 
S. Funke, J. Matilainen, H. Nalenz, K. Bechtold-Peters, H.-C. Mahler, W. Friess. Analysis of thin 
baked-on silicone layers by FTIR and 3D-Laser Scanning Microscopy. Eur. J. Pharm. Biopharm. 
96 (2015) 304–313. © 2015 Elsevier B.V. 
KEYWORDS  
Cartridge, FTIR, 3D-laser scanning microscopy, silicone distribution, silicone layer thickness, 
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ABSTRACT 
Pre-filled syringes (PFS) and auto-injection devices with cartridges are increasingly used for 
parenteral administration. To assure functionality, silicone oil is applied to the inner surface of 
the glass barrel. Silicone oil migration into the product can be minimized by applying a thin, but 
sufficient layer of silicone oil emulsion followed by thermal bake-on versus spraying-on silicone 
oil. Silicone layers thicker than 100 nm resulting from regular spray-on siliconization can be 
characterized using interferometric profilometers. However, the analysis of thin silicone layers 
generated by bake-on siliconization is more challenging. In this paper, we have evaluated Fourier 
transform infrared (FTIR) spectroscopy after solvent extraction and a new 3D-laser scanning 
microscopy (3D-LSM) to overcome this challenge. A multi-step solvent extraction and 
subsequent FTIR spectroscopy enabled to quantify baked-on silicone levels as low as 21-325 µg 
per 5 mL cartridge. 3D-LSM was successfully established to visualize and measure baked-on 
silicone layers as thin as 10 nm. 3D-LSM was additionally used to analyze the silicone oil 
distribution within cartridges at such low levels. Both methods provided new, highly valuable 
insights to characterize the siliconization after processing, in order to achieve functionality. 
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1 INTRODUCTION 
Pre-filled syringes (PFS) and cartridges, which are usually assembled with pens and other devices 
to drug/device combination products, are increasingly used for parenteral administration, mainly 
because they are both convenient and easy-to-handle for the intended user population, such as 
health care professionals and patients. PFS and cartridges additionally assure accurate dose 
delivery and often require less overfill [1,2]. The manufacturing process comprises several unit 
operations from washing, siliconization, thermal depyrogenation to piston placing, filling, further 
assembly, labelling and packaging.  
For different aspects of such products, siliconization of the primary packaging barrel is an 
essential step. The interior of the glass barrels is lubricated to reduce the forces required to 
initiate (break-loose) and perform injection (glide), i.e., siliconization enables moving the piston 
during drug administration [3,4]. 
However, apart from the functionality of the device over the shelf life of a product, possible 
interactions of the silicone with the active ingredient (e.g., protein) and formulation (solution) 
need to be considered [5]. Silicone oil has been reported to increase turbidity and subvisible 
particle levels due to migration into protein solution [6–9]. Increased levels of spiked silicone oil 
have been shown to perturb liquid formulations of some proteins upon agitation [10,11], at 
increased temperatures [12,13] as well as upon agitation at increased temperatures [10]. 
However, there are also numerous proteins, where silicone did not impact stability. Adequate 
formulation development, e.g., the addition of surfactants, has also been reported to protect 
proteins sensitive to silicone oil from related degradation. The presence of silicone oil during 
quiescent storage at room temperature has also not resulted in protein aggregation or precipitation 
[14]. Consequently, it is required to carefully develop siliconization processes to assure 
functionality of the injection device at sufficient silicone levels, and to study product stability 
within the intended process range and design space.  
Typically, two different siliconization procedures are used for syringes. Siliconization of luer tip 
syringes is usually performed using silicone emulsion (e.g., Dow Corning 365 35 % Dimethicone 
NF Emulsion) followed by a high temperature baking process for depyrogenation. Before 
administration, a needle of choice can be attached to the luer tip. Cartridges as part of delivery 
systems are combined with separate pen needles, and can therefore be bake-on siliconized. In 
case of staked-in needles (SIN), where an adhesive (glue) is used to affix a needle into the fluid 
path, bake-on siliconization is not applicable due to the low heat resistance of the adhesive. 
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Therefore, SIN PFS are processed via spray-on siliconization using silicone oil (e.g., Dow 
Corning 360 Medical Fluid) [13,15,16]. The process step of siliconization can be performed 
either at the syringe manufacturer (suppliers) or the pharmaceutical company. Often, a bake-on 
siliconization process is performed prior to fill/finish operations during product manufacturing, 
whereas spray-on siliconization of trayed syringes is performed at the supplier. 
Relatively high silicone levels of approximately 0.2-1.0 mg/container [4,13,15,17] obtained by 
spraying-on silicone oil can be rather easily characterized. In contrast, the analysis of silicone 
levels below 0.1 mg/container [18] as often generated by bake-on siliconization, is still 
challenging with the available methods.  
A simple, though not very precise technique for silicone quantification after spray-on is a 
gravimetric approach by weighing the empty syringe before and after the siliconization process 
[15].  
Siliconization levels of glass barrel interiors and rubber closures in the range of 0.4-
1.3 mg/closure and 0.2-7.3 mg/barrel were determined using atomic absorption spectrometry 
(AAS) and inductively coupled plasma-optical emission spectrometry (ICP-OES) after solvent 
extraction [19–21]. In particular, Lankers et al. could exemplarily quantify 0.2-0.3 mg silicone 
oil/container using AAS after toluene extraction [20]. ICP-OES and AAS are considered as 
highly sensitive techniques to quantify silicone concentrations ≤ 1 µg/mL [17,19]. Reverse-phase 
high-performance liquid chromatography in combination with evaporative light scattering 
detection has been employed to quantify silicone oil in water after liquid-liquid extraction 
reaching a quantification limit of 88 µg/mL silicone oil [6]. 
Because of their sensitivity, the above-mentioned methods are suited for the quantification of low 
baked-on silicone levels. However, these methods require high technical effort. Therefore, these 
techniques are often not selected as routine methods for the quantification of low baked-on 
silicone levels. 
Colorimetric silicone determination, as used in food analysis, is based on acidic heat-induced 
sample decomposition and formation of silica, which forms a complex with ammonium 
molybdate. Silica can be quantified down to 3 µg/mL and is calculated back to silicone of a 
known molecular structure [22]. But this correlation between silica and silicone oil is prone to 
error with the complex structure of polydimethylsiloxane (PDMS) and even less suitable for the 
analysis of silicone levels after bake-on due to heat induced chemical changes of the PDMS. 
Fourier transform infrared (FTIR) spectroscopy after solvent extraction is another suitable 
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method to determine silicone levels on glass barrels and stoppers [6,17,23,24] and silicone oil in 
water emulsions after liquid-liquid extraction [14,25,26]. The extracted silicone oil is quantified 
via the intensity of the characteristic Si–CH3 band at 1260 cm
-1
 [27,28]. FTIR achieves 
quantification limits of 0.2 µg/mL [29], simple potassium bromide or calcium fluoride cells are 
used and above all, it is a fast technique. Although described only for spray-on siliconized 
containers in the literature up to now, it offers great potential also for the quantification of baked-
on silicone layers. In addition, Mundry suggested a correlation between the intensity of individual 
absorption bands in FTIR versus molecular weight and viscosity, respectively [30]. 
The qualitative silicone distribution can be visualized by glass and talcum dust tests, optical 
microscopy and schlieren visualization (e.g., commercially available from ZebraScience, Inc., 
Temecula, USA). Glass and talcum powders or suspensions stick to glass surfaces, which have 
been coated with sprayed-on or baked-on silicone. Non-siliconized glass areas can be identified; 
however, the results are rather subjective. Furthermore, silicone amount and silicone layer 
homogeneity cannot be determined [15,20,31]. 
Thick silicone layers usually show plaque-like structures, which can be visualized by optical 
microscopy [20,32]. In contrast, thin baked-on silicone layers cannot be visualized by simple 
optical microscopy.  
Schlieren visualization observes the optical inhomogeneity along the silicone coated container 
based on the differences in the refractive indices (RI) of silicone oil (RI app. 1.40 [33]) and the 
borosilicate glass matrix (RI app. 1.49 [34]). When passing inhomogeneous media, light refracts 
and deflects, resulting in schlieren, which are not visible to the eye. The glass container is placed 
between a digital microscope equipped with a microscopic lens and a zebra strip pattern in front 
of a back light. Side light is used to illuminate small areas of the syringe. A two-axis motion 
system moves the syringe in order to visualize the entire glass barrel. In filled containers, high 
levels of spray-on silicone lead to micron-sized droplets upon contact with aqueous media. 
Schlieren visualization tracks these droplets, and thus provides fast qualitative information about 
the silicone distribution [31,32]. Thin baked-on silicone layers, however, do not form large 
silicone droplets upon contact with aqueous media, therefore, they are hardly accessible by 
schlieren visualization.  
Eu et al. showed the direct visualization of protein adsorption on non-siliconized container 
surfaces by gold nanoparticles [35]. Therefore, gold nanoparticles are only suitable to indirectly 
visualize the silicone distribution. 
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Semi-quantitative information about the layer thickness can be obtained by interferometric 
profilometers using vertical scanning interferometry (VSI) with white light (commercially 
available as Layer Explorer, rap.ID Particle Systems GmbH, Berlin, Germany). Interference 
reflection spectroscopy is also based on the difference in RI of silicone oil and the glass matrix. 
Since this delta is small, VSI achieves a theoretical detection limit of 80 nm [36], but silicone 
layers below 100 nm have only been exemplarily determined with this method in the literature 
[17,20,37]. For sprayed-on silicone layers above 100 nm, VSI is a reliable, fast and non-
destructive method, which scans the container barrel line-by-line [17,20,31,32,37]. The use of 
phase shift interferometry of a red laser beam to determine thin silicone layers down to 20 nm has 
been claimed [38], but no data have been published yet. 
As an alternative, thin films can be studied by ellipsometry. Based on the change in the state of 
polarization of light upon reflection from a surface, ellipsometry is an accurate technique for thin 
films of known RI deposited on substrates with high reflectance such as metals. Barium fluoride 
layers on chromium ferrotype surfaces in the range of approximately 630-680 Å and fibrinogen 
layers adsorbed on hydrophobic and hydrophilic chromium surfaces as thin as 15 Å have been 
characterized by ellipsometry. Silicone coatings deposited onto polycarbonate have been 
determined in the range of 250-1500 nm. The sensitivity of this technique to surface coatings 
decreases with decreasing difference in RI between the coating and the substrate [39], and 
therefore, thin silicone layers on glass substrates are hardly accessible. 
Scanning electron microscopy has been utilized to characterize film thicknesses in the lower µm-
range, but requires a tedious preparation of perpendicular cross sections, which are mounted face-
up for analysis. Metal or carbon sputtering of the probes, which has to be applied for sample 
preparation, and artifacts caused by vacuum, can additionally alter the measured layer thickness 
[40,41]. 
Furthermore, time-of-flight secondary ion mass spectrometry (ToF SIMS) has been performed to 
determine the lubricant thickness of cross-linked XSi
TM
 siliconized and spray-on siliconized 
syringes in the range of 10-250 nm [37]. 
In summary, high levels of effort in sample preparation and analysis, insufficient detection limits 
as well as the optical properties of siliconized glass surfaces exclude the discussed methods to 
routinely characterize and measure the thickness of thin baked-on silicone layers. 
The objective of this study was to develop a silicone extraction and FTIR quantification method 
to characterize baked-on silicone layers with low quantification limits. In addition, 3D laser 
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scanning microscopy (3D-LSM) was evaluated as a novel analytical technique for both 
qualitative visual evaluation of silicone layers with high resolution and the determination of the 
thickness of thin baked-on silicone layers. 3D-LSM was compared with Atomic Force 
Microscopy (AFM) and step height standards to further assess its potential to visualize and 
quantify very thin silicone layers on glass. Advancing further techniques for the characterization 
of silicone layers improve process understanding, and thus increase reliability in process design 
and functionality of drug/device combination products.  
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
365 35 % Dimethicone NF Emulsion was purchased from Dow Corning GmbH (Wiesbaden, 
Germany). Dilutions were prepared with highly purified water. Cartridges with 5 mL barrels 
(barrel length 32 mm, inner diameter 19 mm, outer diameter 22 mm) were obtained from F. 
Hoffmann-La Roche Ltd (Basel, Switzerland). 
2.2 BAKE-ON SILICONIZATION PROCESS 
An external mixing, two-fluid nozzle was employed to nebulize 365 Dimethicone NF Emulsion 
on a SVS9061 pilot-scale unit from Bausch + Ströbel Maschinenfabrik Ilshofen GmbH+Co. KG 
(Ilshofen, Germany) into 5 mL cartridges. A spray quantity of 16 mg was maintained using a 
high precision rotary piston pump with a gliding disk from Saphirwerk AG (Brügg, Switzerland). 
Emulsion concentrations ranging from 0.35 % (w/w) to 3.5 % (w/w) were prepared by weighing 
on an analytical balance AT261 and precision balance PM-4000 both from Mettler-Toledo 
GmbH (Gießen, Germany). The cartridges were subsequently treated in a Bosch TSQ U03 heat-
tunnel (Robert Bosch GmbH, Stuttgart, Germany) at 316 °C for 12 min.  
2.3 EXTRACTION AND FOURIER TRANSFORM INFRARED (FTIR) 
QUANTIFICATION  
The silicone content in baked-on siliconized cartridges was determined by a combination of 
solvent extraction and quantitative FTIR spectroscopy (Fig. III-1). 
 
Fig. III-1. Multi-step scheme for the extraction and FTIR quantification of baked-on silicone oil. 
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The siliconized cartridges were closed using a rubber stopper at the needle-side and a second, 
non-siliconized cartridge containing a placed piston. A rubber seal was used to closely fasten 
both cartridges at the flange-side. The non-siliconized cartridge, the piston, and the rubber seal 
had been previously washed. Silicone oil was extracted from the siliconized cartridge interior 
barrel into 900 µL heptane under horizontal rotation at 50 rpm for 10 min. Two rinsing steps 
were performed using 900 µL heptane. The solvent extracts were combined in a 2R vial and 
heptane was evaporated to dryness using a flowtherm evaporator at 100 °C and constant nitrogen 
flow of 210 mL/min from Barkey GmbH & Co. KG (Leopoldshöhe, Germany). The dried extract 
was redissolved in 250 µL heptane. This solution was injected into a 250 µm path length FTIR 
calcium fluoride liquid cell from Bruker Optik GmbH (Ettlingen, Germany). 
PDMS was quantified as area under the curve (AUC) of the transmittance spectrum between 
1280 cm
-1
 and 1244 cm
-1
 (PDMS has a characteristic transmittance at 1260 cm
-1
 due to the 
symmetric deformation vibration of the Si-CH3 moieties [27]) using a Tensor 27 FTIR equipped 
with a high sensitivity broad-band mercury cadmium telluride detector from Bruker Optik GmbH 
(Ettlingen, Germany) (Fig. III-2a). High resolution of 4 cm
-1
 and 64 scans were used. Prior to 
each sample, the same number of background scans was performed using heptane. Silicone oil 
solutions in heptane ranging from 0.025 mg/mL to 1.0 mg/mL were used for calibration (Fig. 
III-2b).  
a. 
 
b. 
 
Fig. III-2. Analysis of silicone oil solutions in heptane by FTIR. (a) Infrared transmittance spectra of silicone oil in 
heptane solutions (0.025-1.0 mg/mL, individual heptane blanks subtracted). (b) Silicone oil concentration standard 
curves (R
2
 = 0.994-0.999). 
According to considerations provided in ICH Q2 R1 Validation Analytical Procedure, the limit of 
detection (LOD) of the developed FTIR method was found to be below 1 µg/mL (number of 
calibration curves n = 22). The limit of quantification (LOQ) was 18 µg/mL (n = 22), equivalent 
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to 4 µg per cartridge based on 250 µL dissolution volume. 
A second solvent extraction of a baked-on siliconized cartridge (202 µg ± 12 µg) was performed 
as described above (900 µL heptane, two rinsing steps à 900 µL). Analysis of this second solvent 
extract revealed silicone concentrations below LOQ. Thus, one solvent extraction employing 
three solvent steps with heptane was sufficient for quantitative silicone recovery from the baked-
on silicone layer.  
For a second recovery experiment, 2 mL of a 0.025 mg/mL and 0.05 mg/mL silicone solution in 
heptane, respectively, were filled into non-siliconized cartridges. Horizontal rotation, rinsing 
steps, solvent evaporation, and FTIR quantification were performed as previously described. The 
spiked in heptane solutions containing 50 µg and 100 µg silicone oil were recovered with 
95 ± 3 % and 105 ± 3 %, respectively.  
2.4 3D-LASER SCANNING MICROSCOPY (3D-LSM) 
The silicone layer thickness was determined using a VK-X210 microscope from Keyence 
Deutschland GmbH (Neu-Isenburg, Germany). 3D-LSM allowed height measurements based on 
confocal profiling. The sample was scanned in vertical steps of 0.5 nm so that each point of the 
sample passed the focus of the laser (λ 408 nm). The height of the surface at each point was 
determined by detecting the position of the peak maximum of the axial reflectance response in a 
16-Bit photomultiplier. In addition to conventional lenses, the microscope was equipped with an 
ultra-long range objective (working distance 4.7 mm, magnification 100 x) to facilitate height 
measurements of curved samples.  
Cartridges were covered with adhesive tape, broken up and individual fragments were removed 
from the adhesive tape to enable direct measurements of the thin baked-on silicone layer. 
Breakage as performed by our procedure did not substantially change the silicone layer. Cartridge 
fragments from the flange, middle and top of the cartridge were analyzed to determine the 
silicone distribution within the barrel.  
An artificial glass baseline was created by scratching a 20 G cannula from B. Braun Melsungen 
AG (Melsungen, Germany) over the glass surface to remove the silicone layer. Thicker, partially 
fluid silicone layers may blur out the baseline over time. With regard to thin, baked-on silicone 
layers, scratching was the best method possible to create a straight, defined baseline with a steep 
slope compared to the silicone layer. Although we never observed any change or disappearance 
of the scratch over time, the time between scratching and measurement was kept as short as 
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possible, i.e., not more than 1 min. 
Height profile measurements of 100 µm x 143 µm cartridge areas were performed using VK 
Viewer Software from Keyence (Deutschland GmbH, Neu-Isenburg, Germany) in EasyMode. 
VK Analyzer Software from Keyence Deutschland GmbH (Neu-Isenburg, Germany) was utilized 
to determine the average layer thickness (ALT) as the difference in the average height between 
the glass surface and the silicone layer in multi-line average profile (400 lines) after area and line 
tilt correction (2
nd
 curved line and area auto, respectively).  
The 3D-LSM measurements were compared with step height standards from John P. Kummer 
GmbH (Augsburg, Germany) of 17.3 ± 1.6 nm and 89.4 ± 1.2 nm chrome coating on a quartz 
substrate. The height of the step was measured in Easy Mode by VK Viewer software and 
calculated as the difference between the average height along the base of the step and the top of 
the step in multi-line average profile (200 lines) using VK Analyzer software. At 10 x 
magnification the tilt of the quartz substrate was leveled using automatic area and line plane 
correction.  
To confirm the 3D-LSM measurements, a theoretical average layer thickness was calculated from 
the silicone level quantified via FTIR applying a silicone density of 0.972 g/cm
3
 [33] and a 
cartridge interior surface of 2422 mm
2
.  
Both the integrated optical microscope and 3D-LSM images were additionally employed to 
visualize the distribution of the silicone within an intact cartridge. Lower magnification (10 x) 
was used to visualize larger cartridge areas of 1.2 mm x 0.5 mm. 
2.5 ATOMIC FORCE MICROSCOPY (AFM)  
AFM was performed on a NSCRIPTOR™ DPN
®
 System from NanoInk Inc. (Candor, NY, 
USA). Samples were measured in tapping mode using rectangular, silicon cantilevers with highly 
doped single crystal silicon probes from Applied NanoStuctures Inc. (Mountain View, CA, 
USA), having a nominal resonant frequency of 300 kHz, a nominal spring constant of 37 N/m 
and a guaranteed tip radius below 10 nm. Cartridge fragments were prepared as previously 
described. Forward and reverse scans of 30 µm x 30 μm cartridge areas were performed. The 
ALT was determined as the difference between horizontal lines, i.e., the glass surface and the 
silicone layer, after profile extraction of 110 px multi-lines and tilt correction by mean plane 
subtraction using Gwyddion Software 2.34. (free software, development is supported by the 
Czech Metrology Institute: http://www.cmi.cz/distance) (supporting information Fig. S III-1). 
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2.6 EXTRUSION FORCE MEASUREMENTS 
To assess device functionality, break-loose forces, maximum and minimum gliding forces were 
analyzed using a material testing instrument TA.XT.plus from Winopal Forschungsbedarf GmbH 
(Elze, Germany). A piston was inserted manually into the empty, siliconized cartridge prior to 
filling with 5.16 mL purified water. After stoppering and capping, the cartridge was emptied by 
pushing down the piston using a steady compression rate of 5.6 mm/min over a distance of 
17.5 mm. The barrel length was approximately 32 mm and the “height” of the cartridge shoulder 
was approximately 5 mm. Therefore, the maximum travel distance for the 20 mm piston was 
approximately 17 mm, which was reflected in the chosen measurement set-up. Consequently, the 
entire cartridge barrel was tested.  
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3 RESULTS AND DISCUSSION 
3.1 SILICONE LEVELS IN BAKED-ON SILICONIZED CARTRIDGES 
The silicone levels in baked-on siliconized cartridges were determined using FTIR. For the FTIR 
method, a LOQ of 18 µg/mL, equivalent to 4 µg silicone per cartridge, was found. With 
increasing silicone oil emulsion concentrations ranging from 0.35 % (w/w) to 3.5 % (w/w) the 
amount of baked-on silicone increased steadily from 21 µg to 325 µg per cartridge (Fig. III-3).  
 
Fig. III-3. Silicone levels (n = 3) after bake-on siliconization using a spray quantity of 16 mg. 
FTIR has already been employed for the trace analysis of silicone oil in food (e.g., pineapple 
juice, beer and yeast) with a recommended final concentration of at least 50 µg/mL silicone in the 
solvent solution [22]. After optimized solvent extraction and complex sample preparation 
including the removal of interfering components, an improved sensitivity of 0.2-2 µg/mL could 
be achieved using potassium bromide disks [29]. For pharmaceutical applications, FTIR has been 
utilized to determine silicone amounts of 219 µg on glass barrels [17], down to 4 µg/mL and in 
the range of 25-75 µg on stoppers [17,23], respectively. However, comparison of silicone 
amounts determined in this study and in the literature is aggravated since most method details, 
LOD and LOQ are not described [6,17,23]. For quantification of silicone oil in aqueous 
emulsions by FTIR after liquid-liquid extraction [14,25,26], a LOD of 80 µg/mL and a LOQ of 
190 µg/mL have been reported [26].  
In our work, we found good reproducibility, accuracy (spike recoveries were 95–105 %) and 
better sensitivity (LOD < 1 µg/mL, LOQ = 18 µg/mL) compared to the literature. The simple 
extraction process and fast extract analysis by FTIR spectroscopy using a liquid cell appear to be 
valuable tools for the determination of silicone levels below 0.1 mg/container as present in bake-
on siliconization processes [18] and for sprayed-on silicone levels of approximately 0.2-
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1.0 mg/container [4,13,15,17]. The quantification of the silicone levels within certain cartridge 
sections can also help to understand changes in extrusion, such as plunger sticking or so called 
“chattering” [4]. 
In addition to the silicone levels, the corresponding break-loose forces as well as the maximum 
and minimum gliding forces were analyzed. Reliable functionality over the product shelf life is 
one of the most important measurable outputs of a drug/device combination product. Depending 
on the combination product, injection forces are limited by patient´s strength or by an internal 
spring mechanism. The mean break-loose and gliding forces remained well below 30 N and 15 N, 
respectively, as reference values in this study. But still, both break-loose and gliding forces have 
to be carefully evaluated for each injection device. However, in other studies maximum forces 
were fixed at 30 N [42] and patient-friendly injection was reported with gliding forces up to 15-
20 N [43]. Another study showed that rheumatoid arthritis patients could exert maximum forces 
up to 45 N [44]. Thus, functionality of the device was maintained for all siliconization conditions 
tested. The break-loose forces marginally increased from 3 N, achieved using a silicone 
concentration of 1.75 % (w/w) and 3.5 % (w/w), to 4.5-5 N after application of emulsions with 
lower silicone concentrations. A similar trend was observed in the gliding forces, which increased 
from 2-3 N to 3-5.5 N. The exemplarily shown force profiles for the lowest concentration of 
0.35 % (w/w) and the highest concentration of 3.5 % (w/w) indicated a smooth gliding of the 
piston along the cartridge barrel (Fig. III-4).  
 
Fig. III-4. Exemplary extrusion force profiles after bake-on siliconization using a spray quantity of 16 mg and 
0.35 % (w/w) and 3.5 % (w/w) emulsion. 
The gliding forces slightly increased toward the top of the cartridge. A comprehensive study of 
the impact of spray parameters on the spray pattern of the silicone emulsion and silicone layer 
characteristics, e.g., extrusion performance, baked-on silicone levels and layer thickness 
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distribution along the cartridge barrel, are presented in chapter IV. 
3.2 SILICONE LAYER SURFACE AND DISTRIBUTION 
Optical microscopy can be used to visualize the surface of sprayed-on silicone layers, which were 
reported to show plaque-like and micro-droplet structures surrounded by a thin film layer 
[20,32,37]. These structures obtained by silicone fluid can be related to models that describe the 
wetting of polymers on solid surfaces with spherical capped droplets as a set of horizontal layers 
in parallel to a precursor film in front of the drop [45,46]. Micro-droplets are visible due to the 
high contrast and colored interference rings. Optical microscopy, however, failed to visualize thin 
baked-on silicone layers even at the highest emulsion concentration tested in our study of 
3.5 % (w/w). These thin baked-on layers only exhibited a homogeneous purplish texture without 
any plaques or droplets (Fig. III-5a). 
On the contrary, 3D-LSM revealed the surface characteristics of the baked-on silicone layers and 
the differences over the barrel after preparation from silicone emulsion concentrations from 
0.6 % (w/w) to 3.5 % (w/w) (Fig. III-5b). 3D-LSM images were similar for triplicates. However, 
at an emulsion concentration of 0.35 % (w/w) the silicone layer was too thin to be visualized, 
even by 3D-LSM.  
Within the analyzed cartridge areas of 1.2 mm x 0.5 mm the baked-on silicone layer was 
homogeneously distributed. From flange to top, 3D-LSM suggested thinner silicone layers in the 
middle and at the top of the cartridge. The more pronounced siliconization at the flange was 
attributed to the applied nozzle-to-flange distance of 20 mm, where the spray cone exactly 
reached the flange (see chapter IV).  
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a. 
 
 
b. 
 
Fig. III-5. Silicone layer after bake-on siliconization (16 mg of a 0.35-3.5 % (w/w) emulsion) at various positions. 
(a) Optical microscopy, 10 x magnification. (b) 3D-LSM, 10 x magnification. 
Thus, 3D-LSM imaging was successfully established to visualize thin baked-on silicone layers 
and to track even minor difference in the visual appearance of the silicone surface using intact 
cartridges. The images can be utilized to investigate the distribution of thin baked-on silicone 
layers in different sections within the cartridges. Consequently, 3D-LSM imaging is a new, non-
destructive, highly sensitive and fast technique to visualize and investigate thin baked-on silicone 
layers, which so far were not accessible with optical microscopy. 
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3.3 SILICONE LAYER THICKNESS AND DISTRIBUTION 
 ESTABLISHMENT OF 3D-LSM TO DETERMINE THIN SILICONE 3.3.1
LAYERS 
In addition to the visual appearance as determined by 3D-LSM imaging, the thickness of the 
baked-on silicone layers was determined by 3D-LSM height measurements. To qualify 
measurements of the silicone layer thickness by 3D-LSM, a comparison with chrome-coated step 
height standards was performed. The measured ALT was comparable to the certified heights of 
17.3 ± 1.6 nm and 89.4 ± 1.2 nm (the accuracy was 88-110 %) (Tab. III-1; supporting 
information Fig. S III-2).  
100 x magnification, which has been further used for layer thickness determinations in baked-on 
siliconized cartridges, precisely measured the theoretical values with a standard deviation of 
approximately 2-3 nm. 
Tab. III-1. Measured ALT (n = 6) of step height standards compared to certified values of 17.3 ± 1.6 nm and 
89.4 ± 1.2 nm. 
Certified height [nm] Magnification Average layer thickness [nm] Accuracy [%] 
17.3 ± 1.6 
100 x 19.0 ± 1.8 110 
10 x 16.5 ± 4.4 95 
89.4 ± 1.2 
100 x 79.6 ± 2.8 89 
10 x 78.3 ± 7.7 88 
 
Therefore, the lower detection limit for silicone layers was further challenged. Fig. III-6 
exemplarily shows the surfaces and the respective multi-line average height profiles of silicone 
layers of approximately 10 nm, 20 nm and 50-60 nm thickness. 
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a. 
 
d. 
 
b. 
 
 
e. 
 
c. 
 
 
f. 
 
Fig. III-6. Analysis of ALT by 3D-LSM. Determination of the detection limit. 3D-LSM image of the analyzed 
cartridge section (100 µm x 143 µm). (a) 3D-LSM image ALT of approximately 10 nm. (b) 3D-LSM image ALT of 
approximately 20 nm. (c) 3D-LSM image ALT of approximately 60 nm. Respective multi-line average height profile 
of 400 individual profile lines after area and line tilt correction (2
nd
 curved line and area auto, respectively) of an 
100 µm x 143 µm cartridge section. The average silicone layer thickness was calculated as the difference in the 
average height between the glass surface and the silicone layer as indicated by the lined boxes. (d) Multi-line average 
height profile of approximately 10 nm. (e) Multi-line average height profile of approximately 20 nm. (f) Multi-line 
average height profile of approximately 60 nm.  
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Due to the preparation method, the height profiles showed a negative step, where the silicone 
layer had been artificially removed by a 20 G cannula. By this scratching the silicone layer was 
not only removed from the glass surface, but rather pushed aside by the cannula, which resulted 
in thicker silicone build-ups next to the baseline. These artificial builds-ups were not considered 
for the silicone layer thickness determinations. Silicone layers of approximately 50-60 nm and 
20 nm showed a distinct height difference compared to the negative glass baseline. The height 
profile of 10 nm baked-on silicone layers could still be analyzed, but demonstrated substantial 
noise. The use of 3D-LSM for quantitative evaluation of silicone layers thinner than 10 nm 
cannot be recommended. 
In contrast, an interferometric profilometer using VSI with white light, which is most commonly 
utilized for silicone layer thickness determinations [17,20,32,37], only achieves a theoretical 
detection limit of 80 nm [36]. It suffers from the poor difference in the RI of silicone (1.40) [33] 
and borosilicate glass (1.49) [34]. Compared to interferometry, 3D-LSM height measurements 
required a destructive sample preparation, but achieved a better sensitivity. 
The ALT of silicone layers prepared from 1.75 % (w/w) silicone emulsion was further evaluated 
at four different radial directions (0°, 90°, 180°, 270°) along three sections of the cartridge barrel 
(flange, middle, top). Three cartridges were selected (n1, n2, n3) (Fig. III-7).  
 
Fig. III-7. Silicone layer thickness after bake-on siliconization using 16 mg of a 1.75 % (w/w) emulsion. Layer 
thickness was evaluated at four radial directions in three sections within the cartridge barrel (n = 3, * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.001). 
The mean silicone layer thickness decreased significantly from 58 ± 11 nm to 29 ± 9 nm from the 
flange to the top of the cartridge. The more pronounced siliconization at the flange was attributed 
to the applied nozzle-to-flange distance of 20 mm, where the spray cone exactly reached the 
flange middle top
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flange (see chapter IV). The 3D-LSM height measurements thus confirmed the results from the 
visual appearance of the surface as observed in the 3D-LSM images. The ALTs varied 10-30 nm 
depending on the radial direction measured. Thus, to track the radial silicone distribution along 
the cartridge barrel, it is recommended to measure a set of at least four different radial directions.  
Overall, based on our results, we consider 3D-LSM a valuable tool to investigate the effects of 
different spray parameters on the radial silicone layer distribution and to evaluate silicone 
redistributions during storage, as relevant for spray-on siliconized glass barrels [20]. However, 
the technique requires sophisticated software handling due to the curvature of the sample. The 
total measurement time including sample preparation, height measurements and data analysis 
takes approximately 5 min. In particular, full cartridge mapping in 3D-LSM is labor-intensive 
and time-consuming as the cartridge fragments need to be carefully selected after breakage. In 
contrast, VSI facilitates in-situ thickness measurements of usually one to six radial lines with a 
spot distance of 1 mm along the barrel length and requires only seconds per measurement 
[20,36]. Consequently, interferometric profilometers offer more convenient mapping of 
siliconization, but with far less sensitivity.  
To further assess the suitability of 3D-LSM, layer thicknesses were exemplarily determined using 
AFM for comparison (Tab. III-2).  
Tab. III-2. Silicone layer thickness after bake-on siliconization using 16 mg of a 1.75 % (w/w) emulsion 
a
. 
Cartridge section ALT (3D-LSM) ALT (AFM) ALT (theoretical) 
Flange 57 ± 11 nm 57 ± 7 nm  
Middle 42 ± 15 nm 56 ± 8 nm 68 ± 5 nm 
Top 29 ± 9 nm 47 ± 9 nm  
a ALT was calculated as the mean from individual layer thicknesses at four different radial directions along three sections of the 
cartridge barrel (n = 3) in 3D-LSM. In AFM, ALT was calculated as the mean from the layer height of the forward and reverse 
scan (n = 1). The mean theoretical silicone layer thickness derived from the silicone level quantified via FTIR applying a silicone 
density of 0.972 g/cm3 [33] and a cartridge interior surface of 2422 mm2. 
 
The mean layer thickness values obtained by 3D-LSM were in good agreement with the layer 
thickness values determined by AFM in the middle and flange region of the cartridge barrel. A 
significant difference was observed at the top (p ≤ 0.05). 3D-LSM mean layer thickness results 
were derived from cartridge mapping at four radial directions using three different cartridges, 
whereas AFM was based on single measurements in forward and reverse scan, which puts the 
results in perspective. In addition, AFM is based on mechanical profiling using an oscillating 
probe in tapping mode, whereas 3D-LSM is an optical profiler. However, 3D-LSM stood out 
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with its higher throughput and high-resolution images. Furthermore, 3D-LSM offered contact-
free profiling, which is in particular suitable for soft, flexible silicone layers. We therefore 
believe that 3D-LSM is a suitable method to determine thin, baked-on silicone layers. 
 THICKNESS AND DISTRIBUTION OF THIN BAKED-ON SILICONE 3.3.2
LAYERS 
To investigate the silicone distribution after bake-on siliconization using different emulsion 
concentrations (0.35-3.5 % (w/w)), cartridge fragments were randomly collected from different 
radial directions, assuming that each radial directions was selected at least once and to simplify 
the analytical process. Silicone layers obtained from 0.35 % (w/w) emulsion reached the LOQ of 
10 nm. With increasing emulsion concentrations of 0.6 % (w/w) to 1.75 % (w/w) the ALT 
increased from 20 nm to 70-80 nm (Fig. III-8).  
 
Fig. III-8.ALT after bake-on siliconization using 16 mg. Layer thickness was evaluated at one radial direction in 
three sections within the cartridge barrel (n = 3, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). 
The middle and top sections of the cartridges exhibited a reduced ALT compared to the flange, 
which can be attributed to the spray position of 20 mm below the flange. These quantitative data 
appeared to be consistent with the results obtained from 3D-LSM imaging, which also showed a 
decrease in siliconization from the flange to the top (Fig. III-5). 
The theoretical layer thicknesses ranged from 9 ± 2 nm to 139 ± 29 nm with increasing emulsion 
concentrations. These numbers were systematically higher compared to the measured ALTs at the 
cartridge top and middle, whereas they were in good agreement with the measured ALT at the 
flange. Calculations of the mean theoretical layer thickness were based on the assumption of an 
ideally distributed homogeneous silicone layer within the entire cartridge barrel. Inhomogeneities 
in the silicone oil distribution from the flange to the top as observed in the 3D-LSM imaging can 
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explain the slight differences between the theoretical and measured silicone layer thicknesses. 
In contrast, Wen et al. reported a factor of two between the median layer thickness of 200 nm as 
obtained by VSI and the theoretical layer thickness of 430 nm. They refer this to an even more 
pronounced inhomogeneous silicone distribution, which is also reflected in the layer thicknesses 
ranging from 100 nm to 700 nm [32]. Lankers converted the silicone layer thicknesses obtained 
from VSI into theoretical silicone contents. The obtained values systematically deviated from 
silicone quantification by AAS analysis following toluene extraction. The sprayed-on silicone 
layers also depicted plaque-like structures [20]. 
The thickness of sprayed-on and cross-linked silicone layers was reported in the range of roughly 
50-400 nm with some areas up to 900 nm thickness as determined by VSI [17,20,32,37]. To our  
knowledge, baked-on silicone layers of approximately 50-100 nm were only exemplarily 
determined using VSI [20]. ToF SIMS was also employed to determine the thickness of sprayed-
on silicone layers in the range of 17 nm to 47 nm. It additionally facilitates to identify different 
silicone species in cross-linked silicone layers [37], but due to the intensive sample preparation, 
difficult measurement procedures and data analysis it cannot be considered a routine method. In 
contrast, 3D-LSM combined both, an acceptable measurement time of 5 min per sample and a 
highly sensitive detection limit as low as 10 nm.  
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4 CONCLUSION 
Baked-on siliconized cartridges were examined using FTIR spectroscopy after solvent extraction 
to quantify the baked-on silicone levels. 3D-LSM was utilized to determine the distribution and 
thickness of the baked-on silicone layer quantitatively as well as visually.  
The baked-on silicone level increased from 21 µg to 325 µg with increasing concentrations of the 
silicone oil emulsion from 0.35 % (w/w) to 3.5 % (w/w). FTIR spectroscopy showed a good 
linear response and excellent sensitivity below 1 µg/mL and a LOQ of 18 µg/mL silicone oil in 
the extract corresponding to 4 µg per cartridge. Simultaneously, the ALT increased from 
approximately 10 nm to 70-80 nm. 3D-LSM imaging visualized the concentration-dependent 
change in the silicone surface structure. A decreased layer thickness toward the top of the 
cartridge was visualized in 3D-LSM imaging and was similarly observed in the ALT 
measurements. It was attributed to the spray position of 20 mm below the flange, where the spray 
cone exactly reached the flange (see chapter IV). 3D-LSM is a highly sensitive technique to 
visualize and determine thin baked-on silicone layers below 100 nm.  
Future work aims toward investigating the link between the applied siliconization parameters and 
the silicone distribution within the cartridge barrel. An improved characterization of the silicone 
distribution and a sensitive quantification of the silicone levels may allow further optimization of 
siliconization processes.  
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5 SUPPORTING INFORMATION  
a. 
 
b. 
 
Fig. S III-1. Analysis of ALT by AFM. (a) Exemplary AFM image of an analyzed cartridge section 
(30 µm x 30 µm). Line depicts the 110 px multi-line average height profile. (b) 110 px multi-line average height 
profile. The ALT was determined as the difference between horizontal lines, i.e., the glass surface and the silicone 
layer, after profile extraction of 110 px multi-lines and tilt correction by mean plane subtraction.  
a. 
 
b. 
 
Fig. S III-2.Analysis of ALT of 17.3 ± 1.6 nm step height standards by 3D-LSM. Multi-line average height profile of 
200 individual profile lines. The ALT was calculated as the difference between the average height along the base of 
the step and the top of the step as indicated by the lined boxes. (a) 10 x magnification. At 10 x magnification the tilt 
of the quartz substrate was leveled using automatic area and line plane correction. (b) 100 x magnification.  
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6 ABBREVIATIONS 
3D-LSM 3D-laser scanning microscopy;  
AAS Atomic absorption spectrometry;  
AFM Atomic force microscopy 
ALT Average layer thickness 
AUC Area under the curve 
FTIR Fourier transform infrared (spectroscopy) 
ICP-OES Inductively coupled plasma optical emission spectrometry 
LOD Limit of detection 
LOQ Limit of quantification 
PDMS Polydimethylsiloxane 
PFS Pre-filled syringes 
RI Refractive index 
SIN Staked-in needle 
ToF SIMS Time-of-flight secondary ion mass spectrometry 
VSI Vertical scanning interferometry 
XSi
TM
 Cross-linked silicone layer, prepared by proprietary treatment of Becton-
Dickinson 
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IV OPTIMIZATION OF THE BAKE-ON SILICONIZATION OF 
CARTRIDGES. PART I: OPTIMIZATION OF SPRAY-ON 
PARAMETERS 
Parts of the following chapter are published as research article in the European Journal of 
Pharmaceutics and Biopharmaceutics: 
S. Funke, J. Matilainen, H. Nalenz, K. Bechtold-Peters, H.-C. Mahler, W. Friess. Optimization of 
the Bake-On Siliconization Process of Cartridges. Part I: Optimization of Spray-On Parameters. 
Eur. J. Pharm. Biopharm 104 (2016) 200–215. © 2016 Elsevier B.V. 
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ABSTRACT  
Biopharmaceutical products are increasingly commercialized as drug/device combinations to 
enable self-administration. Siliconization of the inner syringe/cartridge glass barrel for adequate 
functionality is either performed at the supplier or drug product manufacturing site. Yet, 
siliconization processes are often insufficiently investigated. In this study, an optimized bake-on 
siliconization process for cartridges using a pilot-scale siliconization unit was developed. The 
following process parameters were investigated: spray quantity, nozzle position, spray pressure, 
time for pump dosing and the silicone emulsion concentration. 
A spray quantity of 4 mg emulsion showed best, immediate atomization into a fine spray. 16 and 
29 mg emulsion, hence 4 to 7-times the spray volume, first generated an emulsion jet before 
atomization was achieved. The poor atomization of higher quantities correlated with an increased 
spray loss and inhomogeneous silicone distribution, e.g., due to runlets forming build-ups at the 
cartridge lower edge and depositing on the star wheel. A prolonged time for pump dosing of 
175 ms led to a more intensive, long-lasting spray compared to 60 ms as anticipated from a 
higher air-to-liquid ratio. A higher spray pressure of 2.5 bar did not improve atomization but led 
to an increased spray loss. At a 20 mm nozzle-to-flange distance the spray cone exactly reached 
the cartridge flange, which was optimal for thicker silicone layers at the flange to ease piston 
break-loose. Initially, 10 µg silicone was sufficient for adequate extrusion in filled cartridges. 
However, both maximum break-loose and gliding forces in filled cartridges gradually increased 
from 5-8 N to 21-22 N upon 80 weeks of storage at room temperature. The increase for a 30 µg 
silicone level from 3-6 N to 10-12 N was moderate. Overall, the study provides a comprehensive 
insight into critical process parameters during the initial spray-on process and the impact of these 
parameters on the characteristics of the silicone layer, also in context of long-term product 
storage. The presented experimental toolbox may be utilized for development or evaluation of 
siliconization processes. 
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1 INTRODUCTION 
Pre-filled syringes (PFS) and drug/device combination products equipped with cartridges are 
increasingly used to enable self-administration of parenteral medications. They are safe, less 
prone to contamination, user-friendly and often require less overfill [1–5]. 
Usually, the primary container is lubricated with silicone oil to reduce the friction between the 
container wall and the piston, which in turn facilitates good injectability, function and reliable 
dosage with sufficient precision during injection [6–8]. Of note, functionality is still one of the 
major concerns for drug/device combination products [9,10]. 
Siliconization is an established unit operation. Typically, two different siliconization procedures 
are used referred to as spray-on and bake-on siliconization [11,12]. 
Staked-in needle syringes, where an adhesive (glue) is used to embed a needle into the fluid path, 
are processed via spray-on siliconization using silicone oil. Bake-on siliconization, however, is 
not applicable to staked-in needle PFS due to the low heat resistance of the adhesive (glue) 
needed to fix the needle into the fluid path. Polydimethylsiloxanes, e.g., Dow Corning 360 
Medical Fluid [13] with viscosities ranging from about 1000 cSt [14] to 12500 cSt [15], is most 
commonly applied as lubricant, but other linear or branched polydialkysiloxanes such as 
polydipropylsiloxane, polydihexylsiloxane are possible alternatives [15]. Due to the viscosity of 
silicone oil, it may be difficult to precisely deliver a small amount of the lubricant [16]. Spray-on 
silicone layers exhibit individual plaque-like and micro-droplet structures [9,17,18] and an 
uniform homogeneous coating is most likely not readily formed [19]. Therefore, in spray-on 
siliconization processes most commonly higher silicone levels of 0.2-1 mg/barrel are applied 
[8,13,16–18,20–23] compared to < 0.1 mg/barrel for bake-on siliconization processes, where heat 
promotes the formation of a homogeneous silicone layer [20,24,25]. To overcome these 
drawbacks, silicone oil could be applied as a mixture with volatile organic solvents, e.g., alkanes, 
alkenes or with low viscosity liquid silicones (0.1-200 cSt). After evaporation of the solvent or 
low viscosity silicone, the high viscosity silicone remains as lubricant on the glass surface 
[19,26,27]. 
Luer tip syringes with open syringe cones are usually applying bake-on siliconization, using a 
(diluted) silicone emulsion, e.g., Dow Corning 365 35 % Dimethicone NF Emulsion, followed by 
a high temperature process at approximately 300 °C to remove the emulsion water and to 
decompose emulsion stabilizers as well as concomitant pyrogens [28–31]. Before administration, 
a needle can be attached to the luer tip following respective instructions for use of the 
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pharmaceutical manufacturer [8]. Cartridges as part of delivery systems are combined with 
separate pen needles, and can therefore also be bake-on siliconized. The absolute spray amount of 
a diluted silicone emulsion can be precisely adjusted, thereby providing accurate control of the 
total silicone oil content. The thin, but sufficient baked-on silicone layer assures functionality 
during storage and minimizes silicone migration into the drug product [16,18,21,26,32]. 
Although different silicone levels are likely of less relevance for patient safety, it may also be 
beneficial for few, very silicone-sensitive protein therapeutics [12,21]. 
Recently, alternative coating methods utilize cross-linked silicone to further prevent silicone 
leaching from the barrel interior [16,18,23,26,27,33]. In addition, silicone-oil free systems are 
being promoted. These techniques include lubricious, biocompatible coatings for plunger 
stoppers, which may enable adequate extrusion performance in silicone oil free syringes, e.g., 
fluoropolymer coatings (FluroTec®) or proprietary i-coating™, often in combination with 
polymer based syringes (Plajex™, CrystalZenith®) [34–36]. Studies suggest a great potential of 
these systems for highly sensitive protein therapeutics with low protein aggregate and subvisible 
particle levels, but suitability has still to be confirmed with more systematic investigations. 
Additionally, extractables/leachables, oxidation and packaging sterilization may be amongst the 
challenges to be overcome [22].  
So far, siliconization media are well-characterized, whereas the siliconization process itself varies 
from a dipping, spray-on, wipe-on to a washing procedure of the component to be siliconized 
[15,19,27]. Technical aspects of a spray-on process using automated siliconization units were 
described in literature [13,37], but are often considered as proprietary know-how and therefore 
rarely published. Consequently, there is a high variability in the silicone content, distribution and 
leaching from individual PFS [24,38], which increases the need for clearly defined siliconization 
processes. As the demand for PFS and drug/device combination product increases, the 
understanding and optimization of siliconization processes becomes even more relevant. 
Automated siliconization units precisely regulate the spray amount, static or dynamic nozzle 
position including nozzle speed as well as the air atomization pressure and spray time [13,37]. 
Thus, a carefully designed siliconization process results in clearly defined, limited silicone levels 
and reproducible silicone distributions without compromising functionality. 
The objective of the present study was to establish an optimized bake-on siliconization process 
using a pilot-scale siliconization unit. In particular, we investigated different nozzle positions 
below the cartridge flange, and variations in spray quantities, pressures and times for pump 
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dosing to control and optimize the spray pattern as well as the silicone distribution and layer 
thickness along the cartridge barrel. The concentration of the silicone emulsion was clearly 
defined to yield adequate silicone levels ensuring adequate piston extrusion performance even 
after long-term storage. 
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
DC 365 35 % Dimethicone NF Emulsion purchased from Dow Corning GmbH (Wiesbaden, 
Germany) was diluted to 0.06-3.5 % (w/w) using highly purified water. Non-siliconized 5 mL 
cartridges, pistons, serum stoppers and aluminium seals were obtained from F. Hoffmann-La 
Roche Ltd (Basel, Switzerland). Elastomeric components were coated with fluoropolymer 
(FluroTec®). Talcum (Ph. Eur. grade) was purchased from VWR International GmbH 
(Darmstadt, Germany).  
2.2 BAKE-ON SILICONIZATION PROCESS 
Experiments in this study were performed using a SVS9061 pilot-scale siliconization unit from 
Bausch + Ströbel (B+S) Maschinenfabrik Ilshofen GmbH+Co. KG (Ilshofen, Germany). The set-
up employed a high precision rotary piston pump with a gliding disk from Saphirwerk AG 
(Brügg, Switzerland) to deliver silicone emulsion through an external mixing two-fluid nozzle 
with a swirl inset. A sensor dummy (diameter 0.6 mm) was inserted into the inner concentric tube 
(diameter 0.8 mm), which resulted in a hollow cone emulsion stream with an annular slit 
thickness of 0.1 mm (supporting Information Fig. S IV-1). The delivered amount was manually 
adjusted by a micrometer screw with nominal settings from one to three millimetres in 0.1 mm 
increments [39]. The screw setting defined the position of the gliding disk, thereby optimizing the 
gap between the piston and the bottom of the cylinder. Therefore, the micrometer screw allowed 
the absolute adjustment of dosing volume. A servo automated actuator controlled both static and 
dynamic nozzle positions while in turn an operator touch screen provided full control of the servo 
automated actuator settings. For atomization, compressed air was manually controlled by a 
pressure reducer (0.8-2.5 bar) and automatically monitored on the operator touch screen. 
Compressed air was adjusted by a gauge valve prior to emulsion dosing. The time for pump 
dosing was set on the operator touch screen. Up to 18 cartridges were fed manually into the star 
wheel with flange downwards. Finally, a two-hand circuit was used to safely initiate the spray 
process. 
The cartridges were subsequently treated in a TSQ U03 heat-tunnel from Robert Bosch GmbH 
(Stuttgart, Germany) at 316 °C for 12 min.  
In addition, the pilot-scale siliconization unit was equipped with a KA2 automatic spray valve 
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and a simple, external mixing two-fluid nozzle from Optima packaging group GmbH 
(Schwäbisch Hall, Germany).  
2.3 GRAVIMETRIC ANALYSIS  
After every adjustment of the pump screw or spray parameters, the emulsion spray was initially 
collected in a 2R vial, which was previously loaded with a tissue to soak up the absolute spray 
amount without evaporation loss. The vial was weighted before and after the siliconization 
process using an AT261 DeltaRange System high precision balance from Mettler-Toledo GmbH 
(Gießen, Germany). The absolute spray amounts were converted into theoretically sprayed 
silicone amounts using the corresponding concentration of the silicone emulsion. 
2.4 HIGH-SPEED RECORDING  
An Exilim Digital Camera EX-F1 form Casio Europe GmbH (Norderstedt, Germany) in high-
speed recording (600 fps) and continuous shooting mode (60 fps) was employed to characterize 
the spray pattern. 
2.5 TALCUM SUSPENSION TEST  
The cartridge flange was covered with parafilm and filled with 2 ml of 4 % (w/w) talcum 
suspension in purified water. The cartridge was rotated ten times in horizontal position before 
discarding the suspension. Talcum coated cartridges were visually inspected using a DMC-LS75 
digital camera from Panasonic Marketing Europe GmbH (Hamburg, Germany). Talcum adheres 
to silicone coated surfaces and therefore provides a first visual assessment related to silicone 
level and distribution over the cartridge barrel. 
2.6 EXTRACTION AND FOURIER TRANSFORM INFRARED (FTIR) 
QUANTIFICATION  
The baked-on silicone amount was determined by a combination of heptane extraction and 
quantitative FTIR spectroscopy. The baked-on silicone distribution was characterized by 
extracting specific zones at the flange, middle and top of the cartridge barrel (length 32 mm). The 
flange and top zone were equivalent to a filling height of the inner barrel of approximately 
10 mm. The flange-side was closed using a second non-siliconized cartridge with a placed piston. 
Both cartridges were connected using a tight rubber seal. The siliconized cartridge with the flange 
downwards was filled with 2.5 mL heptane, thereby extracting the flange zone. Note that during 
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flange extraction, silicone was also extracted from the cartridge edge. The silicone in the top zone 
was extracted by filling 2.8 mL of heptane into the cartridge with the flange upwards after closing 
the needle-side with a stopper. Two rinsing steps were performed using the same volumes of 
heptane. After flange and top extraction, the cartridge was filled with 900 µL heptane to extract 
the remaining silicone in the middle zone. Again, two rinsing steps were employed. Based on a 
previous study, the applied method led to a quantitative silicone extraction. Silicone extracts and 
FTIR analysis was further performed as previously described [40] (see chapter III). 
According to considerations provided in ICH Q2 R1 Validation Analytical Procedure, the limit of 
detection of the developed FTIR method was below 1 µg/mL (number of calibration curves 
n = 22). The limit of quantification (LOQ) was 18 µg/mL (n = 22), equivalent to 4 µg per 
cartridge based on 250 µL dissolution volume. 
2.7 3D-LASER SCANNING MICROSCOPY (3D-LSM) 
The average silicone layer thickness (ALT) was determined using a VK-X210 microscope 
equipped with VK Viewer Software both from Keyence Deutschland GmbH (Neu-Isenburg, 
Germany) as previously reported [40] (see chapter III). The LOQ was 10 nm. 
Cartridges were covered with adhesive tape, broken up and individual fragments were removed 
from the adhesive tape to enable direct measurements of the thin baked-on silicone layer. 
Cartridge fragments from the edge, flange, middle, and top of the cartridge were analyzed to 
determine the ALT distribution within the barrel.  
To confirm the 3D-LSM measurements, a theoretical average layer thickness was calculated from 
the silicone level quantified via FTIR applying a silicone density of 0.972 g/cm
3
 [41] and a 
cartridge interior surface of 2422 mm
2
.  
3D-LSM images were additionally employed to visualize the distribution of the silicone within an 
intact cartridge as previously described [40] (see chapter III). 
2.8 EXTRUSION FORCE MEASUREMENTS 
After bake-on siliconization, the piston and cartridges were manually assembled. The containers 
were filled with 5.16 mL highly purified water and sealed with stoppers and aluminum caps. 
Pistons in contact with lubricated container walls develop an initial resistance to movement. 
Therefore, movement is not initiated until a certain force is achieved, referred to as break-loose 
force. After a rapid relative movement, the movement sustains applying a gliding force. The 
break-loose, minimum and maximum gliding forces were evaluated by using a material testing 
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instrument TA.XT.plus from Winopal Forschungsbedarf GmbH (Elze, Germany) at a constant 
displacement speed of 5.6 mm/min over a distance of 17.5 mm, which was the maximum travel 
distance for the piston within the cartridge barrel. An approximate injection time of 3 min was 
mimicked for a high filling volume of 5.16 mL in a spring-controlled single injection patch 
device. For long-term extrusion forces, the filled cartridges were stored for 80 weeks at room 
temperature.  
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3 RESULTS AND DISCUSSION 
3.1 IMPACT OF SPRAY PARAMETERS ON THE SPRAY PATTERN AND 
BAKED-ON SILICONE LAYER CHARACTERISTICS 
 IMPACT OF SPRAY QUANTITY 3.1.1
The effect of different spray quantities on the spray pattern and the baked-on silicone layer 
characteristics was investigated. Initially, the nozzle position was set to 10 mm below the flange, 
the spray pressure was 2 bar and the time for pump dosing was specified to be 150 ms. The initial 
concentration of the silicone emulsion was 1.75 % (w/w). 
A nominal screw setting of 1 mm, 2 mm and 3 mm corresponded to an absolute spray amount of 
4.0 ± 0.5 mg, 16.1 ± 0.7 mg and 29.0 ± 0.4 mg silicone emulsion, respectively. These tested spray 
quantities largely covered the range of applicable screw settings from 0 mm to 3 mm. A lower 
spray quantity was not further considered since the screw setting for this condition (e.g. 0.5 mm) 
was not sufficiently accurate.  
A spray quantity of 4 mg emulsion could be instantaneously dispersed into a fine spray for 
approximately 255 ms (Fig. IV-1). The fine emulsion droplets were not visible after deposition 
within the cartridge barrel due to the fast evaporation of emulsion water. A quantity of 16 mg 
resulted in an emulsion jet for 135 ms initially before atomization was reached for 125 ms. A 
quantity of 29 mg emulsion led to a long-lasting solution jet for 150 ms followed by a poor 
atomization for 115 ms. The latter two spray quantities rendered larger emulsion droplets in the 
barrel forming runlets that deposited on the flared cartridge edge. 
The quality of atomization highly depends on the air-to-liquid mass ratio, which decreases with 
higher liquid flow rates [42–45], i.e., with higher spray quantities. A complete theory to describe 
atomizing principles has not been fully developed yet. Basically, it involves the tearing of the 
liquid into filaments at the nozzle orifice, referred to as liquid sheets, and then large droplets. 
Subsequently, the high relative velocity and frictional forces between the air and the liquid result 
in a break-up into smaller droplets. High velocity air readily penetrates low velocity liquids, thus 
yielding the necessary turbulence and energy transfer to form a spray [46]. However, thick liquid 
jets as obtained at higher spray quantities of 16 mg and 29 mg could not be readily penetrated and 
therefore atomization was incomplete with an initial, compact jet in the center of the spray [47]. 
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Fig. IV-1. High-speed images of a 4 mg, 16 mg, 29 mg spray quantity (10 mm nozzle position below the flange, 
spray pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) emulsion concentration). 
The mean break-loose, minimum and maximum gliding forces were below 5 N regardless of the 
spray quantity (Fig. IV-2). The force profiles remained smooth and constant between 3 N to 5 N 
along the cartridge barrel (Fig. IV-2a). Interestingly, an increased spray quantity of 29 mg 
showed even slightly higher extrusion forces. A possible explanation for this observation could 
be that the long-lasting jet failed to sufficiently coat the inner glass barrel even though a high 
silicone quantity was deposited. 
Overall, the theoretically sprayed silicone amount as derived from the absolute spray amount 
collected in tissue filled vials at an emulsion concentration of 1.75 % (w/w) increased from 
70 ± 3 µg to 296 ± 1 µg to 504 ± 13 µg with the increase in spray quantity from 4 mg to 16 mg to 
29 mg (Fig. IV-2b). This clear trend was not reflected in the baked-on silicone levels at the barrel 
inner surface (Fig. IV-2b). A spray quantity of 4 mg resulted in a baked-on silicone level of 
33 ± 9 µg, a spray quantity of 16 mg in 171 ± 18 µg and a spray quantity of 29 mg in 164 ± 11 µg 
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as determined by FTIR. The difference between the sprayed silicone amount and the baked-on 
silicone level on the cartridge interior indicated a higher spray loss for larger spray quantities. 
This was reflected in the emulsion runlets depositing on the flared cartridge edge and the star 
wheel as well as spray blown out through the cartridge orifice as seen in the high-speed images. 
In particular for high spray quantities, also a rebound of the spray within the cartridge barrel and 
backward flow could be observed, which additionally increased the spray loss. It can be argued, 
that in addition to spray loss, silicone may be burned-off during heat-treatment at 316 °C for 
12 min [31] (see chapter V). Overall, a good atomization process using low amounts of spray 
liquid appears to be important. 
a.
 
b. 
 
Fig. IV-2. Impact of a 4 mg, 16 mg, 29 mg spray quantity on (a) extrusion force profiles and (b) mean extrusion 
forces, baked-on silicone levels as determined by FTIR and theoretically sprayed silicone amounts derived from 
gravimetric vial analysis (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001), (10 mm nozzle position below the flange, spray 
pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) emulsion concentration). 
The baked-on silicone levels were below the range of 0.2-1 mg/barrel reported for sprayed-on 
1 mL PFS [8,13,16–18,20–23]. Treatment at 16 mg and 29 mg spray quantities exceeded the 
silicone levels described for bake-on siliconization processes of < 0.1 mg/barrel [20,24,25] while 
at the same time leading to sub-optimal atomization and higher spray loss. Therefore, an 
approach to target sufficient and optimal baked-on silicone levels aimed to adapt the 
concentration of the silicone emulsion while maintaining a spray quantity of 4 mg, which has led 
to good atomization (see 3.2). 
FTIR is a rapid method to quantify silicone with a reported LOQ down to 18 µg/mL [20,40] (see 
chapter III), but without the extraction of specific cartridge zones it fails to characterize the 
silicone distribution within the cartridge barrel. Therefore, additional 3D-LSM (LOQ ~ 10 nm, 
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see chapter III) was performed to analyze the thickness and distribution of the baked-on silicone 
layer (Fig. IV-3).  
a. 
 
b. 
 
Fig. IV-3. 3D-LSM analysis after bake-on siliconization using a 4 mg, 16 mg, 29 mg spray quantity. (a) ALT in four 
different sections within the cartridge barrel (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) and (b) 3D-LSM images 
(10 mm nozzle position below the flange, spray pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) 
emulsion concentration).  
A spray quantity of 4 mg led to a fine spray, which resulted in a thin, homogenous baked-on 
silicone layer of 16-23 nm from flange to top (Fig. IV-3a). 3D-LSM better imaged thin, baked-on 
silicone layers compared to optical microcopy [40] (see chapter III), but the baked-on silicone 
layer obtained by a spray quantity of 4 mg was even too thin to be clearly visualized by 3D-LSM 
(Fig. IV-3b). Spray quantities of 16 mg and 29 mg emulsion led to runlets forming 114-133 nm 
build-ups at the flared cartridge edge. These thicker, baked-on silicone layers showed plaque-like 
and micro-droplet structures comparable to sprayed-on silicone layers [9,17,18]. For both 
quantities, the ALT at the flange was 24-29 nm and increased at the middle and the top to 40-
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48 nm. These thinner, baked-on layers exhibited a homogeneous micro-structure without any 
plaques or droplets. Furthermore, the 3D-LSM images showed more pronounced layer patterns at 
the middle and top, thereby reflecting the measured ALTs. This effective siliconization in the 
middle and top region could be attributed to the initial nozzle-to-flange distance of 10 mm, where 
the spray cone mainly reached the upper part of the cartridge (see 3.1.2). Thus, the different 
atomization qualities were reflected in the baked-on silicone layer distributions.  
A theoretical layer thickness of 14 nm for 4 mg, 73 nm for 16 mg and 70 nm for 29 mg spray 
quantity calculated from FTIR analysis was in good agreement with the ALT obtained from 3D-
LSM measurement (4 mg: 14 nm, 16 mg: 59 nm, 29 mg: 60 nm) (Fig. IV-3a). A spray quantity of 
29 mg did not lead to thicker silicone layers compared to a spray quantity of 16 mg due to a 
markedly observed spray loss as discussed above. 
Low and uniform extrusion forces are critical quality attributes. They did not benefit from high 
spray quantities and silicone accumulation at the flared cartridge edge. On the contrary, these 
higher silicone amounts may migrate to the cartridge lower edge and drip out onto the tub insert 
sheet when stored tip-up as observed in spray-on siliconized PFS [20]. During storage in 
horizontal position, silicone migration led to an increase of the silicone layer thickness from 
initially 350 nm to 1600 nm at the bottom-line already after three days [17]. 
Based on these result, a spray quantity of 4 mg was suggested as optimum within the tested range 
due to an improved atomization quality, adequate baked-on silicone levels in combination with 
low extrusion forces and most homogeneous, thin baked-on silicone layers. A lower range was 
not possible to be tested due to technical limitations. 
 IMPACT OF NOZZLE POSITION BELOW THE FLANGE 3.1.2
The nozzle position below the flange substantially affects the distribution of both the sprayed 
emulsion within the cartridge barrel and consequently the baked-on silicone layer later-on. 
Therefore, fixed nozzle positions of 0 mm, 10 mm, 20 mm, 30 mm and 40 mm below the 
cartridge flange were investigated while the initial spray quantity was 16 mg, the spray pressure 
was set to 2 bar and the spray time was specified to be 150 ms based on initial specifications of 
the manufacturer. The initial concentration of the silicone emulsion was 1.75 % (w/w). 
At a fixed nozzle position of 0 mm close to the flange the spray mostly hit the middle and top of 
the cartridge while the flange was not reached (Fig. IV-4a). In addition, the spray was partially 
blown out through the cartridge orifice. Increasing the distance between nozzle and flange to 
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10 mm and 20 mm improved the spray distribution in the cartridge. At 20 mm the spray cone 
exactly reached the flange while the middle and top were still coated with emulsion. Longer 
nozzle-to-flange distances of 30 mm and 40 mm led to off-spray with emulsion passing outside 
the circumference of the cartridge barrel or being rebounded at the lower edge of the cartridge. 
Therefore, a nozzle position of 20 mm below the flange was suggested to yield an optimum 
distribution of the silicone emulsion over the entire barrel. 
a. 
 
 
b. 
 
Fig. IV-4. High-speed images of (a) fixed nozzle positions 0-40 mm below the flange and (b) dynamic nozzle 
positions 15 mm past the flange to 20 mm below the flange at a retraction speed of 200 mm/s and 400 mm/s (16 mg 
spray quantity, spray pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) emulsion concentration).  
Recently, diving and retracting nozzle positions were reported to be superior to the currently used 
static systems [12,13,16,20,25]. Therefore, retracting the nozzle position at 200 mm/s and 
400 mm/s from 15 mm past the flange to 20 mm below the flange was investigated. In theory, 
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this should provide a sufficient siliconization at both the upper cartridge barrel and the flange. A 
slower retraction speed was shown to improve the silicone distribution in PFS as it offsets the 
upward velocity of the spray droplets less than higher retraction velocities. Thus, with faster 
downward retraction the spray fails to reach the needle-end of the barrel [13]. Conceptually, 
during the dosing step, the piston rotates at maximum speed for 180° to deliver a constant rate of 
spray medium. The initial and the subsequent 90° rotation are used to accelerate and brake the 
piston speed [7]. However, in this study, it was observed that initially a dense spray deposited at 
the top of the cartridge barrel, while with proceeding retraction the spray attenuated independent 
of the applied retraction speed (Fig. IV-4b.). These findings suggested that retracting the nozzle 
position yielded an inhomogeneous distribution. Therefore, fixed nozzle positions of 0-40 mm 
below the flange were further studied instead. 
Independent of the nozzle position, the mean break-loose, minimum and maximum gliding forces 
remained below 6 N. A nozzle position of 0 mm below the flange revealed slightly higher mean 
extrusion forces (Fig. IV-5a and Fig. IV-5b) (will be discussed below).  
a. 
 
b. 
 
Fig. IV-5. Impact of fixed nozzle positions 0-40 mm below the flange on (a) extrusion force profiles and (b) mean 
extrusion forces, baked-on silicone levels as determined by FTIR and theoretically sprayed silicone amounts derived 
from gravimetric vial analysis (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001), (16 mg spray quantity, spray pressure 2 bar, 
time for pump dosing 150 ms, 1.75 % (w/w) emulsion concentration). 
The baked-on silicone levels were systematically lower (171 ± 18 µg to 202 ± 12 µg) than the 
absolute spray amount ranging between 287 ± 6 µg and 297 ± 6 µg independent of the nozzle 
position (Fig. IV-5b). Thus the total spray loss due to blowing out of emulsion through the 
cartridge orifice (particularly for higher nozzle positions), rebound of the spray within the 
cartridge barrel, backward flow out, and off-spray passing the circumference of the barrel 
(particularly for lower nozzle positions) was more or less independent of the nozzle position. 
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The impact of the nozzle position on the distribution of the baked-on silicone level was 
characterized by extracting specific cartridges zones. The total baked-on silicone level as the sum 
of the individual zone extractions ranged from 167 ± 16 µg to 197 ± 18 µg and was comparable 
to the respective baked-on silicone levels after extraction of the entire cartridge barrel (Tab. 
IV-1). 
Tab. IV-1. Impact of fixed nozzle positions 0-40 mm below the flange on the baked-on silicone levels after 
extraction of the entire cartridge barrel and as the sum of individual zone extractions and subsequent FTIR analysis 
(16 mg spray quantity, spray pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) emulsion concentration). 
Nozzle position 
below flange 
Baked-on silicone level after extraction 
entire cartridge barrel [µg] 
Baked-on silicone level as sum of individual 
zone extractions [µg] 
0 mm 195 ± 12 197 ± 18 
10 mm 171 ± 18 167 ± 16 
20 mm 185 ± 10 187 ± 17 
30 mm 202 ± 12 192 ± 18 
40 mm 189 ± 11 178 ± 17 
 
Consequently, the silicone distribution was further described as relative baked-on silicone 
contents within the specific cartridge areas (Fig. IV-6).  
 
Fig. IV-6. Impact of fixed nozzle positions 0-40 mm below the flange on the relative baked-on silicone levels after 
individual zone extractions and subsequent FTIR analysis (16 mg spray quantity, spray pressure 2 bar, time for pump 
dosing 150 ms, 1.75 % (w/w) emulsion concentration). Note that during flange extraction, silicone was also extracted 
from the cartridge edge. 
At a nozzle position of 0 mm and 10 mm below the flange, approximately 50 % baked-on 
silicone was recovered from the top region of the cartridge. The remaining 50 % silicone were 
distributed in the middle and flange region while at a nozzle position of 0 mm the amount in the 
middle region was slightly increased to 25 % compared to maximum 20 % at all other nozzle 
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positions. Longer nozzle-to flange distances of 20 mm, 30 mm and 40 mm led to a gradual 
increase of the baked-on silicone in the flange region up to 60 % at 40 mm at the expense of 
lower silicone ratios in the top region. The relative silicone content in the middle zone needs to 
be interpreted with caution since it was systematically reduced due to the spreading of the solvent 
during the extraction of the flange and top zones as observed in 3D-LSM (data not shown). 
Overall, the nozzle position substantially affected the silicone distribution along the cartridge 
barrel. Thus, the quantification of relative silicone contents within the different cartridge sections 
in addition to the total baked-on silicone level was crucial.  
a. 
 
b. 
 
Fig. IV-7. 3D-LSM analysis after bake-on siliconization using nozzle positions from 0-40 mm below the flange. 
(a) ALT in four different sections within the cartridge barrel (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) and (b) 3D-
LSM images (16 mg spray quantity, spray pressure 2 bar, time for pump dosing 150 ms, 1.75 % (w/w) emulsion 
concentration). 
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The thickness and distribution of the baked-on silicone layer was additionally characterized using 
3D-LSM (Fig. IV-7). Independently of the nozzle position, the medium spray quantity of 16 mg 
partially drained off and induced thicker baked-on silicone layers of 100-140 nm at the flared 
cartridge edge (Fig. IV-7a). A thin silicone layer at the flange (16 nm and 24 nm, respectively) 
resulted at 0 mm to 10 mm nozzle-to-flange distances. At 20 mm the spray cone exactly reached 
the flange, which led to a thicker layer of 122 nm. At 30 mm to 40 mm nozzle positions, where 
the spray cone partially missed the cartridge, the thickness of the flange layer was decreased to 
55-65 nm as compared to a nozzle-to-flange distance of 20 mm. The layer thickness at the middle 
and top was comparable for 0 mm to 20 mm nozzle-to-flange distances with 41 nm to 63 nm. At 
longer nozzle-to-flange distances of 30 mm to 40 mm the spray cone partially missed the 
circumference of the cartridge barrel, which led to decreased layer thicknesses of 20-30 nm at the 
middle and top. These quantitative data corresponded to the 3D-LSM images (Fig. IV-7b). 
Overall, thin, baked-on silicone layers in the range of 15-65 nm showed a homogeneous micro-
structure. As a result of emulsion runlets, thicker, baked-on silicone layers ranging from 100-
140 nm were formed, which showed plaque-like and micro-droplet structures close to the flared 
cartridge edge. These structures are known from spray-on silicone layers [9,17,18]. 
Regardless of the nozzle position, the theoretical layer thicknesses calculated from FTIR analysis 
of approximately 73-86 nm were slightly higher compared to the ALT measured in 3D-LSM 
(0 mm: 51 nm, 10 mm: 59 nm, 20 mm: 95 nm, 30 mm: 56 nm, 40 mm: 66 nm) (Fig. IV-7a). 
Comparably, silicone levels quantified by AAS analysis following toluene extraction [17] or 
calculations using the silicone levels obtained from the PFS manufacturer and the inner barrel 
surface [9] were systematically higher than silicone contents obtained from vertical scanning 
interferometry (VSI) layer analysis. This can be either attributed to an inhomogeneous silicone 
distribution along the cartridge barrel depicting plaque-like structures [9,17] or limitations of 
VSI, which underestimates higher silicone levels due to multiple, interfering thickness values, 
when thick silicone droplets are formed [20]. However, for rather homogeneous silicone layers, 
the theoretical silicone levels derived from VSI are in good agreement with quantified silicone 
levels from FTIR [20]. 
Overall, the nozzle position below the flange was a key factor for the distribution of the baked-on 
silicone layer and its extrusion performance. A nozzle position of 20 mm below the flange was 
optimal as it led to a pronounced deposition of silicone emulsion at the flange. The thicker 
silicone layer and the increased relative baked-on silicone content at the flange particularly 
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facilitated smooth break-loose of the piston during injection. The homogeneous silicone layer at 
the middle and top of the cartridge enabled to sustain a smooth gliding of the piston along the 
cartridge barrel. On contrary, an insufficient siliconization at the flange as obtained from a nozzle 
position of 0 mm below the flange increased the extrusion forces. Thus, a certain amount of 
silicone was required at the flange for lubrication of the piston, in particular the flared ribs, which 
were in direct contact with the container wall. Additionally, it can be argued, that a sufficient 
siliconization at the flange substantially contributed to smooth piston gliding along the entire 
barrel as silicone is pushed forward by the piston movement [13] (see 3.3). 
For longer cartridges or syringe barrels, this nozzle position of 20 mm below the flange may not 
be optimal. Wen et al. reported a significant increase of extrusion forces, or even worse stalling 
of the piston, at the end of injection for 1 mL syringes due to a silicone-rich flange and much less 
silicone at the needle-side [9]. Overall, fixed nozzle positions most commonly resulted in steadily 
decreasing silicone layers from flange to top ranging from 900 nm to 0 nm and 400 nm to 50 nm 
for “1 x” and “2 x” silicone levels, respectively [16], 600 nm to 100 nm [17] or even worse from 
1-2 µm to approximately 250 nm [25]. Pronounced staining with talcum or glass powder of the 
flange and middle but not of the needle-side were observed [12,13,25]. Consequently, 
malfunctions during injection could be attributed to inhomogeneous silicone distributions along 
the cartridge barrel.  
Recently, spray-on siliconization using diving nozzle positions were suggested to improve layer 
thickness homogeneity, thereby providing low extrusion forces and homogeneous coverage with 
talcum or glass powder [12,13,16,18,20,25]. Independent of the barrel position, sprayed-on 
silicone layers were initially 100-250 nm and after filling with protein formulation 50-150 nm 
thick, thereby yielding constant and smooth extrusion forces below 15 N along the 1 mL syringe 
barrel [18]. VSI layer profiles after diving nozzle siliconization demonstrated approximately 
400 nm thick silicone layers at 0-35 mm barrel distance and the silicone layer thickness steadily 
decreased to 150 nm towards the needle-side at 50 mm [20]. Felsovalyi et al. reported 
homogeneous silicone layers ranging from 200 nm to 350 nm up to 40 mm barrel length followed 
by a drop in layer thickness to approximately 50 nm towards the needle-side at 50 mm [16]. In 
addition, diving nozzle position and a spray start close to the needle-side may yield the opposite 
extreme distribution compared to fixed nozzle positions, i.e., a pronounced siliconization at the 
needle-side with 300-600 nm thick layers and only 100 nm thick silicone layers at the flange [17]. 
Besides, the layer distribution after diving nozzle siliconization may be less reproducible [25].  
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There is no clear trend in literature, whether an insufficient siliconization at the flange or needle-
side is more troublesome for functionality. In this study, the tailored bake-on siliconization 
process enabled defined, consistent silicone distributions, which correlated well with the applied 
spray positions and initial distribution of the sprayed emulsion. Thereby, the negative impact of 
an inadequate silicone distribution, e.g., an insufficient siliconization at the flange, was reflected 
in the extrusion profile. 
 IMPACT OF SPRAY PRESSURE AND TIME FOR PUMP DOSING 3.1.3
Parameters were selected to cover two extremes within the possible setting range (4-29 mg spray 
quantity, spray pressure 0.8-2.5 bar, time for pump dosing 60-175 ms) for either spraying small 
droplets (4 mg spray quantity, spray pressure 2.5 bar, time for pump dosing 175 ms) or large 
droplets (29 mg spray quantity, spray pressure 1 bar, time for pump dosing 60 ms) (Fig. IV-8). 
The nozzle position was set to 20 mm below the flange. The concentration of the silicone 
emulsion was 1.75 % (w/w). 
At 2.5 bar a low spray quantity of 4 mg was atomized into a fine spray regardless of the pump 
dosing time. At pump dosing for 175 ms, a high spray pressure of 2.5 bar did not improve 
atomization, but led to uncontrolled splashing and an increased spray loss compared to a spray 
pressure of 1 bar (Fig. IV-8a). Regardless of the spray conditions, a high spray quantity of 29 mg 
resulted in a preliminary solution jet (Fig. IV-8b). A low spray pressure of 1 bar and a short time 
for pump dosing of 60 ms resulted in worst spray conditions: only a weak spray was achieved, 
shortly before the spray process ended. For a steady and fine atomized spray a prolonged time for 
pump dosing of 175 ms was crucial. 
Atomization quality and droplet size are a direct function of the air-to-liquid mass ratio and are 
affected by the applied spray pressure, spray quantity and time for pump dosing. Droplet size 
decreases with higher air-to-liquid ratios and approaches an asymptote for a given nozzle design 
[13,42–44]. Therefore, a longer time for pump dosing of 175 ms compared to 60 ms resulted in a 
slower flow rate and increased the air-to-liquid ratio by a factor of three. Consequently, the 
atomization of a high spray quantity was improved. However, high spray pressure did not show 
the same beneficial effect although the air-to-liquid mass ratio was increased by a factor of 2.5. 
Juslin et al. reported that an insufficient spray pressure was not able to atomize fast flowing 
solutions, i.e., high spray amounts, which led to an increased volume of larger droplets [44]. It 
can be concluded, that a spray pressure of 2.5 bar was still too low to efficiently penetrate the 
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thick liquid jet of a high spray quantity and simply accelerated the jet to the air velocity, thereby 
minimizing the shear forces between air and liquid without inducing atomization [47]. Besides, 
the “true” pressure at the nozzle orifice could have been lower compared to the given gauge 
pressure [13]. In addition, high velocity air streams are suggested to initially form oscillating 
liquid surface and cavities of swirling air at the nozzle edge prior to disintegration [42,47]. 
Consequently, high spray pressure may result in initially turbulent, vibrating air cavities, which 
lead to a sudden, less controlled disintegration of the fed liquid and therefore increased spray loss 
(Fig. IV-8a). High spray pressure additionally disperses droplets farther [13], which contributes 
to the observed spray loss. 
a. 
 
b. 
 
Fig. IV-8. High-speed images of (a) ´small´ droplet setting (4 mg spray quantity, time for pump dosing 175 ms, 
exemplary different spray pressures 1 bar vs. 2.5 bar) and (b) ´large´ droplet setting (29 mg spray quantity, spray 
pressure 1 bar, exemplary different times for pump dosing 60 ms vs. 175 ms). The nozzle position was set to 20 mm 
below the flange. The concentration of the silicone emulsion was 1.75 % (w/w).  
Based on these findings, a prolonged time for pump dosing of 175 ms and a low spray pressure of 
1 bar were most beneficial for atomization. High-speed imaging was presented as a valuable and 
fast approach to characterize the spray process. Further studies could aim to measure droplet size 
and distribution by more advanced techniques such as laser diffraction and phase-Doppler 
anemometry [46–48].  
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 OPTIMIZED SPRAY PARAMETERS IN A BAKE-ON SILICONIZATION 3.1.4
PROCESS – FINAL CONSIDERATIONS 
Based on previous experiments, a low spray quantity of 4 mg resulted in a fine spray and was 
adequate to yield thin, but sufficient baked-on silicone layers. A nozzle position of 20 mm below 
the flange was chosen for optimal distribution of the silicone emulsion within the cartridge barrel. 
At 20 mm the spray cone exactly reached the cartridge flange and led to thicker, baked-on 
silicone layers of approximately 122 nm at the flange, thus ensuring functionality of the injection 
device in particular during break-loose of the piston. A prolonged time for pump dosing of 
175 ms was crucial for a steady, fine spray, whereas a high spray pressure of 2.5 bar was not 
beneficial. On the contrary, a high spray pressure increased the spray loss near the flange 
compared to a lower spray pressure of 1 bar. 
For further fine tuning, a spray quantity of 4 mg and alternatively 16 mg was dispersed using 
either an optimized nozzle position of 20 mm below the flange, a low spray pressure of 1 bar and 
a long time for pump dosing of 175 ms (Fig. IV-9a); or an initial nozzle position of 10 mm below 
the flange, a spray pressure of 2 bar and a time for pump dosing of 150 ms (see 3.1.1).  
A spray quantity of 4 mg was immediately dispersed into a fine spray (Fig. IV-9a). An optimized 
pressure/time setting of 1 bar/175 ms did not further improve the atomization quality. On the 
contrary, for a spray quantity of 16 mg an improved pressure/time setting was beneficial. The 
previous solution jet was reduced to a marginal, conical tip initially followed by break-up into a 
strong spray. 
Finally, experiments with nozzle positions of 15 mm, 20 mm and 25 mm below the flange were 
performed to further specify the optimal nozzle position (Fig. IV-9b). Overall, all three nozzle 
positions could be applied for a homogeneous coating of the cartridge barrel with silicone 
emulsion. However, at a nozzle position of 15 mm below the flange, the spray did not reach the 
flange well. A nozzle position of 20 mm below the flange was confirmed to be optimal as the 
spray cone exactly reached the cartridge flange. At 25 mm below the flange, the spray cone 
tended to pass the circumference of the cartridge barrel, thereby presumably increasing spray 
loss. 
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a. 
 
b. 
 
Fig. IV-9. High-speed images of an optimized spray process using (a) 4 mg and 16 mg spray quantity and (b) fixed 
nozzle positions of 15-25 mm below the flange (1.75 %  (w/w) emulsion concentration; optimized spray parameters: 
spray pressure 1 bar, time for pump dosing 175 ms).  
Based on these final experiments, a low spray quantity of 4 mg, and alternatively 16 mg silicone 
emulsion, a fixed nozzle position of 20 mm below the flange, a low spray pressure of 1 bar and a 
long time for pump dosing of 175 ms were identified as optimal spray parameters. 
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3.2 VARIATION OF THE SILICONE EMULSION CONCENTRATION  
In addition to the spray parameters discussed in the previous chapters, the concentration of the 
silicone emulsion was further investigated to adjust the baked-on silicone level. An optimized 
spray quantity of 4 mg, a nozzle position of 20 mm below flange, a spray pressure of 1 bar and a 
time for pump dosing of 175 ms were adapted from previous experiments.  
Siliconization with emulsions ranging from 0.175 % (w/w) to 3.5 % (w/w) silicone oil content 
resulted in steadily increasing baked-on silicone levels from 4 ± 1 µg to 94 ± 6 µg (Fig. IV-10). A 
0.06 % (w/w) emulsion yielded levels below the LOQ of 18 µg/mL, i.e., below 4 µg/cartridge 
[40] (see chapter III). Correspondingly, the maximum gliding forces decreased from 34 ± 5 N to 
4 ± 0 N with increasing concentrations from 0.06 % (w/w) to 1.2 % (w/w) and remained constant 
at approximately 4 N at higher concentrations of 1.75 % (w/w) and 3.5 % (w/w). The break-loose 
and minimum gliding forces showed the same trend, but less pronounced, with break-loose forces 
decreasing from 13 ± 1 N to 4 ± 1 N. The minimum gliding forces decreased from 11 ± 1 N to 
3 ± 1 N. 
 
Fig. IV-10. Extrusion forces and baked-on silicone levels as determined by FTIR using silicone emulsion 
concentrations from 0.06 % (w/w) to 3.5 % (w/w) (optimized spray parameters: spray quantity 4 mg, fixed nozzle 
position of 20 mm below the flange, spray pressure 1 bar, time for pump dosing 175 ms). Asterisks indicate baked-
on silicone levels below the LOQ of 18 µg/mL, i.e., < 4 µg/cartridge based on 250 µL dissolution volume [40] (see 
chapter III). 
Reliable functionality over the product shelf life is a highly important parameter for a drug/device 
combination product. A baked-on silicone level of 8 ± 1 µg at an emulsion concentration of 
0.35 % (w/w) was sufficient to achieve break-loose forces below 30 N and gliding forces below 
15 N, which were considered as acceptable reference values in this study. A baked-on silicone 
level of 13 ± 3 µg, i.e., an emulsion concentration of 0.6 %, was used as assurance level for 
further experiments. Certainly, both break-loose and gliding forces have to be carefully assessed 
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for each combination product depending on the formulation, drug/device combination product 
technical features, intended user population and shelf life as well as technical requirements. In the 
literature, maximum forces for a manual injection were discussed being at 30 N [49] and 
rheumatoid arthritis patients could even exert maximum forces up to 45 N [50]. Patient-friendly 
injection was reported with gliding forces up to 15-20 N [51] while for empty cartridges a limit of 
10 N is suggested in EN ISO 11608-3 [52]. Consequently, limited baked-on silicone levels as low 
as 10 µg were adequate to maintain functionality in this study. 
The silicone layer may experience a phase transition upon contact with aqueous media as 
observed for other hydrophobic material layers [53]. The extrusion forces may thus be a function 
of different filling media due to a change in de-wetting behavior. In an exemplary experiment, 
different filling media did not affect the extrusion performance for cartridges siliconized with 
4 mg of a 0.6 % (w/w) silicone emulsion and filled with either highly purified water or placebo 
(supporting Information Fig. S IV-2). 
Talcum suspension was utilized for first visual assessment of the silicone level and its 
distribution over the cartridge barrel. Talcum did not adhere to cartridges siliconized with only 
0.06 % (w/w) or 0.175 % (w/w) emulsions (Fig. IV-11). With increasing the concentrations from 
0.35 % (w/w) to 3.5 % (w/w), talcum more adequately coated the container wall and the talcum 
distribution became improved, but still less coated areas remained at the top.  
 
 
Fig. IV-11. Distribution of talcum suspension in cartridges coated with silicone emulsion concentrations from 0.06-
3.5 % (w/w) (optimized spray parameters: spray quantity 4 mg, fixed nozzle position of 20 mm below the flange, 
spray pressure 1 bar, time for pump dosing 175 ms). 
These observations were confirmed by 3D-LSM measurements (Fig. IV-12). Silicone layers 
obtained from 0.06-0.6 % (w/w) emulsions were thinner than the LOQ of 10 nm. 1.2 % (w/w) to 
3.5 % (w/w) emulsions led to increasing baked-on silicone layers from 15 nm to 50 nm at the 
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flange (Fig. IV-12). The middle and top section revealed lower ALTs compared to the flange 
increasing from approximately 10 nm and below the LOQ to 20 nm and 40 nm, respectively. The 
pronounced siliconization of the flange was typical for the optimized nozzle position of 20 mm 
below the flange (see 3.1.2).  
 
Fig. IV-12. 3D-LSM analysis after bake-on siliconization using silicone emulsion concentrations from 0.06-
3.5 % (w/w) ALT in three different sections within the cartridge barrel (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) 
(optimized spray parameters: spray quantity 4 mg, fixed nozzle position of 20 mm below the flange, spray pressure 
1 bar, time for pump dosing 175 ms). 
The theoretical layer thicknesses calculated from FTIR quantification ranged from 11 nm to 
40 nm and were in excellent agreement with the ALTs determined by 3D-LSM (1.2 % (w/w): 
13 nm, 1.75 % (w/w): 18 nm, 3.5 % (w/w): 35 nm). It was demonstrated, that both FTIR and 3D-
LSM were capable to describe the thickness of thin baked-on layers provided that an optimized 
siliconization process was established in advance. 
Consequently, the study confirms that higher silicone emulsion concentrations (i.e., baked-on 
silicone levels and layer thicknesses) result in better functionality [13], but the extrusion forces 
reached a plateau value and were not further decreased, even when the emulsion concentration 
was further increased. Buch et al. observed a moderate reduction in break-loose and gliding 
forces from 4 N to 3 N with increasing the concentration of silicone oil in heptane solutions from 
0.5 % to 1 % (dip siliconization was used) [15]. Spray-on silicone levels ranging from 0.2 mg-
0.6 mg/barrel were reported to decrease gliding forces from 1.8 N to 0.5 N while the break-loose 
forces remained constant with approximately 2 N [25]. In both cases the actual silicone layer 
thickness is not known. But, high levels of silicone are prone to migration, thereby increasing 
silicone-related particulates and turbidity [23,28,54–57]. This could create artefacts during 
particulate measurements, that are, however, likely not relevant and of impact for product quality. 
Silicone has been discussed being a concern related to silicone-protein interactions, but adequate 
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formulation development, e.g., the addition of surfactant can hamper or even inhibit silicone-
protein interactions with regard to adsorption and aggregation [58–62]. The reported protein 
instabilities are rather attributed to synergistic effects of silicone, elevated temperature [21,63], 
agitation [22,23,26,60,62,64], agitation at increased temperatures [60] or periodically rupture of 
the silicone oil-water interface [59]. Based on this study, a low, but sufficient baked-on silicone 
level of 13 ± 3 µg corresponding to a layer thickness of less than 10 nm was suggested as 
optimum.  
3.3 EXTRUSION FORCES DURING STORAGE  
The functional performance of the baked-on silicone layer obtained after siliconizing cartridges 
with 0.6 % (w/w) and 1.2 % (w/w) silicone emulsion was further assessed during storage for 80 
weeks at room temperature. The baked-on silicone levels were 13 ± 3 µg and 27 ± 2 µg, 
respectively. Optimized spray parameters (spray quantity 4 mg, fixed nozzle position of 20 mm 
below flange, spray pressure 1 bar, time for pump dosing 175 ms) were adapted from previous 
experiments. 
Initially, a baked-on silicone level of 13 ± 3 µg and 27 ± 2 µg resulted in mean extrusion forces 
of 5-8 N (Fig. IV-13a) and 3-6 N (Fig. IV-13b), respectively After storage, the low baked-on 
silicone level of 13 ± 3 µg showed a gradual increase in the mean break-loose and maximum 
gliding forces to 21-22 N (Fig. IV-13a). The increase for the higher silicone level was moderate 
to 10-12 N (Fig. IV-13b). The minimum gliding forces marginally increased for both silicone 
levels. The increase of both break-loose and gliding forces could be explained by the respective 
extrusion force profiles (Fig. IV-13c) along the cartridge barrel and 3D-LSM images (Fig. 
IV-14). The initial force profile of a 13 µg baked-on silicone cartridge was smooth with an 
increase in the gliding forces from 5 N to 8 N towards the barrel end (Fig. IV-13c). After fitting 
the piston into the container, the piston ribs were sufficiently lubricated. The baked-on silicone 
was visualized by 3D-LSM between the piston ribs and the container wall (Fig. IV-14a). During 
expelling, this contact area lost silicone. Thereby, the piston ribs became less lubricated (Fig. 
IV-14b), which resulted in an increase in gliding forces towards the top of the cartridge barrel. 
The baked-on silicone did not leach into the fill medium (see chapter VI), but rather accumulated 
between the upper piston plateau and the container wall (Fig. IV-14c). In addition, the baked-on 
silicone layer at the top was initially thinner (Fig. IV-12), which contributed to the lack of 
siliconization of the piston ribs towards the top of the cartridge. 
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a. 
 
b. 
 
c. 
 
 
Fig. IV-13. Extrusion forces after bake-on siliconization with (a) 13 µg baked-on silicone, i.e. emulsion 
concentration of 0.6 % (w/w) and (b) 27 µg baked-on silicone, i.e., emulsion concentration of 1.2 % (w/w). 
(c) Exemplary extrusion force profiles for a 13 µg baked-on silicone level, initially and after 1 year of storage 
(optimized spray parameters (4 mg spray quantity, nozzle position below flange 20 mm, spray pressure 1 bar, time 
for pump dosing 175 ms). Values in brackets were not considered as they did not reflect the trend of the other 
extrusion force values. 
After storage, the variability in the force profile increased and intermittently higher friction was 
built up (Fig. IV-13c), which may be an early warning sign for arising `slip-stick´ phenomena. In 
particular, for low volume dosages, ´slip-stick´ friction profiles are troublesome as they lead to 
irregular and imprecise dosages and are uncomfortable for both health care personnel and patients 
[7,8]. 
Conceptually, the diameter of the piston (19.55 ± 0.15 mm) was slightly greater than the inner 
diameter of the container wall (19.05 ± 0.15 mm) to obtain a sufficient liquid tight engagement 
between the piston and container to exclude leakage. Throughout storage, the adhesion between 
the piston and the container wall gradually increased as the initially compressed piston relaxed 
over time. Thereby the piston ribs partially displaced baked-on silicone from the contacting 
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surface and stuck to the container wall. This phenomenon has already been described for spray-
on silicone layers [12,15,33]. The fingerprint of the piston ribs and upper piston plateau 
squeezing into the baked-on silicone layer at the flange was successfully visualized also after 
expelling stored cartridges (Fig. IV-14d). Potentially aging altered the viscoelastic properties of 
the silicone during storage. The silicone, accumulated close to the piston ribs, was not pushed 
forward during movement of the piston, but similarly remained as a fingerprint at the flange. 
Overall, the tighter contact between the piston and the container wall in combination with a less 
mobile silicone led to an additional increase in the gliding forces along the cartridge barrel after 
storage.  
a. 
 
b. 
 
c. 
 
d. 
 
Fig. IV-14. 3D-LSM images of cartridges baked-on siliconized with 13 µg and 94 µg, respectively. Baked-on 
silicone in the contact surface between (a) piston rib and container wall initially after filling, (b) piston rib and 
container wall and (c) upper piston plateau and container wall both the latter initially after filling+expelling. 
(d) Fingerprint of pistons ribs (rib edges indicated by arrows) and upper piston plateau remaining at the flange after 
storage for 80 weeks and expelling (13 µg baked-on silicone). A high baked-on silicone level of 94 µg served to 
emphasize underlying mechanism during extrusion, but respective extrusion forces were not assessed during storage. 
In addition to the silicone level, container and piston dimensions dictate the obtained extrusion 
forces. It is reported, that by increasing the inner diameter of the container from 9.23 mm to 
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9.44 mm compared to a piston of 9.6 mm in diameter, the pressure applied by the piston on the 
container surfaces and the friction forces are reduced [15]. 
Other studies showed that higher silicone levels up to 0.25 mg or 0.4 mg could enable constant 
extrusion forces of 2.5 N and 10 N for 24 month after filling with buffer and protein formulation, 
respectively [18]. But, spray-on siliconized syringes typically show a gradual increase in 
extrusion forces with storage time, even though higher silicone levels of 0.2-1 mg per 1 mL PFS 
are applied [8,13,16–18,20–23]. An increase in break-loose forces from 5 N to 12 N after 
12 weeks of storage was found in combination with moderate gliding forces reaching 4 N 
compared to initially 2 N (silicone level was not disclosed) [33]. Comparably, in a dip 
siliconization process using 1 % silicone solution in heptane, break-loose forces increased from 
3 N to 8 N after 91 days, whereas gliding forces increased much less from 3 N to 4 N [15]. 
Higher silicone levels can prevent or mitigate storage-related loss in performance, but excess 
spray-on silicone can migrate to the cartridge edge and drip out onto the tub insert sheet when 
stored tip-up [20], or accumulate at the bottom-line when stored horizontally [17]. 
Consequently, a reasonable silicone level balances reliable functionality throughout storage, but 
still limits excess silicone oil that may sloughs of into solution or redistributes. For functionality 
during storage, container and piston dimensions may play an important role to understand 
underlying mechanisms such as silicone displacement during expelling and squeezing of piston 
ribs into the silicone layer, which in turn impact extrusion forces during storage.  
In this study, both baked-on silicone levels resulted in acceptable long-term break-loose forces 
below 30 N, which is considered as a reasonable reference value in this study. A baked-on 
silicone level of 13 µg was inadequate to maintain gliding forces below 15 N throughout storage. 
Therefore, a silicone level of 27 µg is recommended for longer storage times.  
3.4 TRANSFER OF SPRAY PARAMETERS TO A DIFFERENT TWO-FLUID 
NOZZLE SYSTEM  
Spray quantity and nozzle position below the flange were shown to be key parameters that 
determined the distribution of the baked-on silicone layer. A change in system design may also 
drastically affect the established optimized spray parameters. Therefore, the performance of a 
second two-fluid nozzle provided by Optima packaging group GmbH was investigated (Fig. 
IV-15 and Fig. IV-16).  
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a. 
 
b. 
 
Fig. IV-15. Characterization of different spray quantities of an Optima spray nozzle using 4 mg, 16 mg, 28 mg in 
(a) high-speed images and (b) mean extrusion forces, baked-on silicone levels as determined by FTIR and 
theoretically sprayed silicone amounts derived from gravimetric vial analysis (30 mm nozzle position below the 
flange, spray pressure 1 bar, time for pump dosing 175 ms, 1.75 % (w/w) emulsion concentration).  
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The absolute spray amounts of the Optima and B+S spray nozzle were comparable with 
3.7 ± 0.3 mg, 16.2 ± 0.7 mg, 27.5 ± 0.0 mg and 4.0 ± 0.5 mg, 16.1 ± 0.7 mg, 29.0 ± 0.4 mg 
silicone emulsion, respectively. The Optima nozzle was less capable to atomize low spray 
quantities of 4 mg, whereas it outperformed the B+S nozzle regarding higher spray quantities 
(Fig. IV-15a).  
The poorer atomization of low spray quantities was reflected in higher extrusion forces (Fig. 
IV-15b). A spray quantity of 16 mg, i.e., a baked-on silicone level of 161 ± 15 µg, was required 
to achieve extrusion forces below 5 N. To the contrary, for the B+S nozzle a spray quantity of 
4 mg, i.e., a baked-on silicone level of 45 ± 4 µg was sufficient for extrusion forces below 5 N. 
Consequently, spray quantity and atomization quality were confirmed as key parameters during 
development of an optimized bake-on siliconization process with low, but sufficient silicone 
levels. 
a. 
 
b. 
 
Fig. IV-16. Characterization of different nozzle positions of an Optima spray nozzle at 20 mm, 30 mm and 40 mm 
below the flange in (a) high-speed images and (b) extrusion forces, baked-on silicone levels as determined by FTIR 
and theoretically sprayed silicone amounts derived from gravimetric vial analysis (16 mg spray quantity, spray 
pressure 1 bar, time for pump dosing 175 ms, 1.75 % (w/w) emulsion concentration). 
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The swirl inset within the annular air channel of the more versatile B+S nozzle enabled a spray 
angle of approximately 45° compared to the simple external mixing Optima nozzle with its lower 
spray angle [47]. In particular, the more intense center of the spray cone with a low spray angle 
of approximately 15-20° led to a lower optimal nozzle position of 30 mm below the flange (Fig. 
IV-16a and Fig. IV-16b).  
In theory, the Optima full cone nozzle design in combination with a steeper spray cone results in 
a poor atomization quality and increased droplet size compared to the wider, hollow, cone 
designed B+S nozzle [46,47]. Interestingly, the Optima spray nozzle showed a better atomization 
of higher spray quantities. It can be argued, that a longer wetted perimeter forms a thinner liquid 
film, which is disintegrated into smaller droplets [43,47]. 
Consequently, within siliconization processes based on similar equipment designs including 
pump and nozzle, optimized spray parameters may be easily transferable from bench-top to pilot-
scale or even larger manufacturing-scale siliconization units [13]. However, a change of nozzle 
may be challenging and will most probably lead to a different set of optimal spray parameters. 
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4 CONCLUSION 
An optimized bake-on siliconization process was designed to achieve defined baked-on silicone 
levels with lower limits of approximately 10 µg/cartridge barrel in combination with extrusion 
forces below 10 N. An improved atomization quality of a 4 mg spray quantity was most crucial to 
yield thin, homogeneous silicone layers. Spray quantities of 16 mg and 29 mg led to emulsion 
runlets forming thicker build-ups at the flared cartridge edge, which did not improve extrusion 
performance. A longer time for pump dosing was beneficial for the atomization of higher spray 
quantities, whereas higher spray pressures were not of advantage. To achieve adequate baked-on 
silicone levels ranging from 10-100 µg and thin homogeneous silicone layers below 50 nm, it can 
be recommended to maintain an optimized atomization quality, i.e., spray quantity, and adjust the 
emulsion concentration instead. The distribution of the baked-on silicone layer was substantially 
affected by the nozzle position. The silicone distribution was tailored and used in this particular 
case a nozzle position of 20 mm below the flange to yield thicker baked-on silicone layers at the 
flange, thereby facilitating smooth break-loose of the piston. Throughout long-term storage, a 
silicone level of approximately 30 µg resulted in adequate extrusion forces below 15 N.  
The explored set of key process parameters affecting the spray pattern and characteristics of the 
baked-on silicone layer was successfully transferred to a second, differently designed nozzle 
using a fast optimization approach including high-speed images, FTIR quantification and 
extrusion force measurements. High-speed images were very effective in directly characterizing 
the atomization quality and the initial distribution of the silicone emulsion. From experiments 
performed with the B+S nozzle, this initial distribution of the silicone emulsion had a pivotal role 
for the uniformity of the baked-on silicone layer later-on. From an industry perspective, engineers 
and scientist can benefit from a fast optimization approach, but for advanced characterization of 
the baked-on silicone layer, additional 3D-LSM analysis is highly recommended.  
The established bake-on siliconization process in this study balances both sufficient, but limited 
silicone levels in combination with specifically-tuned silicone distributions and adequate 
functionality, which presents a substantial challenge in current siliconization processes. 
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5 SUPPORTING INFORMATION 
 
Fig. S IV-1. Design of the external mixing two-fluid nozzle from B+S with its individual components (left side) and 
nozzle orifice (right side). The nozzle consists of an inner concentric tube with a sensor dummy resulting in an 
annular slit for liquid supply. The air streams concentrically through the outer tube. 
 
Fig. S IV-2. Mean extrusion forces after filling with highly purified water and placebo (20 mM histidine buffer, 
pH 6, 0.04 % (v/w) polysorbate 20 (optimized spray parameters: spray quantity 4 mg, fixed nozzle position of 
20 mm below the flange, spray pressure 1 bar, time for pump dosing 175 ms). 
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6 ABBREVIATIONS 
3D-LSM  3D-laser scanning microscopy 
ALT Average layer thickness 
B+S Bausch+Ströbel 
FTIR Fourier transform infrared (spectroscopy) 
LOQ Limit of quantification 
PFS Pre-filled syringes 
VSI Vertical scanning interferometry 
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ABSTRACT  
Combination products have become popular formats for the delivery of parenteral medications. 
Bake-on siliconization of glass syringes or cartridges allows good piston break-loose and gliding 
during injection at low silicone levels. Although widely implemented in industry, still little is 
known and published on the effect of the bake-on process on the silicone level, layer thickness 
and chemical composition. In this study, cartridges were bake-on siliconized in a heat-tunnel by 
varying both temperature from 200 to 350 °C for 12 min and time from 5 min to 3 h at 316 °C. 
Furthermore, a heat-oven with air-exchange was established as an experimental model. Heat 
treatment led to a time- and temperature-dependent decrease in the silicone level and layer 
thickness. After 1 h at 316 °C lubrication was insufficient. The silicone levels substantially 
decreased between 250 and 316 °C after 12 min. After bake-on, the peak molecular weight of the 
silicone remained unchanged while fractions below 5,000 g/mol were removed at 316 and 
350 °C. Cyclic low molecular weight siloxanes below 500 g/mol were volatilized under all 
conditions. Despite most of the baked-on silicone was solvent-extractable, contact angle analysis 
indicated a strong binding of a remaining, thin silicone film to the glass surface. 
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1 INTRODUCTION 
Pre-filled syringes and cartridge-based drug/device combination products have gained wide 
acceptance in the delivery of parenteral drug products due to several advantages including ease of 
self-administration, accurate dosing, decreased risk for contamination, and less overfill [1–5].  
Silicone oil is used as lubricant allowing the piston to break-loose and glide smoothly within the 
glass barrel during injection [6–9]. Siliconization is performed by either spraying-on silicone oil, 
e.g., Dow Corning 360 Medical Fluid, referred to as spray-on siliconization, or by applying 
silicone emulsion such as diluted Dow Corning 365 35 % Dimethicone NF Emulsion, followed 
by bake-on at elevated temperature of approximately 300 °C for 10-30 min [10–16]. Bake-on 
siliconization results in relatively lower silicone levels < 0.1 mg/barrel [17–19] compared to 
spray-on siliconization with 0.2-1 mg/barrel [8,16,17,20–25]. Alternative siliconization methods 
include dip coating of Dow Corning 360 Medical Fluid dissolved in solvent [26,27] or applying 
cross-linkable silicone, such as VDT-731 by plasma-enhanced chemical vapor deposition [28] 
and Dow Corning MDX4-4159 with subsequent polymerization by ultraviolet irradiation or by 
curing at elevated temperature [27].  
The main advantage of bake-on siliconization is to limit silicone migration into the drug product 
without compromising functionality [18,20,21,24,26,29,30]. However, based on thermal 
decomposition during bake-on, it has been argued that the processing window is narrow due to a 
change in the silicone bulk properties and the potential impact on extrusion forces [21]. 
Volatilization, depolymerization and thermo-oxidation have been identified as main mechanisms 
during thermal decomposition of silicone oil. The most commonly used lubricant trimethylsiloxy-
endcapped polydimethylsiloxane (PDMS) [31] decomposes into volatile low molecular weight 
siloxanes (LMWS), SiO2, H2O and CO2 [32–34]. In parallel, thermo-oxidation may initiate cross-
linking via a complex radical mechanism [33]. As both processes overlap to some extent, the 
change in molecular weight of the polymer is hardly predictable. Thomas et al. found either a 
negligible change or decrease in molecular weight depending on both thermal depolymerization 
and rearrangement of siloxane bonds compensating each other in vacuum [34]. Mundry et al. 
suggested an increase in number and weight average molecular weight (Mn and Mw) attributed to 
the volatilization of a significant portion of LMWS while the peak average molecular weight 
(Mp) remained unchanged. Therefore, cross-linking was unlikely to be the main mechanism upon 
bake-on [10]. Suitable methods to analyze the molecular weight of PDMS are gel permeation 
chromatography (GPC) followed by matrix-assisted laser desorption/ionization time-of-flight 
Chapter V 
92 
mass spectrometry [35,36], evaporative light scattering detection [37,38], inductively coupled 
plasma atomic emission spectrometry [39] or refractive index detection (RID) [10,40,41]. 
The application of silicone oil in health care includes usage as lubricant [31], for the treatment of 
retinal detachment and for soft tissue augmentation due to its biological inertness [42]. However, 
certain LMWS contained as residues from polymer synthesis [43,44] have been assessed for their 
toxic effect. Cyclic LMWS, i.e., cyclodimethylsiloxanes, are indicated as Dn where 
D = [(CH3)2SiO]. In particular, D4 has been associated with impaired fertility (D4 is labeled 
reproductive category II, globally harmonized system [45]). Both D4 and D5 were related to 
potential carcinogenic effects resulting in an increase in uterine tumors, as well as hepatomegaly 
in rats and mice [46,47]. LMWS are known to migrate into various, preferentially lipid-rich 
compartments [48], which increases the risk for a wide and persistent distribution throughout the 
body in mice [49] and human plasma of implant recipients [50]. Other studies suggested D4-
induced denaturation and aggregation of fibronectin and fibrinogen [51,52]. Consequently, the 
thermal decomposition of PDMS into LMWS during bake-on may be of critical toxicological 
concern.  
Most studies mainly investigated the decomposition of silicone bulk samples exposed to artificial 
heat-treatment rather than using baked-on silicone, solvent-extracted from syringes or cartridges. 
Therefore, though thermal “fixation” and “chemical binding” of silicone to the glass surface is 
often postulated [7,13], it is still rarely investigated. After solvent extraction, very thin baked-on 
silicone layers covalently bound to the glass surface have been found by Mundry et al.; however, 
most baked-on silicone was still solvent-soluble and therefore a general fixation of the baked-on 
silicone layer is postulated to be unlikely [12]. 
Thus, there is currently a substantial gap in understanding and analysis of the thermal 
decomposition of silicone emulsion upon bake-on. Although bake-on siliconization is an essential 
step during manufacturing of many parenteral drug products, minimal practical data is available. 
The purpose of this study was to investigate the impact of different burn-in times and 
temperatures on the characteristics of the baked-on silicone layer to identify an adequate 
processing range. Comparable to commercial bake-on siliconization processes, 0.6 % (w/w) 
silicone emulsion was sprayed-on using optimized spray parameters followed by bake-on in a 
heat-tunnel. We propose a toolbox of analytical methods towards full control of the baked-on 
silicone level, layer thickness distribution and coating functionality. The thermal decomposition 
of silicone and pharmaceutically relevant stabilizers of Dow Corning 365 35 % Dimethicone NF 
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Emulsion was characterized with respect to weight loss, cyclic LMWS content and molecular 
weight distribution of the silicone polymer. The formation of covalent bonds was functionally 
addressed by contact angle (CA) measurements after removal of the extractable silicone fraction. 
Finally, the silicone layer characteristics after bake-on in a heat-tunnel were compared with a 
heat-oven as an experimental model for lab-scale experiments. 
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
Non-siliconized 5 mL cartridges, pistons, serum stoppers and aluminum seals were obtained from 
F. Hoffmann-La Roche Ltd (Basel, Switzerland). Elastomeric components were coated with 
fluoropolymer (FluroTec®). Microscope glass slides were obtained from VWR International 
GmbH (Darmstadt, Germany).  
Chemicals were purchased as follows: 365 35 % Dimethicone NF Emulsion and 360 Medical 
Fluid, 350 cSt, from Dow Corning GmbH (Wiesbaden, Germany); heptane from Riedel-de Haën 
(Seelze, Germany); cyclic LMWS D3, D4, D5, methyl paraben, propyl paraben, tert-
butylmethylether and toluene from VWR International GmbH (Darmstadt, Germany); Tween 20 
from Croda GmbH (Nettetal-Kaldenkirchen, Germany); and cyclic LMWS D6, Triton X-100 
from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). ReadyCal-Kit polystyrene 
standards PSS-pskitr-04 were obtained from PSS Polymer Standards Service GmbH (Mainz, 
Germany). 
2.2 BAKE-ON SILICONIZATION PROCESS 
Bake-on siliconization was performed on a SVS9061 pilot-scale siliconization unit from Bausch 
+ Ströbel Maschinenfabrik Ilshofen GmbH+Co. KG (Ilshofen, Germany) equipped with an 
external mixing, two-fluid nozzle. Optimized spray parameters were adapted from previous 
experiments: a spray quantity of 4 mg, or alternatively of 16 mg silicone emulsion, a fixed nozzle 
position of 20 mm below the flange, a spray pressure of 1 bar and time for pump dosing of 
175 ms (see chapter IV).  
For most experiments, Dow Corning 365 35 % Dimethicone NF Emulsion was diluted to 
0.6 % (w/w) using highly purified water. A higher concentrated silicone emulsion of 3.5 % (w/w) 
was utilized for gas chromatography-mass spectrometry (GC-MS) analysis. For CA experiments, 
the emulsion was diluted to 1.75 % (w/w). 
The cartridges were subsequently treated in a TSQ U03 heat-tunnel from Robert Bosch GmbH 
(Stuttgart, Germany). Burn-in temperatures were adjusted from 200 °C to 350 °C at a constant 
treatment time of 12 min. Varying burn-in times ranging from 5 min to 3 h were studied at a 
constant temperature of 316 °C.  
The bake-on process was further investigated in a heat-oven Heraeus WU6100 from Thermo 
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Scientific Inc. (Waltham, MA, USA) without air-exchange and with air-exchange of 2.5 m
3
/h. 
For temperature profile measurements, five cartridges in the center and at each side of a wire 
basket used as holder during bake-on were equipped with two T-type thermocouples (TC) from 
GE Sensing & Inspection Technologies GmbH (Hürth, Germany) at the top and bottom of the 
individual cartridge. TCs were affixed in the cartridge using Kapton 3M™ tape from Reinhard 
Krückemeyer GmbH & Co. KG (Wilnsdorf, Germany) to secure the TC firmly against the neck 
of the cartridge. An additional TC was directly placed into the oven. TCs were calibrated from 
180 °C to 360 °C, and verified at 316 °C with a final accuracy of 315.5 °C ± 0.2 °C. At burn-in 
temperatures ≥ 200 °C a sensitivity of 1 °C is accepted to be sufficient [53]. 
2.3 EXTRACTION AND FOURIER TRANSFORM INFRARED (FTIR) 
QUANTIFICATION  
The baked-on silicone level was determined by a combination of heptane extraction (900 µL 
heptane, two rinsing steps à 900 µL) and quantitative FTIR spectroscopy. According to 
considerations provided in ICH Q2 R1 Validation Analytical Procedure, the limit of detection of 
the developed FTIR method was found to be below 1 µg/mL (number of calibration curves 
n = 22). The limit of quantification was 18 µg/mL (n = 22), equivalent to 4 µg per cartridge based 
on 250 µL dissolution volume [54] (see chapter III). 
2.4 GRAVIMETRIC ANALYSIS  
After every adjustment of the spray parameters, the emulsion spray was initially collected in a 2R 
vial, which was previously loaded with a tissue to soak up the absolute spray amount without 
evaporation loss. The vial was weighted before and after the siliconization process using an 
AT261 DeltaRange System high precision balance from Mettler-Toledo GmbH (Gießen, 
Deutschland). The absolute spray amounts were converted into theoretically sprayed silicone 
amounts using the corresponding concentration of the silicone emulsion. 
2.5 3D-LASER SCANNING MICROSCOPY (3D-LSM) 
The average silicone layer thickness (ALT) was determined using a VK-X210 microscope 
equipped with VK Viewer Software both from Keyence Deutschland GmbH (Neu-Isenburg, 
Germany) as previously reported [54] (see chapter III). The lower limit of detection was 10 nm. 
Cartridges were covered with adhesive tape, broken up and individual fragments were removed 
from the adhesive tape to enable direct measurements of the thin baked-on silicone layer. 
Chapter V 
96 
Cartridge fragments from the flange, middle and top of the cartridge were analyzed to determine 
the ALT distribution within the barrel.  
2.6 EXTRUSION FORCE MEASUREMENTS 
After bake-on siliconization, pistons and cartridges were manually assembled. The containers 
were filled with 5.16 mL highly purified water and sealed with serum stoppers and aluminum 
caps. Pistons in contact with lubricated container walls have shown to develop an initial 
resistance to movement. Therefore, movement is not initiated until a certain force is applied, 
referred to as break-loose force. After a sudden, rapid relative movement, the movement sustains 
applying a gliding force. The break-loose, minimum and maximum gliding forces were evaluated 
by using a material testing instrument TA.XT.plus from Winopal Forschungsbedarf GmbH (Elze, 
Germany) at a constant displacement speed of 5.6 mm/min over a distance of 17.5 mm 
(maximum travel distance for the piston within the cartridge barrel), thereby mimicking 
approximately 3 min injection time for a combination product with a high filling volume.  
2.7 GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) 
A higher concentrated silicone emulsion of 3.5 % (w/w) and a medium spray quantity of 16 mg 
baked-on at 316 °C for 12 min were utilized for GC-MS analysis. Cartridges were extracted as 
described above (900 µL heptane, two rinsing steps à 900 µL) (see 2.3). The extracts of four 
baked-on siliconized cartridges (baked-on silicone level 325 ± 68 µg) were pooled, evaporated to 
dryness using a flowtherm evaporator at 100 °C and constant nitrogen flow of 210 mL/min from 
Barkey GmbH & Co. KG (Leopoldshöhe, Germany). The dried sample was redissolved in 
100 µL tert-butylmethylether. In addition, 108 ± 8 mg 35 % silicone emulsion (n = 8) were 
evaporated to dryness. 1 mg/mL solutions were prepared using tert-butylmethylether. 
Cyclic LMWS and parabens were analyzed using a GC 3800 equipped with a Saturn 2000 MS 
detector using electron ionization at 70 eV both from Varian (Darmstadt, Germany). Separation 
was performed on a VF-5 MS column (30 m x 0.25 mm x 0.25 um) and a 10 m EZ-Guard 
column from Varian. Helium was used as carrier gas at a flow rate of 1.2 mL/min. The injector 
was settled to splitless for 1 min at an injection volume of 2 µL and an inlet temperature of 
250 °C. The oven temperature was held at 50 °C for 5 min, ramped to 240 °C at 25 °C/min, 
followed by a second ramp to 310 °C at 50 °C/min, and then held for 6 min. The glass liner was 
exchanged on a regular basis to avoid artefacts due to high sample concentrations.  
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Peak identification was carried out by comparison with external standards with regard to 
retention times and mass spectra (full scan range m/z 40-500). For quantification, the area under 
the curve (AUC) for selected target ions was recorded following external standard calibration in 
the concentration range of 0.1-1.5 µg/mL (supporting information Fig. S V-1a and Fig. S V-1b). 
The following target ions were used: m/z 209+224 for D3, m/z 281 for D4, m/z 355 for D5, 
m/z 342+429 for D6, m/z 121+152 for methyl paraben and m/z 121+138 for propyl paraben. 
Correlation coefficients R
2 
ranged between 0.976-1.000. Calibration was repeated in each 
sequence.  
2.8 GEL PERMEATION CHROMATOGRAPHY-REFRACTIVE INDEX 
DETECTION (GPC-RID) 
A high performance liquid chromatography system from the 1200 series from Agilent 
Technologies Deutschland GmbH (Waldbronn, Germany) equipped with RID was employed for 
GPC-RID on a SDV linear S, 300 x 8 mm, particle size 5 µm from PSS Polymer Standards 
Service GmbH (Mainz, Germany). The mobile phase was toluene with a flow rate of 0.5 mL/min. 
The temperature of the RID was set to 35 °C while the samples were cooled at 5 °C. Molecular 
weight averages were determined by ChemStation Software Rev. B 02.01 from Agilent, or 
alternatively WinGPC UniChrom Software from PSS Polymer Standards Service GmbH (Mainz, 
Germany). 
The system was calibrated with 12 polystyrene standards with peak molecular weights (Mp) 
ranging from 266 g/mol to 66,000 g/mol (supporting information Tab. S V-1, supporting 
information Fig. S V-2a) and 3
rd
 polynomial fitting with R
2
 = 0.999 (supporting information Fig. 
S V-2b). Injections of a mixture of four polystyrenes at the beginning and the end of each 
sequence were reproducible (variation coefficient not more than 0.06 %).  
The lowest injected silicone amount possible for sufficient baseline separation was 10 µg as 
determined from experiments using 0.5 mg/mL to 6 mg/mL silicone oil in toluene solutions and 
injection volumes of 10 µL, i.e., injected amounts of 5-60 µg (supporting information Fig. S 
V-3). 
To meet these low detection limits for GPC-RID analysis, cartridges bake-on siliconized with a 
medium spray quantity of 16 mg and 0.6 % (w/w) silicone emulsion were used. Bake-on 
conditions in the heat-tunnel were performed as described above (see 2.2). The dried extract of 
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bake-on silicone (see 2.3) was redissolved in 100 µL toluene. As reference, 1 mL 35 % silicone 
emulsion was solvent-extracted with 1 mL toluene. The injection volume was 50 µL. 
For describing the molecular weight distribution of silicone, the molecular weight of the peak 
maximum (Mp) in addition to the following parameters was used: 
- the number average molecular weight (Mn), which is sensitive to changes in the low molecular 
weight fraction: 
𝑀𝑛 =
∑ 𝑁𝑖𝑀𝑖
∑ 𝑁𝑖
 
Eq. V-1 
with the number of particular molecules (Ni) having a particular molecular weight (Mi)  
- the weight average molecular weight (Mw), which reflects changes in the high molecular weight 
fraction:  
𝑀𝑤 =
∑ 𝑁𝑖 𝑀𝑖 2
∑ 𝑁𝑖 𝑀𝑖
=
∑ 𝑊𝑖 𝑀𝑖
∑ 𝑊𝑖
 
Eq. V-2 
given with the weight fraction (Wi) of each type of polymer molecule. 
- the polydispersity index (PDI), which describes the width of the distribution [55]:  
𝑃𝐷𝐼 =
𝑀𝑛
𝑀𝑤
 
Eq. V-3 
2.9 THERMOGRAVIMETRIC ANALYSIS (TGA)  
A Hi-Res TGA 2950 from TA instruments (Eschborn, Germany) was used to follow the weight 
loss during heating at a constant rate of 2 °C/min in ramp mode. In isothermal mode, the 
temperature was increased to 55 °C at a rate of 28 °C/min, held for 12 min, followed by a second 
increase to 316 °C at 28 °C/min, held for 3 min, and finally decreased to 18.4 °C with a rate of 
11 °C/min. Set target temperatures mimic the heat profile in the heat-tunnel, whereas the ramp 
increments in isothermal mode were derived from temperature mapping in the heat-oven. 
Approximately 20-30 mg sample was weighted into 40 µL aluminum pans from Mettler-Toledo 
GmbH (Gießen, Germany) and purged with air at a flow rate of approximately 60 mL/min during 
TGA analysis.  
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2.10 CONTACT ANGLE (CA) MEASUREMENTS  
CAs of 2 µL purified water drops were determined using a Drop Shape Analyzer from Krüss 
GmbH (Hamburg, Germany) in sessile drop mode. CAs were calculated with Krüss Advance 
1.1.02 software 20 s after drop deposition using ellipse (tanget-1) for siliconized samples and 
circle fitting for glass samples based on recommendations of the manufacturer. The baseline was 
set to manual or manual curved.  
For CA analysis, samples were prepared as follows: 3 mL of diluted 1.75 % (w/w) silicone 
emulsion were transferred as a thin fluid layer in a borosilicate glass beaker of 9.5 cm diameter, 
heated at 295 °C for 12 min and extracted with 3 mL heptane. Aliquots of 200 µL were 
evaporated to dryness at room temperature and redissolved in 140 µL heptane to achieve final 
concentrations of 2.5 % (w/v). In addition, 2.5 % (w/v) silicone solutions in heptane were 
prepared. Glass slides were cut into 2.5 x 2.5 cm pieces and siliconized with 5 x 6 µL drops of 
silicone or heat-treated silicone in heptane on a SCI-20 spin-coater from Schaefer Technologies 
GmbH (Lange, Germany) at 100 rpm. Both coatings were established to model bake-on and 
spray-on siliconized glass surfaces, respectively. 
The extraction of these siliconized glass slides was performed by rinsing with 884 µL heptane to 
maintain a similar volume-to-surface-ratio of 141 µL/cm
2
 as valid for cartridge extraction using 
3 x 900 µL heptane. Baked-on siliconized cartridges were initially extracted as described above 
(900 µL heptane, two rinsing steps à 900 µL) (see 2.3). Subsequently, cartridge fragments were 
prepared as described above (see 2.5). Additional extraction regimes included incubation of 
slide/cartridge pieces in 20 mL heptane and ultrasound bath treatment (VWR International 
GmbH, Darmstadt, Germany) for 10 min, as well as wiping with cotton swabs, soaked in 
heptane. After extraction, surfaces were rinsed 10 s with purified water to remove adhering 
heptane and subsequently dried at room temperature. Different harsh extraction regimes were 
employed to challenge the extractability of the different silicone coatings and to functionally 
assess the interactions between silicone and the glass surface. 
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3 RESULTS AND DISCUSSION 
3.1 IMPACT OF BURN-IN TIME AND TEMPERATURE ON THE BAKED-
ON SILICONE LEVEL, LAYER THICKNESS DISTRIBUTION AND 
COATING FUNCTIONALITY  
Cartridges were bake-on siliconized in a heat-tunnel using both different burn-in temperatures 
from 200 °C to 350 °C for 12 min and burn-in times from 5 min to 3 h at 316 °C. The baked-on 
silicone level, layer thickness distribution and coating functionality were evaluated to identify an 
adequate processing range.  
The baked-on silicone level markedly decreased from 26 ± 6 µg and 28 ± 4 µg at 200 °C and 
250 °C, respectively, to 13 ± 3 µg and 11 ± 3 µg at temperatures of 316 °C and 350 °C (Fig. 
V-1a). The different burn-in temperatures did not affect the extrusion forces between 4-7 N.  
a. 
 
b. 
 
Fig. V-1. Extrusion forces, baked-on silicone levels as determined by FTIR and theoretically sprayed silicone 
amount derived from gravimetric vial analysis at burn-in temperatures between 200 °C and 350 °C (12 min) and 
burn-in times between 5 min and 3 h (316 °C) in a heat-tunnel using (a) 4 mg spray quantity and (b) 16 mg spray 
quantity. Asterisks indicate baked-on silicone levels below the limit of quantification of 18 µg/mL, i.e., 
< 4 µg/cartridge based on 250 µL dissolution volume [54] (see chapter III). 
With increasing burn-in times from 5 min to 3 h, the baked-on silicone was steadily burned-off at 
316 °C from 20 ± 1 µg to below 4 µg, which was the lower limit of detection [54] (see chapter 
III). After 1 h at 316 °C an insufficient lubrication was found as indicated by the increase in the 
maximum gliding force to 15 N, which was considered as reference value in this study. The 
break-loose forces exceeded 30 N after 3 h. Both break-loose and gliding forces have to be 
carefully evaluated depending on the injection device used. Overall, for patient-friendly injection, 
maximum gliding forces of 15-20 N were reported [56]. In addition, target values of 15 N were 
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suggested in studies comparing siliconized and BD-42 coated glass syringes [23] and assessing 
the gliding performance for high-concentration monoclonal antibody powder suspensions [57]. 
For empty cartridges a gliding force limit of 10 N is suggested in EN ISO 11608-3 [58]. In other 
studies, maximum forces were fixed at 30 N while rheumatoid arthritis patients were able to exert 
average forces of 28 N and up to a maximum of 45 N [59].  
At moderate burn-in conditions, e.g., 200 °C, 250 °C for 12 min, the baked-on silicone levels 
were in good agreement with the theoretically sprayed silicone amount of 24 ± 3 µg. In a 
previous study, the difference between both values was established as an estimate for spray loss 
(see chapter IV). In this study, it additionally illustrates the reduction of silicone depending on the 
burn-in conditions. Consequently, at 200 °C and 250 °C for 12 min the optimized spray 
parameters led to a quantitative spray process without spray loss and minimal burn-off. 
Therefore, the decrease in the baked-on silicone level at 316 °C ( 15 µg) could be exclusively 
attributed to burn-off rather than spray loss.  
Higher baked-on silicone levels obtained with a medium spray quantity of 16 mg remained 
relatively constant at approximately 68 ± 6 µg to 80 ± 17 µg regardless of the burn-in 
temperature (Fig. V-1b). Extrusion forces remained between 3-7 N. After 30 min at 316 °C the 
baked-on silicone level dropped from 78 ± 15 µg to 27 ± 7 µg and further decreased below 4 µg 
after 3 h. Simultaneously, the gliding forces exceeded 15 N and the break-loose forces increased 
above 30 N. 
At a medium spray quantity of 16 mg, the baked-on silicone level was systematically lower 
compared to the theoretically sprayed silicone amount, even at moderate burn-in conditions of 
200 °C and 250 °C. Consequently, the spray loss was approximately 18-30 %. The rate of burn-
off should be comparable to a low spray quantity of 4 mg, e.g., 15 µg between 250 °C and 
316 °C, as elaborated above. However, a medium spray quantity resulted in a higher variability of 
baked-on silicone levels, which therefore did not directly reflect these slight reductions due to 
burn-off.  
Silicone oil manufacturers suggest a burn-in temperature below 250 °C or even below 150 °C for 
less than two hours, or higher temperatures for substantially shorter time periods [11,60]. Also, 
temperatures above 250 °C [21], up to 320 °C for 15 min, 20 min, 28 min [10,12] or even 350 °C 
[61] are reported. Consequently, the investigated temperature range of 200°C to 350°C and burn-
in time of 12 min, which was routinely used, were in agreement with literature. Nonetheless, 
bake-on conditions in siliconization processes are still not ´standardized´ and are in practice often 
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driven and limited by the temperature and passage time settings for the sterilization and 
depyrogenation of the containers. Adequate sterilization and depyrogenation were not within the 
scope of the study. Of course, this must be verified in a commercial bake-on siliconization 
process. Final temperature and time settings are mutually related: with increasing burn-in 
temperature, the burn-in time may be reduced. However, both settings eventually need to balance 
adequate evaporation of emulsion water, sterilization, depyrogenation and a decrease in silicone 
level, and ultimately extrusion performance [7,15,16,60]. Both applied spray quantities were low 
with 4 mg and 16 mg, thus emulsion water was completely evaporated after bake-on. Thermal 
decomposition started between 250 °C and 316 °C, which was well in line with TGA analysis 
(see 3.2.1). Consequently, only 5 min at 316 °C were sufficient to initiate thermal decomposition, 
but overall burn-in times up to 1 h were not critical with regard to extrusion performance. 
However, for bake-on siliconization processes with minimum silicone levels, interruptions longer 
than 1 h are suggested to be avoided. 
The thin baked-on silicone layers ranged from 10 nm to 70 nm (10 nm was the lower limit of 
detection [54] (see chapter III)) (Fig. V-2).  
 
Fig. V-2. Baked-on silicone layer thickness after 5 min, 12 min and 1 h burn-in at 316 °C and after 12 min burn-in at 
200 °C in a heat-tunnel using a spray quantity of 16 mg. ALT in three different sections within the cartridge barrel 
(* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001). 
Overall, the achieved baked-on silicone layers were thin compared to spray-on silicone layers in 
the range of 50-400 nm with some areas up to 900 nm thickness [21,24,25,62]. Baked-on silicone 
layers of approximately 50 nm to 100 nm were only exemplarily determined using interferometry 
[25]. The effect of bake-on on the ALT was not as clearly reflected as compared to the decrease 
in the baked-on silicone levels. Still a short burn-in time of 5 min at 316 °C and a low burn-in 
temperature of 200 °C for 12 min resulted in a higher ALT. At less moderate burn-in conditions, 
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the thinner ALTs indicated thermal decomposition. However, the effect of the measuring position 
(flange, middle, top) was more pronounced. As described previously, the higher ALT in the 
flange and middle region was attributed to the fixed nozzle position of 20 mm below the flange, 
where the spray cone exactly reached the cartridge flange (see chapter IV). 
To our knowledge, the processing window for bake-on siliconization processes is rarely 
investigated. A decrease in CA from 101° to 31° with increasing burn-in temperatures from 300-
550° for 15 min [63] and from 97° to 26° at 320-600 °C for 15 min suggested silicone being 
burned-off with higher temperatures [14]. However, different CAs may also indicate a different 
orientation of PDMS on the glass surface [64,65], which aggravates interpretation. In this study, 
the effect of different burn-in times and temperatures on the baked-on silicone layer, layer 
thickness and extrusion performance was demonstrated.  
3.2 THERMAL DECOMPOSITION BEHAVIOR OF SILICONE EMULSION  
 THERMAL DECOMPOSITION MECHANISMS AND THERMAL WEIGHT 3.2.1
LOSS OF SILICONE EMULSION AND SELECTED STABILIZERS  
Dow Corning 365 35 % Dimethicone NF Emulsion, which is most commonly used for bake-on 
siliconization processes, contains approximately 35 % Dow Corning 360 Medical Fluid, 350 cSt, 
in water and additional stabilizers such as preservatives (methyl paraben and propyl paraben), 
non-ionic surfactants (Tween 20 and Triton X-100) and co-solvents (propylene glycol) up to 5 % 
each [60,66]. Therefore, thermal decomposition and thermal weight loss of silicone emulsion and 
selected stabilizers in air were evaluated by TGA (Fig. V-3).  
Silicone emulsion showed a weight loss of approximately 56 % upon a temperature increase from 
50 °C to 100 °C, which can be attributed to the evaporation of emulsion water, followed by a 
second weight loss with three overlapping stages in the overall decomposition process (Fig. 
V-3a). TGA profiles for silicone oil and silicone emulsion in air were similarly reported in 
literature [14,33,34]. The small weight loss starting at 200 °C may be attributed to the 
volatilization of low molecular weight fractions remaining as precursors from polymer 
production, which has been described to occur between 150 °C and 250 °C [34,43,44]. The 
second stage with an onset of 313 ± 5 °C was assigned to thermo-oxidation, mainly resulting in 
SiO2, H2O and CO2 [32,33], which was reported to take place around 290-350 °C [33,34,67]. In 
this study, 6 % remained as white silica powder. In literature, it was postulated that condensed 
phase oxidation via a radical mechanism crosslinks the polymer and slows down decomposition 
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of that stage [33]. Thermal depolymerization proceeds via cleavage and rearrangement of 
siloxane bonds to form cyclic LMWS that evaporate [34]. Depolymerization starts at about 350-
410 °C [33,34,68] and is reflected in a third stage of decomposition around 400 °C in this study. 
Overall, both degradation steps finally result in a similar mixture of volatile LMWS with 
additional SiO2, H2O and CO2 [32,33]. 
a. 
 
b. 
 
Fig. V-3. Exemplary TGA of Dow Corning 365 35 % Dimethicone NF Emulsion and its individual ingredients in 
(a) temperature ramp mode and (b) isothermal mode. Vertical, dashed lines indicate standard burn-in conditions of 
316 °C for 12 min. Different stages of the thermal decomposition process were assigned to volatilization of low 
molecular weight fractions 1, thermo-oxidation 2 and depolymerization 3. 
Interestingly, a substantial decrease in the baked-on silicone level was observed between 250 °C 
and 316 °C as described above, which correlates well with the onset of the second weight loss in 
TGA at 313 ± 5 °C. Although the different points of inflection and decomposition stages can be 
assigned to volatilization, thermo-oxidation and thermal depolymerization according to literature, 
all processes overlap to some extent [34] and therefore contribute to the decrease in the baked-on 
silicone level. In addition, oxygen further catalyzes thermal depolymerization, which results in 
lower onset temperatures [33].  
In isothermal mode at 316 °C after the initial evaporation of water, the weight loss was less 
pronounced but steadily proceeded (Fig. V-3b). This was in agreement with the gradual decrease 
in baked-on silicone levels with increasing burn-in time. 
Selected stabilizers of the silicone emulsion, including the preservatives methyl paraben and 
propyl paraben and the co-solvent propylene glycol, completely evaporated below the target 
burn-in temperature of 316 °C. Onset temperatures for the weight loss of propylene glycol, 
methyl and propyl paraben were 97 °C, 160 °C and 179 °C, respectively, in agreement with 
evaporation following zero-order kinetic [69–71]. Consequently, residues of parabens in the 
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baked-on silicone are unlikely. In addition, combinations of methyl paraben and propyl paraben 
in ratios of 7.5:1 or 9:1 are reported as preservative in parenteral formulation, but still the typical-
in-use concentration for each paraben in parenteral biologics is limited to not more than 0.2 % 
[72–75]. Potential minute amounts of parabens remaining in the baked-on silicone were further 
investigated in GC-MS (see 3.2.3). Propylene glycol is not considered as a critical residue in the 
baked-on silicone due to complete evaporation below 316 °C. In addition, it is one of the most 
commonly used co-solvents in parenteral formulations and used up to 80 % in injectables [76,77]. 
For emulsion stability, it is beneficial as it prevents interactions between parabens and Tween 20 
[78]. 
Surfactants such as Triton X-100 and Tween 20 were degraded up to 73 % and 60 % at 316 °C, 
respectively. The onsets for weight loss were at 211 °C for Tween 20 and 234 °C for Triton X-
100. Tween 20 is widely found in parenteral products, e.g., as stabilizer inhibiting protein 
adsorption and aggregation [76,79,80]. Upon heating with and without the addition of water, 
autoxidation is the major degradation pathway, resulting in traces of acetaldehyde, hexane, 
pentane and heptanal, which immediately volatilize [81]. However, in therapeutic protein 
formulations during storage, degradation products such as peroxides, short chain acids (e.g., 
formic acid) and polyoxyethylene esters of fatty acids were found, which may eventually affect 
protein stability [81–85]. In a hypothetical situation with a maximum of 5 % Tween 20 in Dow 
Corning 365 35 % Dimethicone NF Emulsion [66], which was diluted to 0.6 % (w/w) in our 
study, a spray quantity of maximum 16 mg and a theoretical residue of 40 % Tween 20, 
approximately 6 µg Tween 20 would remain in the baked-on silicone layer. Based on a cartridge 
filling volume of 5.16 mL, a maximum of 0.0001 % Tween 20 may end up in the final drug 
product assuming complete migration from the baked-on silicone layer into the formulation. 
Compared to concentrations up to 0.4 % in antibody drugs [86], residues of Tween 20 remaining 
in the baked-on silicone layer can be considered not critical. A comparable low amount 
< 0.0001 % would be reached for Triton X-100. However, limited information are being 
published for the use of Triton X-100 as excipient [87,88] in parenteral formulations, but still, it 
is present in traces in marketed vaccine [89]. 
Overall, dilution of the emulsion prior to bake-on alone effectively dilutes all stabilizers to very 
low levels and reduces a potential interaction of emulsion stabilizers present in the silicone layer 
with the drug product formulation. This is further mitigated by fully or partially evaporation of 
these compounds during thermal bake-on. 
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 MOLECULAR WEIGHT DISTRIBUTION OF BAKED-ON SILICONE  3.2.2
The molecular weight of untreated silicone emulsion and after bake-on was investigated using 
GPC-RID (Fig. V-4).  
a. 
 
 
b. 
 
c.
 
d.
 
Fig. V-4. Molecular weight distribution of PDMS in untreated Dow Corning 365 35 % Dimethicone NF Emulsion 
and after bake-on at temperatures between 200 °C and 350 °C (12 min) in a heat-tunnel using a 16 mg spray 
quantity. (a) and (b) GPC-RID elution profiles of both duplicates, (c) average molecular weights and (d) PDI. 
Cartridge extracts were used for analysis (n = 2). 
Molecular weight parameters for the silicone emulsion with Mn 14,373 ± 630 g/mol, Mw 
22,700 ± 132 g/mol, Mp 22,914 ± 218 g/mol (Fig. V-4c), and PDI of 1.48 ± 0.15 (Fig. V-4d) were 
within the range reported for silicone oils of 350 cSt and 1,000 cSt [10,38,40,90]. After burn-in at 
316 °C and 350 °C for 12 min the lower molecular weight fraction eluting later than 17 min, i.e., 
< 5,000 g/mol (Fig. V-4a and Fig. V-4b), was removed most likely due to volatilization [10]. 
Accordingly, with burn-in temperatures from 200 °C to 350 °C, the Mn steadily increased from 
15,155 ± 1,236 g/mol to 17,463 ± 892 g/mol compared to a lower Mn of silicone emulsion of 
14,373 ± 630 g/mol. Simultaneously, the relative proportion of higher molecular weight fractions 
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increased, which was reflected in the Mw increase from 22,217 ± 1,275 at 200 °C to 
26,896 ± 1,304 g/mol at 350 °C. The Mw of the initial silicone emulsion (22,700 ± 132 g/mol) 
was comparable to the Mw at 200 °C. 
Likewise, Mundry et al. found a reduction of volatile fractions between 0-7,400 g/mol after bake-
on at 320 °C for 28 min, which led to a relative increase in higher molecular weight fractions. 
The Mn and Mw slightly increased from approximately 12,500 g/mol to 17,000 g/mol and 
19,000 g/mol to 21,000 g/mol, respectively [10].  
Furthermore, it can be argued that the Mw increase may be induced by thermo-oxidative cross-
linking [33,34] rather than a change in the relative proportion of higher molecular weight 
fractions. In this study, insufficient baseline separation towards an artefact peak at 10.5 min, 
which was comparably found in non-siliconized and siliconized cartridges after extraction, 
rendered data interpretation difficult. But it has to be kept in mind that chain-lengthening has 
been only observed for hydroxyl-endblocked PDMS after intermolecular condensation rather 
than in trimethylsiloxy-endcapped PDMS [34]. 
In addition, at 316 °C and 350 °C tailing between 14.5-17 min was more pronounced, indicating 
a higher fraction of polymers between 5,000-15,000 g/mol as cleavage products after 
depolymerization. Depolymerization rapidly proceeds to completion until cleavage products 
below 5,000 g/mol finally evaporate [34]. 
The peak maxima at different temperatures from 200 °C to 350 °C were similar at 13.5-14 min. 
Consequently, the Mp remained unchanged between 22,685 ± 107 and 23,777 ± 114 g/mol and 
was comparable to the initial Mp of silicone emulsion with 22914 ± 218 g/mol. The PDI remained 
unchanged as well with 1.46 ± 0.04 to 1.58 ± 0.01. Likewise, Mundry et al. found a negligible 
change in Mp in the range of 18,000-19,000 g/mol after bake-on at 320 °C for 28 min [10]. Our 
findings were in good agreement with this study, although the GPC-RID system was calibrated 
with polystyrene instead of PDMS standards.  
Overall, GPC-RID was successfully transferred to relevant baked-on silicone levels below 80 µg 
and a wider range of burn-in conditions. Interestingly, already burn-in temperatures of 200 °C 
and 250 °C slightly altered the average molecular weights. A more pronounced change in the 
molecular weight distribution was observed at 316 °C and 350 °C.  
Burn-in times of 5 min and 12 min at 316 °C showed comparable average molecular weights. 
Analysis of longer burn-in times was not feasible due to poor baseline separation, indicating 
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depolymerization and evaporation of the decomposed silicone species under such conditions, 
even though two cartridge extracts were pooled.  
 ANALYSIS OF CYCLIC LOW MOLECULAR WEIGHT SILOXANES 3.2.3
(LMWS) AND PARABENS IN BAKED-ON SILICONE  
Similar, consecutive cyclic LMWS with repeating units of dimethylsiloxane are either formed 
together with the polymer in synthesis or produced in the thermal depolymerization process 
[34,44], independent of the applied pyrolysis temperature, initial silicone viscosity [91] or 
whether thermal decomposition is performed in air or inert atmosphere [32]. Dow Corning 365 
35 % Dimethicone NF Emulsion and baked-on silicone (316 °C for 12 min) extracted from 
cartridges were analyzed for cyclic LMWS by GC-MS. In addition, GC-MS was utilized to track 
minute amounts of parabens. GC-MS has been reported as sensitive method to characterize 
LMWS [10,92,93] and parabens [94,95]. 
Referred to 100 µg silicone, the initial silicone emulsion contained 0.12 % (123 ± 50 ng) D3, 
0.04 % (40 ± 22 ng) D5 and 0.03 % (30 ± 15 ng) D6 (Fig. V-5).  
 
Fig. V-5. Cyclic LMWS in untreated Dow Corning 365 35 % Dimethicone NF Emulsion (n = 8, each performed as 
double injection). Asterisk indicates LMWS < calibration range 0.1 µg/mL, i.e. 10 ng LMWS/100 µg silicone. 
D3 is used as precursor in polymer synthesis [43] and is consequently present at higher levels. 
The amounts of cyclic LMWS from D6 to D10 in Dow Corning Medical Fluids, 100-12500 cSt, 
have been reported to be below a detection limit of 1 µg/mL [96]. Species up to 3,700 g/mol, i.e., 
up to 50 siloxane units, are less than 1.65-2.35 % [10]. Overall, volatile species are limited to 2 % 
in the pertinent Ph. Eur. monograph [31]. Consequently, with approximately 0.2 % cyclic LMWS 
in untreated silicone in this study we were well within the limits given for LMWS.  
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GC-MS demonstrated that the amount of cyclic LMWS in the baked-on silicone after extraction 
was below 0.001 %, referred to the lowest calibration range for cyclic LMWS of 0.1 µg/mL and a 
high baked-on silicone concentration of 13 mg/mL used in this study (see 2.7). From TGA 
analysis it is known, that PDMS breaks down between 200-450 °C. Upon thermal decomposition 
in air, cyclic LMWS in the range of D3-D9 [44], D3-D14 [32], D3-D7 [91] are formed with D3 
being the most prominent species [32,44,91]. However, these species are immediately removed 
during bake-on due to their volatile properties [10,96]. In addition, GPC showed a reduction in 
the lower molecular weight fraction < 5,000 g/mol (see 3.2.2) and volatilization in TGA started at 
200 °C (see 3.2.1). Thus, after bake-on siliconization no toxicological concern exists regarding 
increased levels of cyclic LMWS potentially affecting protein stability in formulation [51,52] or 
distributing in human plasma after injection [50] as elaborated previously. 
Additionally, GC-MS analysis demonstrated 1052 ± 98 µg methyl paraben and 365 ± 35 µg 
propyl paraben in the untreated silicone, which equals approximately 0.36 % methyl paraben and 
0.1 % propyl paraben in 35 % silicone emulsion (definite paraben content not accessible for 
comparison due to proprietary reasons) (Fig. V-5). After bake-on, amounts of both parabens were 
below 0.001 % in baked-on silicone, which is in agreement with complete evaporation below 
316 °C in TGA. 
 FORMATION OF COVALENT BONDS BETWEEN THE BAKED-ON 3.2.4
SILICONE AND THE GLASS SURFACE  
Baked-on silicone was extracted for analysis of the molecular weight distribution and to quantify 
cyclic LMWS. To directly characterize the silicone layer baked-on the glass surface and after 
extraction, the glass surface was analyzed by CA measurements.  
A second solvent extraction of baked-on siliconized cartridges with a high silicone level of 
202 µg ± 12 µg was performed as described previously (900 µL heptane, two rinsing steps à 
900 µL heptane). Silicone concentrations in this second heptane extract were below the limit of 
quantification of 18 µg/mL (n = 22), equivalent to 4 µg per cartridge based on 250 µL dissolution 
volume. Consequently, one solvent extraction employing three solvent steps with heptane was 
sufficient for quantitative silicone recovery, even at high silicone levels [54] (see chapter III).  
For CA analysis, cartridges with low baked-on silicone levels of 6 ± 2 µg were utilized, thereby 
enhancing quantitative extraction and enabling direct analysis of the non-extractable silicone 
fraction.  
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The CAs of non-siliconized glass slides were 8 ± 2° (Tab. V-1). Glass surfaces theoretically 
exhibit a CA of 0° [14,97], but due to the adsorption of hydrophobic, air-borne contaminants the 
CA may increase up to 31° [14] or 46.4° [97], which was reflected in the CA of 49 ± 5° for non-
siliconized cartridges. Higher CAs of 47 ± 2° and 62 ± 2° were observed after heptane treatment 
for the glass slide and the cartridge, respectively. In theory, water on heptane results in a CA of 
115°. On a microscopic scale, the water drop displaces a monolayer heptane film remaining on 
the glass surface, which yields the observed, merged CA between 8 ± 2° on glass and 115 ° on 
heptane [98]. 
Spin-coating with untreated silicone oil significantly increased the CA to 81 ± 1° (Tab. V-1 and 
Fig. V-6a). For vials siliconized with Dow Corning Medial Fluid 360 without additional heat 
treatment, Mathes found a comparable CA of 78° [97]. Silicone spread between glass slides or 
after dip coating in 1 % silicone solution in benzene exhibited lower CAs of 44° [14] and 31° 
[63], respectively, but this mode of preparation of experimental glass slides may have 
substantially affected the achieved CAs.  
Tab. V-1. CA of purified water on glass slides; non-siliconized and after spin-coating with either silicone or heat-
treated silicone and after multiple extraction sequences, in comparison to bake-on siliconized cartridges. 
 
Initial [°] After extraction [°] 
After additional 
incubation with 
ultrasound [°] 
After additional wiping [°] 
Number of procedures - #1 #2-3 #1 #1 #2 #3 
Slide        
Non-siliconized 8 ± 2 47 ± 2 - - - - - 
Silicone 81 ± 1 68 ± 3 60 ± 1 65 ± 3 44 ± 3 - - 
Heat-treated silicone 101 ± 3 107 ± 8 107 ± 1 106 ± 0 58 ± 1 50  ± 2 53 ± 2 
Cartridge        
Non-siliconized 49 ± 5 62 ± 2 - - - - - 
Bake-on siliconized 103 ± 2 105 ± 3 101 ± 4 101 ± 1 98 ± 2 96 ± 3 97 ± 1 
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Fig. V-6. CA images of purified water on glass slides after spin-coating with either (a, d) silicone or (b, e) heat-
treated silicone and after multiple extraction sequences in comparison to (c, f) bake-on siliconized cartridges. 
Models describing defined states of orientation during compression of PDMS films on water can 
be transferred to solid surfaces, e.g., glass surfaces [65]. The polar glass surface induces a 
rearrangement of PDMS in a caterpillar-like, fully-stretched configuration with all silicon atoms 
in line and oxygen arranged towards the silanol groups of the glass surface by hydrogen bonds. 
The methyl groups closely assemble on the other side of the PDMS chain thereby yielding a 
hydrophobic surface [99–101]. In thin films, a gradual transformation to regular helices oriented 
parallel to the interface [102] or a horizontally folding multi-layer conformation of the caterpillar-
like monolayer is described upon higher surface coverage [103]. In a three-dimensional, further 
compressed bulk state, the PDMS layer collapses resulting in irregular, standing coils 
[99,100,104] or circular, isolated domains of standing helices and multilayers that spread slowly 
[105–107]. Water may enter the wedges between the disordered methyl groups or sequences of 
water molecules access between neighboring PDMS chains as observed in hydrated states of 
PDMS [108]. Consequently, the CA for glass surfaces excessively coated with silicone in a bulk 
phase may exhibit a lower CA than thin spin-coated silicone surfaces.  
Heat-treated silicone coated on glass slides and bake-on siliconized cartridges exhibited even 
higher CAs of 101 ± 3° and 103 ± 2°, respectively (Fig. V-6b and Fig. V-6c). Similarly, CAs 
after bake-on are reported with 97° (2.5 % emulsion, 330 °C for 20 min) [14], 100-104° (1 % 
silicone in benzene, 300 °C for 15-180 min) [63] and 95° (1.75 % emulsion, 300 °C for 20 min) 
[109]. The spin-coating method on glass slides was comparable for silicone and heat-treated 
silicone. Therefore, different orientation states of the silicone layer as previously discussed can be 
excluded. GPC indicated a decrease in the low molecular weight fraction < 5,000 g/mol, an 
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increase in the fraction between 500 g/mol and 15,000 g/mol and no substantial formation of 
molecules with more than 50,000 g/mol by cross-linking with increasing burn-in temperatures 
from 200 °C to 350 °C (see 3.2.2). Lower molecular weight fractions have shown to migrate into 
micro-inhomogeneities on the glass surface [110] or silicone rubber [111] due to great mobility 
and thereby lead to a disorientation of the applied layer [110]. This may results in a lower CA for 
untreated silicone oil.  
Multiple extraction steps were required to decrease the CA of slides coated with untreated 
silicone from 81 ± 1° to 44 ± 3° (Fig. V-6a and Fig. V-6d) and heat-treated silicone from 
101 ± 3° to 53 ± 2° (Fig. V-6b and Fig. V-6e). Those final values equal the CAs of glass slides 
treated with heptane as control. Silicone and heat-treated silicone were finally quantitatively 
extracted and the glass contact angle prevailed. 
On contrary, after extraction of bake-on siliconized cartridges and all tested additional cleaning 
procedures, the CA remained high with 97 ± 1° (Fig. V-6f). The baked-on silicone becomes more 
intimately associated due to both stronger physical attraction after removal of hydration water 
from the glass surface and polymer matrix [11,64,112] and covalent siloxane bond formation 
with the glass surface [12]. Thus, CA analysis points to the formation of a thin covalently-bound 
silicone layer remaining after extraction of baked-on siliconized cartridges. 
3.3 HEAT-OVEN TREATMENT AS AN EXPERIMENTAL MODEL FOR 
HEAT-TUNNEL BAKE-ON 
Heat-tunnels are widely used for bake-on, continuous sterilization and concomitant 
depyrogenation in pharmaceutical manufacturing and pilot-scale set-ups, but for lab-scale 
experiments they are difficult to handle. Bake-on in a heat-tunnel showed a time- and 
temperature-dependent decrease in the silicone level and layer thickness. For functional 
performance the silicone level during bake-on is most critical. In addition, air velocity in the 
tunnel might be strongly equipment specific and also contributes to siliconization performance. 
The transferability of these parameters to a heat-oven as an experimental model is therefore of 
significant value and was investigated by controlling air-exchange and temperature. 
Temperature profiles without and with air-exchange in the heat-oven were found to be 
comparable for all TCs positioned in the cartridge barrel with consistent maximum temperatures 
of 196 ± 0 °C and 196 ± 1 °C at an oven set temperature of 200 °C. Similarly, 312 ± 1 °C and 
311 ± 1 °C were reached at a target temperature of 316 °C (Tab. V-2).  
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Tab. V-2. Average temperatures (T) for bake-on in a heat-oven at 316 °C and 200 °C for 12 min, either without or 
with air-exchange. Values given for cartridges average measured temperatures of five cartridges in the center and at 
each side of a wire basket. Each cartridge was equipped with two TCs at the cartridge top and the bottom. An 
additional TC was directly placed into the oven. 
 
Max. T 
oven 
Max. T 
cartridge 
Max.T gradient 
TCtop-TCbottom 
during heating 
Max. T gradient 
TCtop-TCbottom 
during cooling 
Without air-exchange at 200 °C 200 ± 1 196 ± 0 11 ± 7 -13 ± 5 
With air exchange at 200 °C 198 ± 1 196 ± 1 8 ± 4 -15 ± 7 
Without air-exchange at 316 °C 312 ± 4 312 ± 1 14 ± 8 -21 ± 7 
With air exchange at 316 °C 312 ± 2 311 ± 1 11 ± 7 -19 ± 4 
 
Besides facilitating bake-on siliconization, heat treatment is employed for sterilization and 
depyrogenation [7,15,16]. Therefore, temperature control without cold spots, i.e., areas with 
substantially lower temperatures, is crucial [113]. For temperature mapping in dry heat-tunnels 
and ovens at 250 °C and greater temperatures, an average of ± 15 °C of the setpoint is 
recommended [114]. In comparison, validation studies in a tunnel sterilizer showed maximum 
temperatures of 319 ± 13 °C for 10 mL containers at a set maximum temperature of 300 °C. 
Differences between the left and right side of the belt were between 3-4 °C [53]. In our study, 
maximum temperatures were within the range ± 15 °C of the setpoint and deviated less than 1 °C, 
thus temperature distribution was homogeneous and no cold spots were observed between 
cartridges in the center and at each side of a wire basket.  
Interestingly, during heating and cooling, a temperature gradient built-up within the cartridge as 
the top of the cartridge heated and cooled faster (Supporting information Fig. S V-4). The effect 
that leads to this temperature gradient is not clear from this study. The thickness of the container 
wall apparently affects heat penetration [53], but in this study cartridges had a comparable wall 
thickness of 1.5 mm along the barrel.  
Overall, the heat-oven allowed consistent, comparable temperature control regardless of the 
process conditions such as different target temperatures or airflow. On contrary, baked-on 
silicone levels were substantially affected by the investigated process conditions. Bake-on 
siliconization in the heat-oven without air-exchange led to higher silicone levels compared to the 
heat-tunnel (Fig. V-7a and Fig. V-7b). Consequently, an adequate experimental model mimicking 
heat-tunnel required air-exchange.  
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b.
 
Fig. V-7. Baked-on silicone levels as determined by FTIR after 5 min, 12 min and 1 h burn-in at 316 °C and after 
12 min burn-in at 200 °C in a heat-tunnel and heat-oven, either without or with air-exchange using (a) 4 mg spray 
quantity and (b) 16 mg spray quantity. 
Both, heat-ovens and heat-tunnels, are used to sterilize and depyrogenate glass containers for 
parenteral drug products [115,116]. Overall, dry heat is transferred by convection, conduction or 
radiation [113]. In the heating zone of the tunnel, quartz tubes covered with polished reflector 
plates provide uniform heat distribution by radiation in addition to convective heat transfer due to 
laminar air circulation [117,118]. In case of parallel siliconization, silicone is burned-off and 
decomposition products are immediately blown out of the cartridge. In the oven, a fan at the back 
leads to a horizontal heat circulation by convection after jacket heating of fresh air [118,119]. At 
first, the cartridge glass wall heats up followed by heat conduction to the cartridge interior. In 
both processes heat may be partially conducted from the mesh conveyor belt in the heat-tunnel or 
wire basket and grid in the heat-oven. Without air-exchange in the heat-oven, burned-off silicone 
may accumulate within the cartridge interior or burn-off is slowed down due to saturation effects. 
In turn, air-exchange efficiently removes burned-off silicone from the cartridge and oven interior, 
thereby decreasing the final baked-on silicone level. As bake-on without and with air-exchange 
led to comparable temperature profiles, the different baked-on silicone levels in the heat-oven 
were exclusively attributed to differences in the air-exchange.  
Air-exchange led to lower baked-on silicone levels, but the extrusion forces were comparable for 
bake-on processes without and with air-exchange. Regardless of the burn-in time, extrusion 
forces ranged between 4-7 N at a low spray quantity of 4 mg and 2-5 N at a medium spray 
quantity of 16 mg (Tab. V-3) (burn-in temperature of 200 °C discussed below).  
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Tab. V-3. Extrusion forces after 5 min, 12 min and 1 h burn-in at 316 °C and after 12 min burn-in at 200 °C in a 
heat-oven either without or with air-exchange using 4 mg spray quantity and 16 mg spray quantity. 
Spray quantity 4 mg    
Without air-exchange Break-loose force [N] Maximum gliding force [N] Minimum gliding force [N] 
316 °C for 5 min 6 ± 1 6 ± 0 4 ± 0 
316 °C for 12 min 6 ± 0 5 ± 0 4 ± 0 
316 °C for 1 h 7 ± 1 6 ± 1 5 ± 0 
200 °C for 12 min 7 ± 1 8 ± 1 5 ± 0 
With air-exchange Break-loose force [N] Maximum gliding force [N] Minimum gliding force [N] 
316 °C for 5 min 6 ± 0 6 ± 1 4 ± 0 
316 °C for 12 min 6 ± 0 7 ± 1 5 ± 0 
316 °C for 1 h 6 ± 0 7 ± 1 5 ± 0 
200 °C for 12 min 9 ± 1 8 ± 0 6 ± 0 
    
Spray quantity 16 mg    
Without air-exchange Break-loose force [N] Maximum gliding force [N] Minimum gliding force [N] 
316 °C for 5 min 3 ± 1 4 ± 1 3 ± 0 
316 °C for 12 min 4 ± 1 3 ± 0 2 ± 0 
316 °C for 1 h 4 ± 1 4 ± 0 3 ± 0 
200 °C for 12 min 7 ± 1 5 ± 1 4 ± 0 
With air-exchange Break-loose force [N] Maximum gliding force [N] Minimum gliding force [N] 
316 °C for 5 min 3 ± 0 3 ± 0 3 ± 0 
316 °C for 12 min 4 ± 0 3 ± 0 3 ± 0 
316 °C for 1 h 5 ± 2 4 ± 1 4 ± 1 
200 °C for 12 min 11 ± 1 8 ± 1 6 ± 1 
 
Functionality does not ultimately benefit from higher silicone levels. Extrusion forces reach a 
minimum plateau value while the silicone levels still increase. In a previous study in the heat-
tunnel, extrusion forces leveled at 4-8 N for baked-on silicone levels of approximately 
10 µg/cartridge, and 3-4 N at higher baked-on silicone levels from 20-100 µg/cartridge (see 
chapter IV). This was well in line with extrusion forces obtained in this study  
Only a substantial decrease in the baked-on silicone level to 4 µg was clearly reflected in high 
extrusion forces up to 22 N (see chapter IV). During bake-on in the heat-oven, silicone levels 
were 9 ± 2 µg or higher, thus moderate extrusion forces were maintained after 1 h at 316 °C. On 
contrary, during bake-on in the heat-tunnel extrusion forces increased to 15 N after 1 h at 316 °C 
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with final baked-on silicone levels of 7 ± 2 µg. Already these slight differences in the baked-on 
silicone level of 2 µg between the heat-oven with air-exchange and the heat-tunnel after 1 h may 
lead to different force profiles. However, for moderate burn-in times at 316 °C, the heat-oven 
represents an adequate experimental model to mimic silicone levels and extrusion forces obtained 
by bake-on in the heat-tunnel.  
Interestingly, both bake-on at 200 °C for 12 min in the heat-tunnel and the heat-oven led to 
slightly higher extrusion forces compared to bake-on at 316 °C for 12 min although the baked-on 
silicone levels were higher. Wetting of polymers on solid surfaces can be described as spherical 
capped droplets with a set of horizontal layers in parallel to a precursor film in front of the drop 
[120,121]. Heat promotes spreading by lowering the liquid-surface tension and the liquid 
viscosity [122]. Thereby, a more uniform silicone layer is suggested [11]. The ALTs after bake-
on at 200 °C and 316 °C for 12 min in a heat-oven without air-exchange were comparable, but 
the silicone layers after bake-on at 200 °C for 12 min exhibited an irregular texture with small, 
darker grey spots along the cartridge barrel (Fig. V-8).  
 
 
Fig. V-8. 3D-LSM analysis after bake-on siliconization in a heat-oven with air-exchange at 200 °C and 316 °C for 
12 min using 16 mg spray quantity. Builds-ups next to the baseline derived from scratching with a 20 G cannula to 
create an artificial glass baseline and were not considered for ALT measurements. 3D-LSM images were similar for 
replicates. 
At 316 °C the baked-on silicone layer was more homogeneous. In addition, larger, dark grey 
spots were observed indicating spreading and coalescence of the individual droplets. 
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Consequently, it can be argued that not only the baked-on silicone level, the measured ALTs and 
silicone distribution along the cartridge barrel substantially affect extrusion performance, but a 
certain temperature is essential to form a homogeneous baked-on silicone layer. 
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4 CONCLUSION 
Bake-on siliconization for 12 min at 316 °C in a heat-tunnel provided functionality of cartridges 
with silicone levels as low as 13 ± 3 µg. A burn-in time of 1 h resulted in an insufficient 
lubrication as the maximum gliding forces increased due to decreased levels of silicone caused by 
burn-off. Thus, longer interruptions of the bake-on processes, i.e., longer exposure times at 
standard heat-tunnel conditions, should be avoided when using silicone levels below 
30 µg/cartridge. However, at a baked-on silicone level of approximately 80 µg/cartridge longer 
burn-in times up to 2 h at 316 °C were well tolerated with regard to functionality. 
A burn-in temperature around 300 °C correlated to the onset of the main weight loss in TGA at 
313 ± 5 °C and at low baked-on silicone amounts, the layer thickness and the silicone level 
substantially decreased between 250 °C and 316 °C. Lower molecular weight fractions 
< 5,000 g/mol were removed at 316 °C and 350 °C and thus the relative proportion of higher 
molecular weight fractions increased. As a consequence, the average molecular weight of the 
bulk polymer remained rather constant at approximately 23,000 g/mol regardless of the burn-in 
temperature between 200 °C and 350 °C. In addition, peak tailing indicated an increased fraction 
between 5,000-15,000 g/mol as depolymerization products. Cyclic LMWS < 500 g/mol, which 
have been associated with toxicological concerns, did not remain in the baked-on silicone layer. 
Likewise, parabens and propylene glycol present as stabilizer in the silicone emulsion were 
quantitatively removed even below the standard burn-in temperature of 316 °C in this study, 
whereas thermal decomposition of non-ionic surfactants (Tween 20, Triton X-100) was 
incomplete.  
Heat-oven treatment as an alternative to heat-tunnel bake-on led to comparable temperature 
profiles both without and with air-exchange. Air-exchange in the heat-oven was essential to 
model the baked-on silicone levels as achieved in the heat-tunnel at different burn-in times and 
temperatures since the airflow is necessary to remove silicone decomposition products. Bake-on 
studies at 200 °C and 316 °C for 12 min revealed, that a certain temperature above 200 °C was 
crucial to form a homogenous silicone layer. 
Both untreated silicone oil and heat-treated silicone oil spin-coated on glass slides resulted in 
highly hydrophobic surfaces as indicated by CA measurements. These layers could apparently be 
removed from the glass surface. Although most of the silicone of directly baked-on siliconized 
cartridges was solvent-extractable, CA analysis suggested a thin silicone film remaining on the 
glass surface most likely due covalent siloxane bonds between silicone and the glass surface.  
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Bake-on siliconization processes are technically challenging as temperature and time settings are 
mutually related. Heat-treatment led to a time- and temperature-dependent decrease in the 
silicone level and layer thickness, but still for optimal spreading and uniform silicone layers 
temperatures as high as 300 °C may be essential. Overall, this study provides valuable insights 
into relevant parameters for bake-on siliconization processes. An extensive toolbox of methods 
was established to analyze associated heat-induced alterations of the baked-on silicone, which 
can be useful for the development of robust siliconization processes. For a short summary of all 
key results please refer to Tab. V-4. 
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Tab. V-4. Summary of key results. 
Baked-on silicone 
layer characteristics 
Impact of the bake-on process 
Silicone level and 
coating functionality 
• Silicone level decrease between 250 °C and 316 °C (12 min), no impact on functionality 
• Gradual silicone level decrease with longer burn-in times at 316 °C, insufficient 
functionality after 1 h 
• Higher silicone levels above 30 µg less dependent on burn-in conditions, bake-on 
induced changes covered by inherent variability in the initial silicone level 
Silicone layer 
thickness distribution 
• Thin silicone layers in the range of 10 nm to 70 nm (10 nm limit of detection [54], (see 
chapter III)) 
• Higher ALT at short burn-in time of 5 min at 316 °C 
• Higher ALT at low burn-in temperature of 200 °C for 12 min 
• Higher ALT at flange attributed to fixed nozzle position (20 mm below flange) (see 
chapter IV) 
Thermal weight loss 
• Onset main weight loss at 313 ± 5 °C correlated with silicone level decrease between 
250 °C and 316 °C 
• Gradual weight loss in isothermal mode over time in agreement with gradual silicone 
level decrease with longer burn-in times 
• Residues of silicone emulsion stabilizers of no concern due to evaporation below 316 °C 
and effective dilution to low levels 
Molecular weight 
distribution 
• Decrease in molecular weight fraction < 5,000 g/mol at higher temperatures (316 °C, 
350 °C) (Mn ↑) due to volatilization 
• Increase in relative proportion of higher molecular weight fractions (Mw↑) 
• Peak maxima unchanged (Mp) 
• Tailing at 316 °C and 350 °C indicating fraction of polymers between 5,000-
15,000 g/mol as thermal cleavage products 
Cyclic LMWS and 
parabens 
• < calibration range, i.e., 0.001 % 
• No toxicological concern associated with LMWS 
Covalent bonds 
• Quantitative extraction of spin-coated silicone and heat-treated silicone, glass contact 
angle prevailed (glass slides) 
• Quantitative silicone recovery in FTIR from cartridges with high baked-on silicone levels 
• CA remained high on baked-on siliconized cartridges after harsh extraction indicating 
formation of thin covalently-bound silicone layer 
Heat-oven as 
experimental model 
• Consistent, comparable temperature profile at different target temperatures and airflow 
• Air-exchange to mimic silicone levels in heat-tunnel 
• Extrusion forces leveled at 4-7 N for silicone levels of approximately 10-20 µg/cartridge, 
2-5 N for silicone levels of 20-100 µg/cartridge comparable to previous study in heat-
tunnel (see chapter IV) 
• Coating functionality sensitive to silicone levels < 10 µg/cartridge 
• Certain temperature > 200 °C essential to form homogeneous silicone layer 
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5 SUPPORTING INFORMATION 
Tab. S V-1. Peak molecular weights (Mp) and elution times of three different polystyrene standards in toluene 
(concentration 6 mg/mL, 5 µL injection volume). 
Standard 1 (n = 5) Standard 2 Standard 3 
Elution time [min] Mp [g/mol] Elution time [min] Mp [g/mol] Elution time [min] Mp [g/mol] 
11.591 ± 0.007 66000 13.296 28000 12.315 44200 
13.956 ± 0.006 21500 15.580 9130 14.565 15700 
17.136 ± 0.006 4920 20.787 682 17.827 3470 
18.708 ± 0.006 2280 22.199 266 19.698 1250 
 
a.
 
 
b. 
 
Fig. S V-1. Exemplary GC-MS calibration for (a) cyclic LMWS and (b) parabens ranging from 0.1-1.5 µg/mL. 
a.
 
b.
 
Fig. S V-2. GPC-RID calibration with three different polystyrene standards (concentration 6 mg/mL, 5 µL injection 
volume). (a) GPC-RID elution profiles and (b) 3rd polynomial fit calibration curve with R
2
 = 0.999. 
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Fig. S V-3. GPC-RID elution profiles for double injections of 5-60 µg silicone oil in toluene (concentrations 0.5-
6 mg/mL, 10 µL injection volume). 
 
Fig. S V-4. Temperature profile within the oven interior and an exemplary cartridge, positioned at the left of the wire 
basket used during bake-on at 316 °C for 12 min, without air-exchange. TCs were positioned at the top and bottom 
of the cartridge. 
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6 ABBREVIATIONS 
ALT Average layer thickness 
AUC Area under the curve 
CA Contact angle 
D3 Hexamethylcyclotrisiloxane 
D4 Octamethylcyclotetrasiloxane 
D5 Decamethylcyclopentasiloxane 
D6 Dodecamethylcycloshexasiloxane 
FTIR Fourier transform infrared (spectroscopy) 
GC-MS Gas chromatography-mass spectrometry 
GPC Gel permeation chromatography 
LMWS Low molecular weight siloxanes 
3D-LSM 3D-laser scanning microscopy 
Mn Number average molecular weight 
Mw Weight average molecular weight 
Mp Molecular weight of the peak maximum 
PDI Polydispersity index 
PDMS Polydimethylsiloxane 
RID Refractive index detection 
TC Thermocouple 
TGA Thermogravimetric analysis 
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ABSTRACT 
A significant amount of therapeutic proteins are marketed as pre-filled syringes or other 
drug/device combination products, and have been safely used in these formats for years. Silicone 
oil, which is used as lubricant, can migrate into the drug product and has been suggested to be 
potentially critical for protein stability. In this study, particles in the size range of 0.2-5 µm and 
≥ 1 µm as determined by resonant mass measurement and micro-flow imaging/light obscuration, 
respectively, resulted from silicone sloughing off the container barrel after agitation. The degree 
of droplet formation correlated well with the applied baked-on silicone levels of 13 µg and 94 µg 
per cartridge. Silicone migration was comparable in placebo, 2 mg/mL and 33 mg/mL IgG1 
formulations containing 0.04 % (w/v) polysorbate 20. Headspace substantially increased the 
formation of silicone droplets during agitation. The highest particle concentrations reached, 
however, were still very low compared to numbers described for spray-on siliconized containers. 
When applying adequate baked-on silicone levels below 100 µg, bake-on siliconization 
efficiently limits silicone migration into the drug product without compromising device 
functionality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is intended for publication. 
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1 INTRODUCTION 
Particle formation in biopharmaceutical drug products has become the subject of increasing 
scrutiny within the biopharmaceutical industry [1–3]. Aggregation and particle formation are 
important degradation pathway for proteins, possibly triggered by a wide range of stress 
conditions such as temperature, freeze/thaw and agitation [4–6]. Some levels of particles are 
ubiquitously found in marketed products, but without evidence of safety risks [3]. In addition to 
proteinaceous particles, the contact with various materials during manufacturing may result in 
heterogeneous or nonproteinaceous particles originating e.g., from stainless steel pumps, filters, 
tubing or glass containers [7–10]. 
In particular, the compatibility of proteins with siliconized drug product containers has been 
critically addressed in the literature as pre-filled syringes (PFS) and cartridges have become 
increasingly used primary containers in health care [11–14]. High levels of silicone have been 
reported to lead to protein aggregation in formulation when not appropriately formulated, in 
particular upon agitation [15–21], at increased temperatures [22,23] or upon periodically rupture 
of the silicone oil-water interface [24]. However, increased levels of spiked-in silicone did not 
result in aggregation or precipitation during quiescent storage at 4 °C and 37 °C [20] or room 
temperature [25,26]. Other studies also suggest that particle level and turbidity increase are most 
likely due to silicone migration rather than enhanced protein instability [18,27–31]. Nonetheless, 
proteins have a high propensity to interact with surfaces, making them susceptible to adsorption 
at the liquid-silicone oil interface, however, only in the absence of surfactants in the formulation 
[19,20,25,26,32].  
Several approaches can be envisaged to mitigate protein-silicone oil interactions. First, state-of-
the-art formulation development, e.g., the addition of surfactants, has been shown to prevent 
proteins from adsorption and degradation [19,20,24–26,32]. Second, optimized siliconization 
processes with sufficient, but limited silicone levels and well defined silicone distribution can be 
utilized (see chapter IV). Silicone oil is essential as lubricant for device functionality to ensure 
smooth and easy injection [12,13,33]. In traditional spray-on siliconization processes 
approximately 0.2 mg to 1 mg silicone oil per container is applied [17,18,23,33–39] compared to 
bake-on processes, which employ an aqueous silicone emulsion followed by bake-on at 
approximately 300 °C for 10-30 min [27,40–42]. Bake-on siliconization results in limited silicone 
levels below approximately 0.1 mg per container [34,43,44]. Thereby, bake-on siliconized 
primary containers present less likelihood to slough off silicone droplets into the formulation 
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compared to spray-on siliconized containers [15,23,35,37]. Recently, alternative siliconization 
methods using cross-linkable silicone have been reported to further prevent silicone transfer into 
the product [15,18,35,37].  
In this work, we applied a bake-on siliconization process that has been developed and optimized 
previously (see chapter IV and V) to evaluate the effect of different baked-on silicone levels 
below 100 µg on the formation of particles in cartridges filled with placebo after expelling, 
shaking and a combination thereof. Different sampling via expelling and shaking stress as well as 
different silicone levels may result in entirely different particle concentrations [35]. In addition, 
the subvisible particle formation was assessed after filling with two different concentrations of 
monoclonal antibody solution (mAb) (2 mg/mL and 33 mg/mL) followed by shaking in the 
presence and absence of headspace. No single analytical technique is able to cover the entire 
range from soluble aggregates to visible particles. A number of reviews highlight the selection of 
appropriate orthogonal techniques including advantages and limitations to monitor aggregates 
and particulates [45–51]. Therefore, a set of different analytical techniques was applied also to 
benefit from advances that have been made to discriminate silicone oil droplets from 
proteinaceous particles using resonant mass measurements (RMM) and micro-flow imaging 
(MFI) [52–56]. As polysorbates are most frequently used as excipients [57–59], studies were 
performed in the presence of 0.04 % (w/v) polysorbate 20. 
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
Non-siliconized 5 mL cartridges (barrel length 32 mm, inner diameter 19 mm, outer diameter 
22 mm), pistons, serum stoppers and aluminum seals were provided by F. Hoffmann-La Roche 
Ltd (Basel, Switzerland). Elastomeric components were coated with fluoropolymer (FluroTec®). 
Polyethersulfone syringe filters (0.2 µm) were obtained from VWR International GmbH 
(Darmstadt, Germany). Whatman Anatop 10 (0.02 µm) filters were purchased from GE 
Healthcare Europe GmbH (Freiburg Germany). 4R vials and stoppers (both non-siliconized) were 
provided by Schott AG (Mainz, Germany) and West Pharmaceutical Services, Inc. (Exton, PA, 
USA), respectively. Disposable silicone oil-free1 mL plastic syringes and 22 G, 40 mm thin wall 
needles were obtained from Henke-Sass, Wolf GmbH (Tuttlingen, Germany) and Terumo 
Deutschland GmbH (Wettingen, Germany), respectively.  
Chemicals were purchased as follows: 365 35 % Dimethicone NF Emulsion and 360 Medical 
Fluid, 350 cSt, from Dow Corning GmbH (Wiesbaden, Germany); heptane from Riedel-de Haën 
(Seelze, Germany); L-histidine monohydrochloride monohydrate and L-histidine both from 
Ajinomoto Europe S.A.S (Louvain-la-Neuve, Belgium); sodium hydroxide standard volumetric 
solution 1 M from AppliChem GmbH (Darmstadt, Germany); polysorbate 20 from Croda GmbH 
(Nettetal-Kaldenkirchen, Germany); polystyrene particle standards 0.994 µm from Thermo 
Scientific Inc. (Waltham, MA, USA) and tergazyme® enzyme detergent from Alconex Inc. (New 
York, NY, USA). A 33.4 mg/mL IgG1 mAb stock solution in 20 mM histidine buffer pH 5.4 was 
kindly provided by Roche Deutschland Holding GmbH (Penzberg, Germany). 
2.2 BAKE-ON SILICONIZATION PROCESS 
Bake-on siliconization was performed on a SVS9061 pilot-scale siliconization unit from Bausch 
+ Ströbel Maschinenfabrik Ilshofen GmbH+Co. KG (Ilshofen, Germany) equipped with an 
external mixing, two-fluid nozzle. Optimized spray parameters were established in previous 
experiments: spray quantity of 4 mg silicone emulsion, fixed nozzle position of 20 mm below the 
flange, spray pressure of 1 bar and time for pump dosing of 175 ms (see chapter IV). The 
cartridges were subsequently treated at 316 °C for 12 min in a TSQ U03 heat-tunnel from Robert 
Bosch GmbH (Stuttgart, Germany).  
Dow Corning 365 35 % Dimethicone NF Emulsion was diluted to 0.6 % (w/w) or 3.5 % (w/w) 
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with highly purified water to obtain a final baked-on silicone level of 13 ± 3 µg/cartridge and 
94 ± 6 µg/cartridge, respectively (see chapter IV).  
2.3 PREPARATION OF PROTEIN SAMPLES 
20 mM histidine buffer, pH 6, containing 0.04 % (w/v) polysorbate 20 was used as placebo. 
Solutions of 2 mg/mL (mAb) and 33 mg/mL (mAb HC, higher concentration) in 20 mM histidine 
buffer, pH 6, and 0.04 % (w/v) polysorbate 20 were prepared from stock solutions. After 
filtration (0.2 µm), mAb concentrations were verified by UV at 280 nm using a NanoDrop 2000 
spectrophotometer from Thermo Fisher Scientific Inc. (Waltham, MA, USA) and an extinction 
coefficient of 1.51 cm
2
/mg.  
2.4 SAMPLE PREPARATION/AGITATION STUDIES 
After bake-on siliconization, the pistons and cartridges were manually assembled. The containers 
were filled with a target volume of 5.16 mL placebo, mAb or mAb HC solution and sealed with 
serum stoppers and aluminum caps. After stoppering, the headspace was calculated as 611 µL 
assuming a final fluid level of 9.6 ± 0.1 mm from the cartridge top. For experiments without 
headspace, cartridges were filled and carefully stoppered so that no visible air bubble remained. 
Cartridges were expelled through the needle using a material testing instrument TA.XT.plus from 
Winopal Forschungsbedarf GmbH (Elze, Germany) at a constant displacement speed of 
5.6 mm/min over a distance of 17.5 mm (maximum travel distance for the piston within the 
cartridge barrel), thereby mimicking approximately 3 min injection time.  
Agitation was performed at 240 rpm on a 360° horizontal Certomat IS rotator from B. Braun 
Biotech International GmbH (Melsungen, Germany) for 1 h at 23 °C with cartridges positioned 
horizontally. The horizontal rotation frequency and test duration followed vehicle vibration tests 
from ISTA 2A and ASTM D 4169 – 08. Samples were collected by pipetting or decanting 
through the cartridge orifice after removing the serum stopper. 
2.5 LIGHT OBSCURATION (LO) 
LO analysis was performed using a PAMAS SVSS-C instrument equipped with a standard sensor 
HCB-LD-25/25 from Partikel- und Analysensysteme GmbH (Rutesheim, Germany). Prior to 
analysis, the system was flushed with highly purified water (at least 5 mL) until the cumulative 
particle concentration ≥ 1 µm was below 30 particles/mL. Samples were analyzed at least in 
triplicates. Each measurement consisted of a pre-run volume of 0.5 mL followed by three runs of 
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0.3 mL sample at an emptying and rinse rate of 5 mL/min. Particle concentrations were reported 
by PAMAS PMA V 2.1.2.0. 
2.6 MICRO-FLOW IMAGING (MFI) 
A MFI system DPA4100 from ProteinSimple (Santa Clara, CA, USA) equipped with a 470 nm 
LED light source and a high magnification (14 x) 100 µL flow cell was controlled by MFI View 
Software version 6.9. Placebo was used to “optimize illumination” prior or each measurement. 
The sample purge volume was 0.3 mL followed by 0.65 mL dispensed sample at a flow rate of 
0.1 mL/min. “Edge particle rejection” and “fill particle” option were activated. Between each 
sample, the system was flushed with 5 mL highly purified water at maximum flow rate and 
visually checked for flow cell cleanliness. Samples were analyzed at least in duplicates. MVAS 
version 3.1 from ProteinSimple was used for data analysis. The “find similar” operation was 
employed to discriminate silicone-like from other particles based on the optical parameters of 
30 particles ≥ 5 µm that were visually identified as silicone droplets. Optical filter parameters 
selected from MVAS for silicone-like particles were 514 ≤ intensity mean ≤ 740, 0.8 ≤ aspect 
ratio ≤ 1.1 and 0.4 ≤ circularity ≤ 0.9. 
2.7 TURBIDITY 
A Nephla LPG239 turbidimeter from Hach Lange GmbH (Düsseldorf, Germany) was employed 
for turbidity measurements at λ = 860 nm in prerinsed 12 mm clear glass test tubes. Samples 
were analyzed at least in duplicates and results are given in formazin nephelometric units (FNU). 
2.8 RESONANT MASS MEASUREMENTS (RMM) 
RMM measurements were performed using an Archimedes system from Malvern Instruments 
Ltd. (Herrenberg, Germany) equipped with a Hi-Q micro sensor (size range 0.15-5 µm, channel 
dimension 8 µm x 8 µm). Initially, the sensor was calibrated with 0.994 ± 0.050 µm polystyrene 
size standards with an accuracy of ≥ 95 %. The lower limit of detection was determined in 
automatic mode for exemplary placebo and mAb HC samples. Subsequently, a mean value of 
0.034 ± 0.013 Hz was manually selected as threshold limit for sample analysis. The density of 
positive buoyant particles was adjusted to 0.972 g/cm
3
 [60] (referred to as “silicone-like”). 
Furthermore, the density of negative buoyant particles was set to 1.32 g/cm
3
 (“other particles”) as 
suggested by the RMM manufacturer and well within the density range reported for proteins in 
literature between 1.28 g/cm
3
 to 1.43 g/cm
3
 [61–63]. A fluid density of 1.000 g/cm was measured 
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for placebo and mAb samples, whereas for mAb HC samples the density was adjusted to 
1.009 g/cm
3
 (see 2.11). Before each measurement, the system was rinsed with highly purified 
water for 5 min, 1 % tergazyme® for 1 min and finally with highly purified water until a clean 
frequency trace was achieved. Between each rinsing step, additionally three “sneeze” operations 
were employed to remove possible impurities. Subsequently, the sample was loaded until a stable 
baseline was achieved (at least 45 s). The endpoint of measurement was 20 min with sample 
volumes ranging from 0.1-0.5 µL. The “autoreplenish” function was activated every 5 min for 5 s 
to periodically flush the fluidic tubing with fresh sample. Samples were analyzed at least in 
triplicates using ParticleLab software version 1.8.510 from Malvern Instruments Ltd. 
(Herrenberg, Germany). 
2.9 DYNAMIC LIGHT SCATTERING (DLS) 
DLS measurements were performed with a Zetasizer Nano-ZS ZEN3600 system from Malvern 
Instruments Ltd. (Herrenberg, Germany) equipped with a 633 nm He-Ne laser and non-invasive 
backscatter detection at an angle of 173°. Samples were analyzed at least in triplicates with three 
measurements each using automatic attenuation factor, measurement position and duration after 
20 s equilibration time at 25 °C. A sample volume of 420 µL was measured in disposable semi-
micro polymethyl methacrylate cuvettes from Brand GmbH + Co. KG (Wertheim, Germany). 
The Z-average diameter and polydispersity index (PDI) were calculated from the autocorrelation 
function obtained in “general purpose mode (normal resolution)” using Zetasizer software 7.03. 
2.10 NANOPARTICLE TRACKING ANALYSIS (NTA) 
NTA was performed using NS200, LM20 series from Nanosight Ltd (Amesbury, UK) equipped 
with a 405 nm laser. Prior to analysis, the sample chamber was flushed with 3 mL 0.02 µm 
filtered water. Samples were injected using a 1 mL syringe and a pre-run volume of 300 µL 
followed by 200 µL sample for first video analysis at stopped flow. For each triplicate sample, 
three video files were recorded with 200 µL sample flushed between each video. NTA 2.2 
software was used for capturing and analyzing the data as well as automatic temperature 
acquisition. The focus was adjusted to obtain clear particle images without refractive rings. 
Initially, shutter and gain were optimized until no more new particles appeared on the screen and 
best contrast between background and particles was achieved. For placebo and mAb samples, the 
shutter was set to 597-603, the gain to 298-303 and the capture duration was 60 s for each video. 
In mAb HC samples, the gain was decreased to zero due to background light scattering of the 
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mAb solution matrix. For analysis the detection threshold was seven and the blur was set to 7 x 7. 
A minimum track length of ten and automatic minimum expected particle size were utilized. For 
placebo and low concentration mAb samples, the viscosity was 1.00 ± 0.01 mPa*s and 
1.02 ± 0.01 mPa*s at 20 °C, respectively. Therefore, the viscosity was software-based adapted 
from water as dispersant (0.88 mPa*s at 25 °C) while for mAb HC the viscosity was adjusted to 
1.42 ± 0.01 mPa*s at 20 °C (see 2.11).  
2.11 PHYSICOCHEMICAL PROPERTIES OF THE SAMPLE SOLUTIONS 
The refractive index (RI) was measured using an Abbé refractometer from Carl Zeiss (Jena, 
Germany) at a wavelength of 589 nm at room temperature.  
Viscosity measurements were performed on a mVROC viscosimeter from Rheosense Inc. (San 
Ramon, CA, USA) equipped with an A-series chip with a flow channel depth of 50.8 µm at a 
constant shear rate of 1.90*10
7 
s-
1 
and 20 °C. Control software v2.6 was utilized for data analysis. 
The density was determined using DMA 38 density meter from Anton Paar GmbH (Graz, 
Austria) at 20 °C.  
2.12 MIGRATED SILICONE AMOUNT IN PLACEBO BY FOURIER 
TRANSFORM INFRARED (FTIR) QUANTIFICATION  
The migrated silicone amount in placebo was determined by FTIR spectroscopy after solvent 
extraction. Placebo samples after agitation were quantitatively decanted from the cartridges 
through the needle-side orifice into 4R vials and evaporated to dryness using a flowtherm 
evaporator at 100 °C and constant nitrogen flow of 210 mL/min from Barkey GmbH & Co. KG 
(Leopoldshöhe, Germany). Silicone in the dried extract was redissolved in 1 mL heptane. Two 
extracts were combined, followed by two rinsing steps à 1 mL heptane for each vial. The 
combined extracts were evaporated to dryness and finally redissolved in 250 µL heptane for 
FTIR analysis. According to considerations provided in ICH Q2 R1 Validation Analytical 
Procedure, the limit of detection of the developed FTIR method was found to be below 1 µg/mL 
(number of calibration curves n = 22). The limit of quantification was 18 µg/mL (n = 22). The 
analytical method was thus capable to quantify down to 4 µg per cartridge based on 250 µL 
dissolution volume [64] (see chapter III). 
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3 RESULTS  
3.1 SILICONE MIGRATION IN PLACEBO  
MFI and LO analysis were used to elucidate the effect of different baked-on silicone levels 
(13 µg and 94 µg per cartridge) on silicone migration into placebo. In addition, the effect of 
different sampling via expelling through the needle and shaking stress with and without 
headspace were evaluated as they may result in entirely different particle concentrations [35].  
After expelling, low concentrations of particles ≥ 1 µm were detected in non-siliconized and 
different bake-on siliconized cartridges with headspace by MFI (3,200-4,100 particles/mL) and 
LO (2,000-2,400 particles/mL) (Fig. VI-1a). The concentration of particles generated through 
shaking with headspace increased to 3,500 particles/mL and 35,300 particles/mL in MFI, and to 
1,300 particles/mL and 23,100 particles /mL in LO with higher silicone levels of 13 µg and 94 µg 
per cartridge, respectively. A combination of both shaking and expelling resulted in similar 
particle concentrations as compared to shaking alone.  
a. 
 
b. 
 
Fig. VI-1. Particle concentration ≥ 1 µm/mL (MFI and LO) in 20 mM histidine placebo, pH 6, as a function of 
baked-on silicone levels and different sampling/agitation stress (a) with headspace and (b) without headspace. Non-
siliconized cartridges were abbreviated with NS.  
Expelling had a less pronounced effect on particle formation and was therefore not further 
evaluated in cartridges without headspace (Fig. VI-1b). In the absence of headspace, fewer 
particles were formed. In non-siliconized cartridges, the particle concentration was below 
1,800 particles/mL in MFI and below 500 particles/mL in LO after different sampling. Both 
shaking and shaking+expelling in combination with a higher silicone level of 94 µg per cartridge 
similarly increased the particle concentration to 4,700-5,400 particles/mL in MFI and to 1,300-
2,000 particles/mL in LO.  
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MFI and LO reflected the same trends in particle concentrations, but MFI consistently detected 
higher particle concentrations, which can be attributed to an increased sensitivity for more 
transparent particles such as silicone droplets or protein particles [70,82–84].  
None of these samples showed a change in turbidity (Tab. VI-1).  
Tab. VI-1. Turbidity in 20 mM histidine placebo, pH 6, as a function of baked-on silicone levels and different 
sampling/agitation stress with and without headspace. 
Sample description Turbidity [FNU] Turbidity [FNU] 
Expel With headspace Without headspace 
NS < 1 - 
13 µg < 1 - 
94 µg < 1 - 
Shake With headspace Without headspace 
NS < 1 < 1 
13 µg < 1 - 
94 µg < 1 < 1 
Shake+expel With headspace Without headspace 
NS < 1 < 1 
13 µg < 1 - 
94 µg < 1 < 1 
 
3.2 PARTICLE FORMATION AFTER AGITATION IN MAB SOLUTIONS 
 CONCENTRATION OF PARTICLES ≥ 1 µm/mL (MFI AND LO) AND 3.2.1
TURBIDITY 
Since shaking showed the most severe effect on particle formation in placebo, cartridges filled 
with 2 mg/mL mAb and 33 mg/mL mAb HC were also exposed to this stress. Non-siliconized 
cartridges with headspace contained 900-2,700 particles ≥ 1 µm per mL in MFI and 400-
1,200 particles ≥ 1 µm per mL in LO for the different filling solutions (Fig. VI-2a). With higher 
silicone levels of 13 µg and 94 µg per cartridge, particle concentrations increased up to 
6,300 particles/mL and 55,400 particles/mL in MFI, respectively, and to 1,400 particles/mL and 
3,400 particles/mL in LO. The same trend but at lower particle concentrations was observed in 
cartridges without headspace (Fig. VI-2b). The mAb concentration did not affect the particle 
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counts ≥ 1 µm per mL in bake-on siliconized cartridges with and without headspace (Fig. VI-2a 
and Fig. VI-2b).  
a. 
 
b. 
 
c. 
 
 
Fig. VI-2. Particle concentration ≥ 1 µm/mL (MFI and LO) after agitation as a function of baked-on silicone levels 
and mAb concentrations (a) with headspace and (b) without headspace. (c) Subvisible particles ≥ 10 µm and ≥ 25 µm 
per container (94 µg baked-on silicone, after agitation with headspace) by LO are additionally shown as outlined by 
pharmacopeia. Cartridges were filled with 20 mM histidine placebo, pH 6, 2 mg/mL mAb or 33 mg/mL mAb HC.  
Also, the particle numbers in cartridges with a high silicone level of 94 µg per cartridge and 
agitated with headspace (650-700 particles/container ≥ 10 µm and 2-60 particles/container 
≥ 25 µm (Fig. VI-2c) remained well below the limits of current pharmacopeia for parenteral 
products, in particular for protein injections (≤ 6,000 particles/container ≥ 10 µm and 
≤ 600 particles/container ≥ 25 µm [68–70]). 
Additionally, both mAb and mAb HC pre-filled in cartridges with a 13 µg silicone level met the 
requirements for ophthalmic solutions (≤ 50 particles/mL ≥ 10 µm and ≤ 5 particles/mL ≥ 25 µm 
[71]), whereas cartridges with a 94 µg baked-on silicone level failed these tight criteria (Tab. 
VI-2). 
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Tab. VI-2. Subvisible particle concentration ≥ 10 µm and ≥ 25 µm per mL by LO as outlined by pharmacopeia for 
ophthalmic solutions. Cartridges were filled with 20 mM histidine placebo, pH 6, 2 mg/mL mAb or 33 mg/mL mAb 
HC. 
Sample description LO ≥ 10 µm/mL LO ≥ 25 µm/mL 
Placebo 
    
NS 22 ± 14 4 ± 6 
13 µg 25 ± 22 1 ± 2 
94 µg 97 ± 21 2 ± 1 
mAb 
    
NS 10 ± 5 2 ± < 1 
13 µg 14 ± 6 1 ± 2 
94 µg 64 ± 33 1 ± 1 
mAb HC 
    
NS 7 ± 2 1 ± 1 
13 µg 19 ± 3 1 ± 1 
94 µg 90 ± 22 0 ± < 1 
 
The turbidity was < 1 FNU for 2 mg/mL and 3-4 FNU for 33 mg/mL mAb formulations and did 
not change with higher silicone levels (Tab. VI-3).  
Tab. VI-3. Turbidity after agitation as a function of baked-on silicone levels and mAb concentrations with and 
without headspace. Cartridges were filled with 20 mM histidine placebo, pH 6, 2 mg/mL mAb or 33 mg/mL mAb 
HC. 
Sample description Turbidity [FNU] Turbidity [FNU] 
Placebo With headspace Without headspace 
NS < 1 < 1 
13 µg < 1 - 
94 µg < 1 < 1 
mAb With headspace Without headspace 
NS < 1 < 1 
13 µg < 1 < 1 
94 µg < 1 < 1 
mAb HC With headspace Without headspace 
NS 3 ± < 1 3 ± < 1 
13 µg 4 ± < 1 4 ± < 1 
94 µg 3 ± < 1 3 ± < 1 
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 DISCRIMINATION BETWEEN SILICONE DROPLETS AND OTHER 3.2.2
PARTICLES BY MFI AND RMM 
In particular for biopharmaceutical drug products in PFS and other drug/device combination 
products lubricated with silicone oil, the discrimination between silicone droplets and other 
particles becomes increasingly important. The MFI built-in “find similar” filter (see 2.6) was 
initially based on visual analysis of particles and showed that discrimination between the two 
groups is reasonable for particles larger than 5 µm [54,56]. Therefore, a lower size limit of 5 µm 
was utilized in this study although “find similar” and customized filters were reported to resolve 
particle sizes down to 2 µm [53,55]. Cartridges filled with headspace showed highest particle 
numbers ≥ 1µm (see above) and were therefore further analyzed to evaluate the appearance of 
silicone droplets and other particles. The total concentration of particles ≥ 5 µm in non-
siliconized and siliconized cartridges with 13 µg silicone was comparably low (50-
300 particles/mL), which limits statistical representation of the sample population and 
discrimination (Fig. VI-3). Cartridges with a silicone level of 94 µg showed 2800 particles/mL to 
4700 particles/mL ≥ 5 µm with 91 % to 97 % classified as silicone droplets independent of the 
contained formulation, i.e., placebo, 2 mg/mL mAb or 33 mg/mL mAb HC.  
  
Fig. VI-3. Discrimination between silicone-like and other particles after agitation with headspace as a function of 
baked-on silicone levels and mAb concentrations as obtained by MFI for particles ≥ 5 µm. Cartridges were filled 
with 20 mM histidine placebo, pH 6, 2 mg/mL mAb or 33 mg/mL mAb HC.  
Exemplary MFI particle images and scatter plots for placebo or mAb HC samples from cartridges 
with 94 µg silicone demonstrated the formation of well-defined spherical shapes (Fig. VI-4) as 
well as high values for aspect ratio (Fig. VI-5a) and circularity (Fig. VI-5b) as reported for 
silicone droplets [52–54,56]. Typically, silicone droplets ≥ 5 µm exhibit very dark edges and a 
bright center, which results in similar or lower mean object intensities compared to protein 
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aggregates (Fig. VI-5c) [27,55]. The remaining population exhibited a similar morphology and 
did not show irregular, dense clusters or fibrous like particles with noticeable different scatter 
values as described for protein [52–56]. These particles were therefore most likely falsely marked 
as other particles. 
 
Fig. VI-4. Exemplary MFI images of silicone-like and other particles ≥ 5 µm detected in a sample of 33 mg/mL mAb 
HC after agitation with headspace in cartridges with 94 µg silicone. 
a. 
 
b. 
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c. 
 
 
Fig. VI-5. Exemplary scatter plots of particle parameters in MFI: (a) aspect ratio, (b) circularity and (c) intensity 
mean for placebo and 33 mg/mL mAb HC after agitation with headspace. Cartridges were bake-on siliconized with 
94 µg silicone. 
In addition, selected agitated samples were analyzed by RMM. In the size range of 0.2-5 µm, all 
non-siliconized cartridges either filled with placebo, mAb or mAb HC showed similar particle 
concentrations below 8.8×10
4
/mL (Fig. VI-6). In cartridges siliconized at a higher silicone level 
(94 µg per cartridge), RMM determined comparable particle concentrations up to 2.2×10
5
/mL 
and 1.6×10
5
/mL after filling with placebo and mAb, respectively. The highest particle 
concentration (4.9×10
5
/mL) was observed in cartridges with 94 µg silicone filled with mAb HC. 
About 90-95 % of these particles could be attributed to silicone droplets regardless of the fill 
medium. 
 
Fig. VI-6. Discrimination between silicone-like and other particles after agitation with headspace as a function of 
baked-on silicone levels and different mAb concentrations as obtained by RMM for particles in the range of 0.2 µm 
to 5 µm. Cartridges were filled with 20 mM histidine placebo, pH 6, 2 mg/mL mAb or 33 mg/mL mAb HC.  
Samples revealed comparable particle size distributions in both MFI and RMM with the smaller 
particles being the largest fraction (Fig. VI-7). RMM detected more droplets of 1-3 µm, whereas 
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MFI determined the same number or more droplets in the size range from 3-5 µm. These results 
indicate that both methods do not yield comparable size information as described for MFI and 
RMM previously [55]. 
a. 
 
b. 
 
c. 
 
 
Fig. VI-7. Exemplary particle size distributions in the range of 0.2-5 µm/mL obtained from MFI and RMM after 
agitation with headspace in cartridges with 94 µg silicone. Cartridges were filled with (a) 20 mM histidine placebo, 
pH 6, (b) 2 mg/mL mAb and (c) 33 mg/mL mAb HC.  
 CHARACTERIZATION OF NANOSCALE PARTICLES USING NTA AND 3.2.3
DLS 
Additionally, NTA was applied to evaluate the different sample sets for particles in the 
submicron size range (Fig. VI-8).  
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a. 
 
b. 
 
c. 
 
d. 
 
e. 
 
f. 
 
Fig. VI-8. (a, c, e) Particle size distributions by NTA after agitation with headspace in non-siliconized and 
siliconized cartridges (94 µg silicone) and (b, d, f) corresponding exemplary NTA frames. Cartridges were filled 
with (a, b) 20 mM histidine placebo, pH 6, (c, d) 2 mg/mL mAb and (e, f) 33 mg/mL mAb HC. For placebo and 
mAb samples, the shutter was set to 597-603 and the gain to 298-303. In mAb HC samples, the gain was decreased 
to zero due to high background scattering. 
In NTA, sensitivity is inversely correlated with the mAb concentration, i.e., with higher protein 
concentration the background scattering from the solution matrix itself increased (Fig. VI-8b, Fig. 
VI-8d, Fig. VI-8f) as did turbidity (Tab. VI-3), which makes visualization of particles more 
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difficult [72,73]. Therefore NTA settings were adjusted for mAb HC (see 2.10). Comparison of 
particle concentrations between placebo and the different protein concentrations is thus not 
reasonable while particle sizing is less affected by protein concentration [73]. 
In placebo and mAb samples, the particle size distributions were fairly broad from 50 nm to 
500 nm with a main peak at 110-130 nm (Fig. VI-8a, Fig. VI-8c). The concentrations for particles 
of the main peak were approximately 4×10
7
/mL, which is at the lower end of the concentration 
range suggested as suitable for NTA (10
7
-10
9
 particles/mL [74]). As previously highlighted, 
particle detection was strongly impeded with higher protein concentration, hence the results do 
not allow a reliable determination of particle size for mAb HC (Fig. VI-8e). Overall, no change in 
the submicron particle distribution or increase in the particle level was observed between non-
siliconized cartridges and the corresponding siliconized cartridges (94 µg). 
DLS detected the monomeric mAb with a Z-average diameter between 8 nm to 11 nm fairly 
independent of silicone and mAb concentration (Tab. VI-4) [75,76]. A PDI ≤ 0.1 indicated 
monodisperse samples [76]. Minor differences in the Z-average as a function of concentration 
were within the variability of this method (± 2 nm) [75]. The particle fraction around 110-130 nm 
found by NTA was not detected by DLS due to the lower peak resolution and the low overall 
number of particles in that size range (peak intensity of the mAb monomer peak was 97-100 % in 
DLS) [74,77,78]. 
Tab. VI-4. PDI and Z-average diameter in DLS analysis after agitation with and without headspace as a function of 
baked-on silicone levels and mAb concentrations. Cartridges were filled with 20 mM histidine placebo, pH 6, 
2 mg/mL mAb or 33 mg/mL mAb HC. 
Sample description Z-average [d.nm] PDI Z-average [d.nm] PDI 
mAb With headspace Without headspace 
NS 10.5 ± 0.1 0.04 ± 0.02 10.6 ± 0.2 0.06 ± 0.02 
13 µg 11.2 ± 1.1 0.10 ± 0.07 10.7 ± 0.2 0.05 ± 0.03 
94 µg 10.5 ± < 0.1 0.05 ± 0.01 11.3 ± 1.4 0.09 ± 0.08 
mAb HC With headspace Without headspace 
NS 8.0 ± 0.1 0.03 ± 0.01 9.0 ± < 0.1 0.03 ± < 0.01 
13 µg 8.8 ± < 0.1 0.02 ± < 0.01 8.9 ± < 0.1 0.03 ± 0.01 
94 µg 8.9 ± < 0.1 0.03 ± < 0.01 8.9 ± < 0.1 0.03 ± 0.01 
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4 DISCUSSION 
4.1 SILICONE MIGRATION IN PLACEBO 
For each PFS and other drug/device combination product, a variety of factors such as the 
siliconization process, the formulation and the set-up for stress testing contributes to the number, 
size and morphology of particles present. In this paper, silicone migration from baked-on 
siliconized cartridges with two different silicone levels (13 ± 3 µg and 94 ± 6 µg per cartridge) 
was assessed in placebo after expelling, shaking and a combination thereof. Samples were filled 
with (Fig. VI-1a) and without headspace (Fig. VI-1b). 
Previous work indicated that the method for sample collection substantially affects the amount of 
silicone droplets sloughing off from the container wall. Increased numbers of silicone droplets 
were observed in spray-on siliconized PFS with placebo after expelling compared to sample 
collection through the flange using a pipette after removal of the piston [35]. In this study, the 
particle levels ≥ 1 µm in placebo were comparably low in non-siliconized cartridges and at both 
silicone levels after expelling (Fig. VI-1). It has been previously observed that by expelling the 
thin baked-on silicone layer is pushed towards the needle-side of the cartridge and finally 
accumulates between the glass surface and the upper piston plateau (see chapter IV) rather than 
detaching into the fill medium. The expelling effect is likely highly relevant for sprayed-on 
silicone regarding silicone entry into solution, but of less relevance for thin baked-on silicone 
layers.  
Mechanical stress methods such as agitation or stirring are commonly used during the 
development of therapeutic proteins to test robustness against different interfacial stresses, which 
they may encounter during manufacturing, transport and final administration [79]. The horizontal 
rotation frequency and test duration in this work followed vehicle vibration tests from ISTA 2A 
and ASTM D 4169 – 08 as guidelines for performance testing of shipping containers. With 
higher baked-on silicone levels, shaking substantially increased the particle counts ≥ 1 µm in 
placebo. Furthermore, a higher number of silicone droplets was displaced from the container wall 
of cartridges with headspace, likely induced by bulk fluid shear forces due to the movement of 
the air bubble [16]. Additional expelling after shaking had no effect on the particle counts, which 
is consistent with the negligible effect of expelling alone.  
Consequently, for siliconization processes that have been previously optimized in terms of 
adequate silicone levels and reproducible silicone distributions, shaking studies with placebo can 
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be useful to understand if silicone is shed into product solution under worst-case conditions. They 
may serve to challenge the container performance and to guide the selection of siliconized 
product containers. However, this is not likely to reduce the number of testing (e.g., silicone in 
solution and functionality) for the particular container expected to be performed on stability. 
4.2 PARTICLE FORMATION AFTER AGITATION IN MAB SOLUTIONS 
As PFS and other drug/device combination products lubricated with silicone oil have become 
popular delivery formats for protein therapeutics [11–13], one of the aspects with potential 
quality impact proteins may encounter are silicone oil-water interfaces. The combination of 
different protein concentrations (2 mg/mL and 33 mg/mL), agitation and headspace on the 
particle formation in baked-on siliconized cartridges was investigated. Other authors have used 
silicone spiking studies to evaluate the impact on particle appearance [19,20,22,24–26,32]. These 
spiking studies miss relevant silicone levels as they utilize silicone concentrations far beyond the 
amount typically present in PFS and other drug/device combination products [79]. This is why 
we chose to evaluate two practically relevant baked-on silicone levels (13 ± 3 µg and 94 ± 6 µg 
per cartridge). 
Overall, higher baked-on silicone levels led to higher particle concentrations ≥ 1 µm in LO and 
MFI (Fig. VI-2) and in the size range of 0.2-5 µm in RMM (Fig. VI-6). The particle 
concentrations were comparable in cartridges with placebo and at different mAb concentrations.  
It may be argued that with an increased RI of the formulation, i.e., with a higher mAb 
concentration, the particle concentration is likely to be underestimated or in case of an RI match, 
particles disappear in MFI and LO [28,80–82]. In this study, the RI of 1.34 of the mAb 
formulation at higher protein concentration was very similar to the measured RI for mAb and 
placebo of 1.33. Thus, within this range, no substantial influence of formulation RI on both the 
number of silicone droplets (RI 1.40) and amorphous mAb particles (RI 1.41, [80]) was expected. 
The majority of particles ≥ 5 µm in MFI (Fig. VI-3 - Fig. VI-5) and in the size range of 0.2-5 µm 
in RMM (Fig. VI-6) were silicone droplets without substantial protein-related matter independent 
of the formulation studied. RMM analysis was based on a small number of measured particles 
(< 300) due to the overall low particle concentration at the lower limit of the recommended range 
from 3×10
5
 to 1×10
7
/mL [55]. The sample volume (0.1-0.5 µL) was low, but within a range 
previously reported for RMM [55]. The statistical representation of the sample population in 
RMM was thus limited due to low sampling efficiency and the corresponding large extrapolations 
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factors [83], thereby questioning the noticeable difference in particle concentration between 
placebo, mAb and mAb HC. Nonetheless, solely silicone droplets contributed to the particle 
counts in RMM. In this study, applying both MFI and RMM brought noticeable benefit to cover a 
size range as broad as possible. As both methods are relatively new for the discrimination of 
silicone droplets and other particles and are not considered to be ready for quality control 
purposes, particle analysis with these methods is however challenging and results have to be 
interpreted with caution.  
The submicron particle populations were comparable in non-siliconized and baked-on siliconized 
cartridges with an abundance of monomeric mAb in DLS (Tab. VI-4) and an additional particle 
subfraction around 110-130 nm as suggested by NTA data (Fig. VI-8). The increase in silicone 
droplets with higher baked-on silicone levels was moderate. Turbidity did not change compared 
to controls (Tab. VI-3), and was only reflecting turbidity as a function of protein concentration as 
described previously [72,75]. In cartridges siliconized with 94 µg silicone and filled with 
placebo, the migrated silicone amount after agitation was exemplarily determined to be 3 ± 1 µg 
by FTIR. This equals a weight fraction of 6×10
-5
 % (m/m) at a target filling volume of 5.16 mL 
placebo (see 2.4) with a density of 1.000 g/cm (see 2.8). A similar mass of approximately 2 µg 
and 5 µg was calculated from MFI and LO results, respectively, based on droplet counts and the 
density of silicone oil (0.972 g/cm
3
 [60]). Similarly, Scherer observed a poor turbidity sensitivity 
at low weight fractions of 5×10
-5
 % (m/m) [78].  
It has been previously indicated that the particles in PFS primarily consist of silicone droplets 
suggesting that silicone has a minimal impact on protein stability in the presence of surfactant 
[18,27–31]. On the contrary, in surfactant-free protein samples in PFS, increased particle 
concentrations were observed, and silicone droplets were suggested to be entangled in a fibrous 
protein aggregate structure due to silicone oil-water and air-water interfacial shear stress [15–18]. 
A disruption of the gelled protein layer at the silicone oil-water interface was considered 
followed by a release of gelled particles and agglomerates of silicone oil and protein aggregates 
[16]. In addition, agitation may provoke a collapse of the adsorbed protein layer at the air-water 
interface, gel buckling and subsequent detachment of protein particles into the bulk. [84]. In this 
work, the addition of polysorbate 20 0.04 % (w/v) protected mAb against aggregation and 
particle formation at both the silicone oil-water and air-water interface during agitation.  
Overall, the baked-on silicone levels corresponded well with the number of silicone droplets. The 
highest numbers of silicone droplets were reached in cartridges with a silicone level of 94 µg 
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after agitation with headspace independent of the formulation. Still, particle counts ≥ 1 µm 
remained low with up to 3,400 particles/mL in LO and up to 55,500 particle/mL in MFI (Fig. 
VI-2a), and below 5,000 particles/mL above ≥ 5 µm in MFI (Fig. VI-3). In addition, particles 
≥ 10 µm and ≥ 25 µm -650-700 particles/container and 2-60 particles/container (Fig. VI-2c), 
respectively- were well below the limits of current compendial monographs for parenteral 
products and protein injections [68–70]. The low silicone level of 13 µg was shown to be suitable 
as primary container for ophthalmic solutions with meeting the more stringent compendial limits 
for subvisible particle levels (Tab. VI-2) [71]. In the literature, both the siliconization method and 
the applied silicone level strongly affect the particle counts. High numbers of silicone droplets 
were reported for placebo samples in spray-on siliconized syringes with up to 10,000
 
particles/mL ≥ 2 µm in LO, 10
6
 particles/mL ≥ 1 µm and 1.2×10
5
 particles/mL ≥ 2 µm in MFI 
after agitation [35,37]. Similarly, baked-on siliconized vials with albinterferon alfa-2b fusion 
protein stabilized with 0.01 % polysorbate 80 contained 2.5×10
6
 to 1.5×10
7
 particles/mL from 
1 µm to 10 µm in MFI with increasing baked-on silicone levels (specific silicone levels were not 
disclosed) [27]. In other studies using siliconized PFS and plastic syringes filled with IgG1, 
interferon beta-1a, bevacizumab and adalimumab, particle concentrations of 9,000 particles/mL 
≥ 5 µm [28] and 3×10
5
 to 6×10
5
 particles/mL ≥ 1 µm were observed in MFI (surfactant was 
added for protein stability) [30,31,55]. Particles detected in these studies were primarily 
determined to be silicone droplets. Although the higher baked-on silicone level of 94 µg 
approached the upper limit of 0.1 mg/container reported for baked-on silicone levels [34,43,44], 
particle levels were clearly lower as compared to literature. Thus, adequate bake-on siliconization 
provides a viable alternative to limit subvisible particle formation compared to spray-on 
siliconization process [15,23,35,37].  
Recently, cross-linked silicone layers were presented as an attractive method to achieve similar 
[15] or reduced subvisible particle levels compared to bake-on processes [35,37] and 
substantially less compared to spray-on layers [18]. Nevertheless, piston extrusion performance 
of these cross-linked layers needs to be further investigated as some studies have shown 
contradicting extrusion force profiles [15,18,35,37]. It was further suggested that in bake-on 
siliconization processes, high temperature exposure alters the bulk properties of silicone, thereby 
affecting gliding performance in addition to a narrow processing window [35]. From our 
experience, baked-on silicone levels below 100 µg were sufficient for adequate lubrication 
without a substantial change in the silicone bulk properties (see chapter V). 
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The biological relevance of visible and subvisible particles with respect to trigger an 
immunogenic response is still unclear and without consensus among academy, industry and 
regulatory authorities [85–90]. Considering subvisible particles consisting of silicone, safety is 
not seen to be a concern for parenteral and not even for intraocular administration [3,91]. 
However, it still remains important to consider the particle burden during formulation and 
process development as well as during in-use administration testing of parenteral drug products. 
Monitoring particles above 10 µm and 25 µm, which is required by current compendia using LO 
[68–70], remains the gold standard. Characterizing particles in the lower size range using more 
novel methods may provide further insight to differentiate the nature of particulates, e.g., by MFI 
and RMM [53–55], and enables relative ranking of samples. Yet, new methods such as NTA are 
not suggested for routine use and data evaluation needs to be done with care [73,77,83]. 
In summary, after shaking in the presence of headspace the number of particles for samples in 
siliconized cartridges increased as compared to expelling alone. Studies in absence of headspace 
provided further insight into the mechanism of silicone migration. Still, baked-on silicone levels 
below 100 µg resulted in low particle levels mainly comprising silicone droplets without 
compromising protein stability in formulations with 0.04 % (w/v) polysorbate 20. Lower baked-
on silicone levels may even further limit silicone migration into the bulk solutions. 
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5 CONCLUSION 
Particle formation is known to occur under a variety of different stress conditions. In this work, 
the particle appearance in mAb formulations in bake-on siliconized cartridges was investigated 
using two practically relevant baked-on silicone levels (13 µg and 94 µg per cartridge), different 
mAb concentrations (2 mg/mL and 33 mg/mL) as well as agitation with and without headspace. 
A toolbox of methods was utilized to cover a particle size range as broad as possible including 
DLS, NTA, RMM, turbidity, LO and MFI.  
The robustness of mAb was demonstrated at both silicone levels independent of the protein 
concentration. The presence of 0.04 % (w/v) polysorbate 20 inhibited the formation of protein 
particles during agitation. Overall, the baked-on silicone levels corresponded well with the 
particle concentrations in the size range of 0.2-5 µm (RMM) and ≥ 1 µm (MFI, LO); and were 
comparable between placebo, 2 mg/mL mAb and 33 mg/mL mAb HC. The majority of particles 
was clearly identified as silicone droplets. Agitation with headspace caused an increase in particle 
concentration compared to samples without headspace, which was primarily attributed to silicone 
sloughing off from the container wall. Highest particle concentrations were observed in cartridges 
siliconized with 94 µg silicone after agitation with headspace independent of the filling medium 
(up to 55400 particles/mL ≥ 1 µm in MFI, 3400 particles/mL ≥ 1 µm in LO and 1.6-4.9×10
5
/mL 
between 0.2-5 µm in RMM). Although the presence of baked-on silicone obviously increased the 
particle concentration, silicone migration was still efficiently minimized compared to spray-on 
siliconized primary containers as described in literature (see above). Based on silicone migration 
studies in placebo, highest silicone levels were observed after shaking, whereas expelling alone 
or after agitation did not enhance silicone migration.  
Surely, silicone oil in sufficient concentration is essential as lubricant on the inner barrel of PFS 
and other drug/device combination products to maintain functionality over shelf life. An 
approach that could be taken to guide and limit the selection of siliconized primary containers 
may include i) optimized siliconization processes that balance adequate but limited silicone 
levels, reproducible silicone distributions and functionality; and ii) initial container performance 
testing with placebo, e.g., using shaking, which was most challenging for systems with low 
baked-on silicone levels; followed by iii) forced degradation and long-term protein stability 
studies including functionality testing (at intended and accelerated conditions) within the 
preselected containers under relevant formulation conditions such as the presence of surfactant. 
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6 ABBREVIATIONS 
DLS Dynamic light scattering 
FNU Formazine nephelometric units 
FTIR Fourier transform infrared (spectroscopy) 
LO Light obscuration 
mAb Monoclonal antibody 
mAb HC Monoclonal antibody at higher concentration (33 mg/mL) 
MFI Micro-flow imaging 
NTA Nanoparticle tracking analysis 
NS Non-siliconized 
PDI Polydispersity index 
PFS Pre-filled syringe 
RMM Resonant mass measurement 
RI Refractive index  
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ABSTRACT  
The adsorption of a monoclonal antibody (mAb) to model spray-on and bake-on silicone surfaces 
was investigated with a quartz crystal microbalance (QCM) and by fluorescence activated cell 
sorting (FACS). In QCM, maximum adsorption on spray-on silicone surfaces was found around 
the protein´s isoelectric point at pH 8 with 6.8 ± 0.2 mg/m
2
. In comparison, adsorption to the 
slightly more hydrophobic bake-on silicone surface was increased at pH 8 (8.7 ± 1.6 mg/m
2
) and 
pH 6 (7.0 ± 0.6 mg/m
2
) and less reversible upon rinsing with buffer. In QCM, labeled mAb-
Atto 633, which exhibited an increased hydrophobicity, adsorbed to a higher extent at pH 6 and 
pH 8 with 8.9-9.2 mg/m
2
 and less reversible as compared to unlabeled mAb. The pH-dependent 
adsorption profile was similarly observed in FACS. In addition, mAb-Atto 633 was not 
exchanged with unlabeled species in FACS, which underscored the irreversible adsorption of 
mAb-Atto 633 in comparison to unlabeled mAb. Still, the addition of polysorbate 20 at a 
concentration of 0.005 % (m/v) markedly decreased the mAb-Atto 633 adsorption. Overall, both 
an increased hydrophobicity of the surface and of the adsorbed species strongly influenced the 
adsorption profile. Likewise, these results demonstrated that fluorescently labeled proteins have 
to be selected with care to clarify the label impact on the protein adsorption profile. 
 
 
 
 
 
 
 
 
 
 
 
 
Parts of the following chapter are intended for publication.  
Parts of the QCM protein adsorption and surface characterization experiments were performed by 
Samuel Scholl during his bachelor thesis (“The Effect of pH on the Adsorption of Monoclonal 
Antibody to Spray-On and Bake-On Silicone Oil Surfaces Studied by QCM”, 2015). 
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1 INTRODUCTION 
Protein adsorption at interfaces is a common phenomenon encountered in various areas of 
biotechnology including therapeutic proteins [1], biosensing [2], biomaterials [3], bioseparation 
in chromatography [4] and filtration [5]. Due to their complex molecular structure therapeutic 
proteins may interact with a number of surfaces during manufacturing (e.g., stainless steel tanks 
or pipes, filters, plastic tubing), storage (e.g., glass, rubber stoppers) and drug administration 
(e.g., plastic infusion bags, stainless steel needles) [1].  
Silicone surfaces are particularly relevant since silicone oil is commonly used as lubricant to ease 
syringe piston movement during injection and enable good device performance, The silicone 
coating is applied by spraying either pure silicone oil without further treatment or silicone 
emulsion that is further baked-on the glass surface [6–8]. Bake-on siliconization typically results 
in silicone levels below 0.1 mg per container compared to 0.2 mg to 1 mg per container in spray-
on siliconization processes [9–12].  
One focus of research is to prevent or mitigate protein adsorption by the use of surfactants [13] or 
protein-resistant surface coatings (e.g., polyethylene glycol [14], polyglycerol [15]). 
Alternatively, studies seek to fundamentally understand the protein adsorption phenomenon 
[16,17]. Various models have been developed to describe the behavior of proteins in close 
proximity or adsorbed onto the surface, with the Langmuir isotherm being the most direct and 
simplest reference model [18,19]. Based on the assumption of a monomolecular layer of non-
interacting substrates that reversibly occupy equivalent adsorption sites, the applicability of this 
model is limited [20]. Additional characteristics considered in certain models are heterogeneous 
adsorption sites [21] and discrete protein adsorption states arising from different orientations 
(e.g., for Y-shaped IgG end-on, side-on, flat-on) [22] or conformational changes that may allow 
further desorption [23,24] and/or self-exchange with other proteins [25]. Apart from the 
individual behavior of protein molecules at the interface, the structure of the adsorbed protein 
layer is described by random sequential adsorption (RSA). Accordingly, adsorbing proteins do 
not overlap with any other pre-adsorbed species, otherwise they are rejected back into the bulk 
[26]. Thus, the RSA model is equivalent to negative cooperative adsorption [16]. In this 
framework, positive cooperative adsorption implies that a protein molecule is more likely to 
adsorb if there are already pre-adsorbed protein molecules. Thereby, proteins may form two-
dimensional clusters of protein monomers on the solid surface through direct attachment or 
surface diffusion of monomers to precursor clusters [27–29]. Alternatively, larger protein 
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assemblies formed in solution can deposit on the surface, subsequently spread, flatten and 
coalescence to surface clusters [30,31]. Furthermore, a combination of cooperative and non-
cooperative adsorption is realized in a guiding mechanism. Accordingly, monomers are attracted 
by the surface in vertical direction and tracked laterally to the nearest available binding site by 
complex local electrostatic fields from pre-adsorbed proteins rather than being necessarily 
rejected from the surface. Thereby, proteins preferentially adsorb in the close vicinity of pre-
adsorbed species but without direct contact [32,33]. Consequently, several adequate models are 
available to describe the formation of protein layers at solid interfaces, which should hold true for 
thin silicone layers in pre-filled syringes and other lubricated drug/device combination products.  
Protein adsorption to silicone oil-water interfaces may be studied either by using emulsified 
silicone oil droplets or by the use of material surfaces coated with silicone oil. Interfacial 
adsorption at liquid-liquid interfaces is typically based on similar models with monomers forming 
homogeneous, closely packed, “soft glassy” layers or heterogeneous adsorption implying 
interfacial protein clustering [34,35].  
The adsorption of proteins is affected by multiple factors such as the properties of the protein 
(“hard” or “soft” protein, isoelectric point (IEP), spatial charge distribution etc.) and the substrate 
surface (polarity, charge, morphology etc.) as well as environmental conditions (temperature, 
ionic strength, pH etc.). Depending on these factors protein adsorption can be governed by a 
combination of hydrogen bonding, electrostatic and hydrophobic forces [16,36,37]. In particular 
on hydrophobic surfaces, adsorption is substantially driven by a gain in entropy from dehydration 
of the sorbent surface, counter ion release and loss of ordered conformational structure within the 
protein molecule [38]. Overall, the total amount of adsorbed proteins is rather low and loss of 
protein may be only of concern for diluted protein therapeutics of low concentration [37,39]. 
Rather, a potential conformational change upon adsorption followed by exchange or desorption 
of these species back into solution receives attention since these altered structures are considered 
as precursor for protein aggregation and particle formation [40–42]. These subsequently induced 
protein particles may give rise to concerns about an increased risk of an immune response to the 
protein drug, which is controversially discussed in literature [43–48]. 
Among the many approaches used to investigate protein adsorption, quantifying the net protein 
accumulation over time, at different protein concentrations or in different formulations by bulk 
depletion technique [49,50] or after quantitative desorption from the surface [51,52] is rather 
popular. After fitting to an adequate model, the rate constant for adsorption and desorption, layer 
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thickness, average surface area per protein molecule and the irreversibly adsorbed fraction may 
be obtained. A direct measurement of the adsorbed amount and thus layer thickness, as well as in 
situ real-time adsorption/desorption kinetics can be conducted by surface plasmon resonance [53] 
and quartz crystal microbalance (QCM) with high sensitivity in the ng/cm
2
 range [54,55]. Due to 
its ability to monitor the viscoelastic properties of the adsorbed layer and entrapped water in 
parallel to easy handling and flexibility in material surfaces, QCM has been increasingly used for 
protein adsorption studies [56,57]. Other applied techniques to assess the adsorbed layer 
thickness are ellipsometry [58], optical waveguide lightmode spectroscopy [58] and neutron 
reflection [59]. In addition, the average protein conformation can be determined using attenuated 
total internal reflectance-infrared spectroscopy [60], Raman spectroscopy [61] and circular 
dichroism [62]. Each of these techniques has its own advantages and constraints to investigate 
protein adsorption and its impact on protein conformation, which have been thoroughly reviewed 
[16,37,63]. 
In recent years, fluorescence based techniques such as total internal reflection fluorescence 
microscopy [17,34], Förster resonance energy transfer [30,64] and fluorescence correlation 
spectroscopy [65,66] have been increasingly applied to track individual protein species at 
interfaces with highest sensitivity. In addition, fluorescence activated cell sorting (FACS) has 
become a highly appreciated tool in protein analytics, e.g., for label-free counting [67] and 
preparative sorting of subvisible proteinaceous particles [68,69] as well as for the differentiation 
between silicone droplets, proteinaceous particles and protein-coated silicone droplets using 
combinations of different fluorescent dyes [70–72]. The utility of FACS to identify 
heterogeneous silicone droplets with adsorbed proteins particularly offers great potential for 
efficient monitoring of protein adsorption. Obviously, an inherent drawback of most fluorescence 
methods is the attachment of a fluorescent label, which may perturb the nature of the protein and 
thus change the adsorption behavior [73–76]. Therefore, the potential impact of these labels 
needs to be clarified.  
In this study, we explored QCM and FACS to detect and characterize the adsorption of a 
monoclonal IgG1 antibody (mAb) on silicone oil surfaces. QCM was used as a highly sensitive 
method to determine the adsorbed mass, thickness and protein layer viscoelasticity on silicone oil 
and heat-treated silicone mimicking sprayed-on and baked-on siliconized surfaces. Furthermore, 
the adsorption of labeled mAb-Atto 633 to silicone droplets was studied in QCM and FACS for 
comparative evaluation of both novel techniques. The adsorption experiments were performed as 
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a function of protein concentration, time and at three different pH values, i.e., protein charge 
conditions, for a mechanistic understanding of the driving forces that trigger adsorption. In 
addition, a comprehensive set of experiments was performed in FACS to clarify the effect of Atto 
633-labeling on the adsorption behavior of mAb.  
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
Non-siliconized 2R vials from Schott AG (Mainz, Germany) and stoppers from West 
Pharmaceutical Services, Inc. (Exton, PA, USA) were used. Polyethersulfone (0.2 µm, 
Ø 27 mm), polytetrafluorethylene (0.2 µm, Ø 13 mm) and cellulose acetate (0.45 μm, Ø 27 mm) 
syringe filters were obtained from VWR International GmbH (Darmstadt, Germany). Cellulose 
acetate filters (0.2 µm, Ø 47 mm) were from Sartorius Stedim Biotech GmbH (Göttingen 
Deutschland). Slyde-A-Lyzer™ dialysis cassettes (molecular weight cut-off 10 kDa, volume 0.5-
3 mL) were purchased from Thermo Scientific Inc. (Waltham, MA, USA). 
Chemicals were obtained as follows: 365 35 % Dimethicone NF Emulsion and 360 Medical 
Fluid, 350 cSt, from Dow Corning GmbH (Wiesbaden, Germany); heptane from Riedel-de Haën 
(Seelze, Germany); diiodomethane, disodium hydrogen phosphate dihydrate, sodium chloride, 
diammonium sulfate and toluene from VWR International GmbH (Darmstadt, Germany); L-
histidine monohydrochloride monohydrate and L-histidine both from Ajinomoto Europe S.A.S 
(Louvain-la-Neuve, Belgium); 1 M sodium hydroxide and 1 M hydrochloric acid standard 
volumetric solutions both from AppliChem GmbH (Darmstadt, Germany); sodium dodecyl 
sulfate (SDS) from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany); sodium dihydrogen 
phosphate dihydrate from Carl Roth GmbH + Co. KG (Karlsruhe, Germany); polysorbate 20 
from Croda GmbH (Nettetal-Kaldenkirchen, Germany); potassium chloride from Caesar & 
Loretz GmbH (Hilden, Germany); dimethyl sulfoxid from Merck KGaA (Darmstadt, Germany); 
Atto 633 N-hydroxylsuccinimidyl (NHS)-ester from Atto-Tec GmbH (Siegen, Germany) and 4,4-
difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (Bodipy 493/503) from Invitrogen/ 
Life Technologies GmbH (Darmstadt, Germany). A 33.4 mg/mL IgG1 mAb stock solution in 
20 mM histidine buffer pH 5.4 was kindly donated by Roche Deutschland Holding GmbH 
(Penzberg, Germany). Silica microparticles with a diameter of 1.5 µm were purchased from 
Kisker Biotech GmbH & Company KG (Steinfurt, Germany). 
2.2 QUARTZ CRYSTAL MICROBALANCE (QCM) EQUIPMENT AND 
MEASUREMENT PRINCIPLE 
QCM experiments were performed on a qCell T from 3T GmbH & Co. KG (Tuttlingen, 
Germany) at 25 ± 0.1 °C equipped with an Ismatec peristaltic pump at a flow rate of 60 µL/min 
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from Cole-Parmer GmbH (Wertheim, Germany). Disc-shaped, AT-cut piezoelectric quartz 
crystals oscillating at a resonant frequency of 10 MHz with gold-plated electrodes and gold-
coated active surfaces were obtained from 3T GmbH & Co. KG (Tuttlingen, Germany). 3T 
qGraph Software was utilized for instrument control and data analysis. Frequency and damping 
signals were monitored until stable values of ± 1 Hz and ± 10 Hz, respectively, were achieved for 
10 min.  
A homogeneous, thin, rigid mass deposition can be calculated from the frequency shift (ΔfSauerbrey 
in Hz) according to Sauerbrey: 
𝛥𝑚𝑆𝑎𝑢𝑒𝑟𝑏𝑟𝑒𝑦 =
𝐶 ∗ 𝛥𝑓𝑆𝑎𝑢𝑒𝑟𝑏𝑟𝑒𝑦
𝐴
 
Eq. VII-1 
with ΔmSauerbrey as the mass change per area (in mg/m
2
), C as the instrument specific crystal 
sensitivity constant (0.86×10
-6
 mg/Hz) and A as electrode active area (1.96×10
-5
 m
2
) [77,78]. The 
above equation only holds for vacuum and gaseous phase. Kanazawa and Gordon expanded this 
model to sensors immersed in Newtonian liquid with a frequency shift (ΔfKanazawa in Hz) due to 
the viscosity (η) and density (ρ) of the surrounding medium defined by: 
𝛥𝑓𝐾𝑎𝑛𝑎𝑧𝑎𝑤𝑎 = −√𝑓0
3
𝜂𝜌
𝛱𝜇𝑞𝜌𝑞
 
Eq. VII-2 
where f0 is the fundamental resonant frequency (10×10
6
 Hz) [77], μq is the shear module of the 
quartz (2.947×10
16
 mg/m·s
2
) and ρq is the density of the quartz (2.648×10
9
 mg/m
3
) [79]. In a 
model system composed of a rigidly adsorbed layer immersed in liquid, the Sauerbrey and 
Kanazawa frequency shift both add up to an overall final shift [55]. This model for rigid and 
liquid-loaded sensors was further developed by various contributors, remarkably Rodahl et al. 
[80,81] and Voinova et al. [82]. Viscoelastic layers induce an exponentially-damped sinusoidal 
frequency decay of a freely oscillating crystal. Here, damping (ΔD) for liquid-loaded sensors can 
be derived from: 
𝛥𝐷 = 2√
𝑓0
𝜂𝛱
 
1
𝜐𝑞𝜌𝑞
√𝜌𝜂 
Eq. VII-3 
with υq as the speed of sound in quartz (3340 m/s) [83]. 
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The dissipation factor (D) (e.g., in QCM-D instruments from Q-Sense), half the bandwidth at half 
maximum of the resonance frequency (Γ) (e.g., in qCell T from 3T GmbH & Co. KG) and the 
motional resistance (R) are interchangeable terms and are commonly used to describe dissipation:  
𝐷 =
2𝛤
𝑓0
=  
 𝑅 ∗ 𝑓0
2 𝛱 ∗ 𝐿𝑞
 
Eq. VII-4 
with Lq as the equivalent (motional) inductance of the bare quartz crystal (8.2×10
-3
 Ω/Hz) 
[80,84,85]. The dissipation thus gives valuable information on the film´s complex viscoelasticity 
since energy is dissipated due to oscillatory motion within the soft film, trapped liquid that moves 
within the film after deformation and load from bulk liquid [56].  
2.3 SILICONE MODEL SURFACES FOR QCM 
 SPIN-COATING PROCESS FOR MODEL SPRAY-ON AND BAKE-ON 2.3.1
SILICONE COATINGS 
Silicone oil was dissolved in heptane at a final concentration of 1.75 % (w/v) and 3.5 % (w/v). 
Silicone emulsion was diluted to 1.75 % (w/w) using highly purified water. 3 mL of the diluted 
silicone emulsion were transferred as a thin fluid layer in a borosilicate glass beaker of 9.5 cm 
diameter, heated at 295 °C for 12 min and extracted with 3 mL heptane. Aliquots of 200 µL were 
evaporated to dryness at room temperature and redissolved in 140 µL or 200 µL heptane to 
achieve final concentrations of 1.75 % (w/v) and 2.5 % (w/v), respectively. 
Initially, the resonant frequency of the blank quartz chip was recorded. Quartz chips were then 
siliconized with 5 x 6 µL drops of silicone (i.e., model spray-on coating) or heat-treated silicone 
(i.e., model bake-on coating) in heptane on a SCI-20 spin-coater from Schaefer Technologies 
GmbH (Lange, Germany) at 100 rpm. After drying, the coated mass was derived from the 
frequency shift between the uncoated and the siliconized quartz chip according to Sauerbrey (Eq. 
V-1). For reuse, the quartz chips were cleaned with 6 x 6 µL drops of toluene during spinning at 
100 rpm and additional wiping with cotton swab, soaked in solvent.  
A silicone layer density of 0.97 g/cm
3
 [86] was utilized to calculate the coated layer thickness. In 
addition, ΔΓ/Δf was introduced as a measure for layer rigidity. Comparable to ΔD/Δf quotients, 
more rigid layer yield small ΔΓ/Δf and vice versa [87] (see 2.4.3).  
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 CONTACT ANGLE AND SURFACE FREE ENERGY 2.3.2
Contact angles of 1 µL purified water drops were determined at four different positions of the 
siliconized quartz chip using a Drop Shape Analyzer from Krüss GmbH (Hamburg, Germany) in 
sessile drop mode. Contact angles were calculated with Krüss Advance 1.1.02 software 20 s after 
drop deposition by ellipse (tangent-1) fitting and automatic baseline adjustment. For the 
calculation of the surface free energy including disperse and polar fractions, the Owens, Wendt, 
Rabel and Kaeble method was applied using the contact angles of 0.9 µL diiodomethane droplets 
as second liquid with known polar and disperse fractions [88]. 
 ZETA POTENTIAL AND ISOELECTRIC POINT (IEP) 2.3.3
The zeta potential (ζ-potential) was determined using a Zetasizer Nano-ZS ZEN3600 from 
Malvern Instruments Ltd (Herrenberg, Germany) in monomodal mode (50 V const.) with three 
measurements per sample with 10-40 subruns each at 25 °C. For the determination of IEP, the 
disposable zeta cell was connected to a Malvern MPT-2 Autotitrator. The pH of 12 mL sample in 
a polypropylene tube was automatically adjusted from pH 12.5 to pH 1.5 in increments of 0.5 pH 
using 1 M NaOH and 1 M HCl under constant stirring. The ζ-potential and IEP were calculated 
by Zetasizer Software v6.32.  
Pure silicone oil was dispersed in highly purified water to a final concentration of 10 % (w/v). 
After vortexing briefly with Vortex Genie 2 from VWR International GmbH (Darmstadt, 
Germany) and ultrasound treatment (VWR International GmbH, Darmstadt, Germany) both for 
10 min, the emulsion was diluted to 5 % (w/v). Heat-treated silicone was dispersed in highly 
purified water to a final concentration of 1.5 % (w/v) using ultrasound treatment for 30 min. The 
emulsion was further diluted to 0.5 % (w/v). Both emulsions were exposed to a second 
ultrasound treatment for 10 min followed by 0.45 µm filtration prior to analysis. The emulsion 
preparation was adjusted to obtain adequate mean count rates. Fresh silicone emulsions were 
prepared on the day of the measurement. 
 3D-LASER SCANNING MICROSCOPY (3D-LSM)  2.3.4
The average silicone layer thickness was determined using a VK-X210 microscope from 
Keyence Deutschland GmbH (Neu-Isenburg, Germany) as previously reported [89] (see chapter 
III). The limit of quantification was 10 nm. The silicone coating was artificially removed from 
the quartz chip surface by smoothly scratching an Eppendorf pipette tip (0.1-10 µL) over the 
surface. Height profile measurements of 1.5 x 1.1 mm surface areas (10 x magnification) were 
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performed using Keyence VK Viewer Software in EasyMode. The average layer thickness at the 
center, right and left side of the chip was determined as the difference in the average height 
between the gold surface and the silicone coating in multi-line average profile (400 lines) after 
area and line plane tilt correction. The integrated optical microscope (10 x magnification) was 
additionally employed to visualize the intact silicone coating at the center and each side of the 
chip. 
2.4 ANALYSIS OF MAB AND MAB-ATTO 633 ADSORPTION IN QCM 
 PREPARATION OF BUFFERS AND PROTEIN SAMPLES FOR QCM 2.4.1
MEASUREMENTS 
The standard buffer was 20 mM histidine, pH 6. For additional mAb adsorption experiments, the 
pH was adjusted to pH 8 and pH 10 using 1 M NaOH. A consistent ionic strength of 50 mM for 
all histidine buffers was obtained by adding adequate amounts of sodium chloride based on 
iterative calculations previously described by Mathes [90]. Buffers were 0.2 µm filtered using 
pressurized nitrogen.  
A concentrated solution (33.4 mg/mL) of mAb was diluted into the corresponding buffers to final 
concentrations from 0.1 mg/mL to 4 mg/mL. The equilibrium concentration in QCM was reached 
at 2 mg/ml (supporting information Fig. S VII-1). Thus, for further adsorption experiments, a 
2 mg/mL mAb concentration was used. Similarly, mAb-Atto 633 (see 2.5.1) was diluted to 
2 mg/mL using histidine buffers of defined pH and consistent ionic strength of 50 mM.  
Prior to analysis, all solutions were 0.2 µm filtered and mAb concentrations were verified by UV 
absorption at 280 nm using a NanoDrop 2000 spectrophotometer from Thermo Fisher Scientific 
Inc. (Waltham, MA, USA) and an extinction coefficient of 1.51 cm
2
/mg. The mAb-Atto 633 
concentration was determined as recommended in the procedure for labeling [91]. All buffers and 
samples were carefully degassed in a desiccator equipped with a Laboport vacuum pump from 
KNF Neuberger GmbH (Freiburg, Germany) before analysis. 
 SUMMARY OF THE EXPERIMENTAL SEQUENCE FOR PROTEIN 2.4.2
SAMPLES IN QCM 
For protein adsorption studies, measurements started with buffer at a flow rate of 60 µL/min until 
a stable baseline in frequency (± 1 Hz for 10 min) and damping (± 10 Hz for 10 min) was 
achieved. Equilibration of the silicone coating in buffer prior to each measurement was crucial 
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since up to 0.5-1.9 mg/m
2
 silicone leached upon rinsing with buffer (supporting information Fig. 
S VII-2). An aliquot of 244 µL protein solution in the respective buffer was then injected at 
60 µL/min corresponding to a surface-to-volume ratio of 0.447 µL/cm
2
 as exemplarily valid for 
5 mL cartridges (tubing dead volume of 74 µL and 0.38 cm
2
 chip area exposed to liquid were 
considered). Protein samples were further statically incubated until frequency and damping 
signals were stabilized. Subsequently, the corresponding buffer was introduced at 60 µL/min 
until damping and frequency became stable. The sequential steps involved in the experiments are 
exemplarily illustrated in Fig. VII-1. 
 
Fig. VII-1. Typical time course of frequency and damping changes in QCM upon adsorption of mAb at the silicone 
oil-buffer interface as a function of time. 
After each measurement the QCM system was rinsed with 10 mM phosphate buffer containing 
145 mM sodium chloride and 0.05 % (w/v) SDS (pH 7.2) to desorb bound protein followed by 
highly purified water. SDS increased silicone leaching up to 3.7-8.4 mg/m
2
 (supporting 
information Fig. S VII-2). Therefore, frequency shifts during/after SDS exposure were not 
considered for further analysis. The silicone coating was subsequently removed as described 
above.  
 DATA ANALYSIS OF PROTEIN SAMPLES IN QCM 2.4.3
The frequency shift between the first buffer rinse and the equilibrium during static protein 
incubation was utilized to determine total adsorption (irreversible plus reversible). The liquid-
induced frequency and damping shifts (Kanazawa contributions) due to the different media were 
calculated according to Eq. VII-2 and Eq. VII-3, respectively, based on the densities and 
viscosities of both buffer and protein solutions, and finally subtracted from the corresponding 
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initial frequency and damping shifts. This final corrected frequency shift was transferred into 
total adsorbed mass according to Sauerbrey (Eq. VII-1). 
The frequency shift between the first buffer rinse and the end of the second buffer rinse directly 
corresponded to the irreversibly adsorbed mass based on Sauerbrey (Eq. VII-1) without 
Kanazawa contributions due to the same bulk media. 
The density of the adsorbed protein layer was assumed to be 1.35 g/cm
3
 to calculate the adsorbed 
layer thickness [92]. In addition, ΔΓ/Δf was introduced as a measure for layer rigidity. 
Comparable to ΔD/Δf quotients, more rigid layers result in small ΔΓ/Δf and vice versa [87]. 
Rigid layers are described by ΔΓ/Δf < 0.25 as suggested by Paul et al. [93] while Muramatsu et 
al. found ΔΓ/Δf < 0.1 (given ΔR/Δf and ΔD/Δf terms were transferred according to Eq. VII-4. 
Thus, for rigid layers, a rigidity quotient ΔΓ/Δf ~ 0-0.25 was considered reasonable. 
In this study, we present QCM adsorption data based on the Sauerbrey model, well aware that for 
highly viscoelastic films in liquid media the adsorbed mass becomes underestimated compared to 
Voigt-based data modeling [94]. However, it was reported that for frequency shifts up to 2 % of 
the unloaded frequency [95] and for layer thicknesses below 100 nm [96] or less than 10 nm [97] 
the Sauerbrey model is adequate. 
2.5 ANALYSIS OF MAB-ATTO 633 ADSORPTION IN FLUORESCENCE 
ACTIVATED CELL SORTING (FACS) 
 MAB FLUORESCENT LABELING WITH ATTO 633 NHS-ESTER 2.5.1
mAb was fluorescently labeled with amine-reactive Atto 633 NHS-ester according to the 
manufacturer´s recommended procedure for labeling [91].  Atto 633 shows best excitation at 
λex = 629  nm and emission at λem = 657 nm [98]. Before labeling, a 33.4 mg/mL concentrated 
mAb solution was dialyzed (ratio 1:600) into 10 mM phosphate-buffered saline (pH 7.4, 135 mM 
NaCl, 3 mM KCl) to mitigate dye reactions with histidine in the initial buffer bulk. The dialyzed 
mAb solution was diluted to 5 mg/mL and pH adjusted with 0.2 M sodium bicarbonate solution 
(pH 9) to pH 8.3. The mAb concentration was verified by UV absorption at 280 nm as described 
above followed by labeling an aliquot of 3.5 mL protein solution with 16 µL of Atto 633 NHS-
ester at 10 mg/mL in dimethyl sulfoxide for 1 h at room temperature protected from light. After 
labeling, the mAb-Atto 633 conjugate was immediately dialyzed (ratio 1:600) in the 
corresponding histidine buffers of defined pH and consistent ionic strength of 50 mM to remove 
excess unassociated dye.  
Chapter VII 
176 
The mAb-Atto 633 concentration and the degree of labeling (DOL), i.e., average number of 
molecules coupled to a protein, were determined as recommended in the procedure for labeling 
[91]. The DOL was 1.3 ± 0.1. The concentration of mAb-Atto 633 after dialysis and 0.2 µm 
filtration ranged between 3.5 mg/mL to 4.7 mg/mL (further referred to as mAb-Atto 633 stock 
solution).  
 SILICONE STAINING WITH BODIPY 493/503  2.5.2
A 100 mg aliquot of silicone oil (0.2 µm filtered) was dissolved in 300 µL toluene and mixed 
with 16 µL Bodipy 493/503 at a concentration of 2.5 mg/mL in dimethyl sulfoxide. Both solvents 
were removed under constant nitrogen flow of 210 mL/min at 30 °C for 3 h protected from light 
using a thermal evaporator from Barkey GmbH & Co. KG (Leopoldshöhe, Germany). Bodipy 
493/503 shows best excitation at λex = 493 ± 3 nm and emission at λem = 504 ± 4 nm [99]. 
 PREPARATION OF SILICONE OIL EMULSION 2.5.3
An aliquot of 40 mg silicone (0.2 µm filtered) or Bodipy 493/503-stained silicone was dispersed 
in 200 µL highly purified water to generate an emulsion without additives, which may affect the 
emulsification process. After vortexing for 30 s with Vortex Genie 2 form VWR International 
GmbH (Darmstadt, Germany), the emulsion was homogenized using an ultraturrax T 10 basic 
from IKA Laboratories (Staufen, Germany) for 1 min and diluted to 8 mg/mL in highly purified 
water. Fresh 8 mg/mL silicone stock emulsion was prepared on the day of the measurement.  
 PREPARATION OF MIXED SAMPLES OF SILICONE OIL AND PROTEIN 2.5.4
FOR FACS MEASUREMENTS 
2.5.4.1 FLUORESCENCE CONTRIBUTIONS FROM UNSPECIFIC SILICONE 
INTERACTIONS 
A set of mixtures with final protein concentrations of 0.05 mg/mL mAb-Atto 633, equimolar 
concentrations of free Atto 633 and 0.2 mg/mL Bodipy 493/503-stained or non-stained silicone 
oil in 20 mM histidine buffer, pH 6, was prepared from the stock solutions described above. At 
least 2 h prior to sample preparation, the 10 mg/mL Atto 633 NHS-ester stock solution in 
dimethyl sulfoxide was diluted 1:100 in 20 mM histidine buffer, pH 6, such that the functional 
groups were hydrolyzed followed by 0.2 µm filtration. 
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2.5.4.2 CONCENTRATION DEPENDENT ADSORPTION OF MAB-ATTO 633 AND FREE 
ATTO 633 
mAb-Atto 633 stock solution (dialyzed in 20 mM histidine buffer, pH 6, 0.2 µm filtrated) was 
mixed at concentrations from 0.01 mg/mL to 1 mg/mL with 0.2 mg/mL Bodipy 493/503-stained 
silicone emulsion in the corresponding histidine buffer. Similarly, mixtures of free Atto 633 dye 
and silicone emulsion were prepared (Atto 633 concentration was equimolar to the corresponding 
mAb concentration).  
2.5.4.3 DISPLACEMENT STUDIES 
A mixture of 0.01 mg/mL mAb-Atto 633 and 0.2 mg/mL Bodipy 493/503-stained silicone 
emulsion in 20 mM histidine buffer, pH 6, was allowed to incubate for 2 h (time based on 
previous experiments where the equilibrium was reached after approximately 2 h, supporting 
information Fig. S VII-3). Subsequently, an excess of unlabeled mAb was added to obtain a final 
ratio of 1:10 mAb-Atto 633 to mAb. Experiments were performed incubating mAb first followed 
by addition of an excess of mAb-Atto 633. Bodipy 483/503 and Atto 633 fluorescence signals 
were recorded up to 6 h after the second incubation step.  
2.5.4.4 MAB-ATTO 633 ADSORPTION AS A FUNCTION OF PH AND ADDITION OF 
POLYSORBATE 20 
Experiments were performed with mixtures of 0.05 mg/mL mAb-Atto 633 and 0.2 mg/mL 
Bodipy 493/503-stained silicone emulsion in histidine buffer of defined pH at constant ionic 
strength of 50 mM. Samples with surfactant additionally contained 0.005 % (m/v) to 
0.04 % (m/v) polysorbate 20. The mixtures were allowed to adsorb for 2 h before analysis. 
 DETECTION OF PROTEIN ADSORPTION IN FACS 2.5.5
A 200 µL sample aliquot was analyzed for 1 min using a FACSCanto II flow cytometer from 
Becton, Dickinson and Company (Heidelberg, Germany) at a low sample flow (approximately 
10 µL/min). Fluorescence signals of both Bodipy 493/503 and Atto 633 were simultaneously 
analyzed after excitation using a 488 nm blue laser (air-cooled, solid state, 20 mV laser output) 
and a 633 nm red laser (HeNe, 17 mW laser output); and fluorescence detector bands of 
530/30 nm and 660/20 nm at 509 V and 400 V, respectively. A multicolor approach facilitated 
minimum overlap of the fluorescence response of both dyes and thus less spill-over in the 
emission filters (max. 1.4 %) [100]. Low angle forward light scatter (FSC) and 90° side scatter 
(SSC) detector voltages were set to 85 V and 300 V, respectively. Mean Bodipy 483/503 and 
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Atto 633 fluorescence intensities, FSC and SSC were recorded immediately after sample 
preparation unless otherwise stated. The approximate size range detected in FSC was studied 
with silica microparticle suspensions with a diameter of 1.5 µm after dilution in 20 mM histidine 
buffer, pH 6. 
2.6 PHYSICOCHEMICAL PROPERTIES OF THE SAMPLE SOLUTIONS 
Viscosity measurements were performed with a mVROC viscosimeter from Rheosense Inc. (San 
Ramon, CA, USA) equipped with an A-series chip with a flow channel depth of 50.8 µm at a 
constant shear rate of 1.90*10
7 
s-
1
. Control software v2.6 was utilized for data analysis. Densities 
were determined using DMA 38 density meter from Anton Paar GmbH (Graz, Austria) at 20 °C. 
2.7 HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC) 
HIC analysis was performed on a 35 x 4.6 mm TSKgel Butyl-NR column from Tosoh Bioscience 
GmbH (Darmstadt, Germany) and an Alliance 2695 high performance liquid chromatography 
system from Waters GmbH (Eschborn, Germany) with gradient elution (buffer A: 1.5 M 
(NH4)2SO4, 20 mM histidine, pH 6; buffer B: 20 mM histidine, pH 6; linear gradient 0-100 % 
buffer B until 17 min, 100 % buffer B until 21.5 min, linear gradient buffer A 0-100 % until 
26 min, 100 % buffer A until 34.5 min) at a flow rate of 0.8 mL/min and 25 °C column 
temperature. mAb and mAb-Atto 633 samples were diluted to 1 mg/mL in 20 mM histidine 
buffer, pH 6, and cooled at 4 °C before injecting 20 µg. The elution was monitored with UV 
detection at λ = 280 nm (mAb absorption) and λ = 629 nm (Atto 633 absorption). 
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3 RESULTS AND DISCUSSION 
3.1 DEVELOPMENT OF MODEL SPRAY-ON AND BAKE-ON SILICONE 
COATINGS IN QCM  
Different silicone coatings were established as model surfaces for therapeutic drug product 
containers, which are lubricated by either spraying-on silicone oil or silicone emulsion that is 
further baked-on the glass surface [6–8]. The coatings were optimized in terms of coated mass, 
thickness and rigidity to exclude an effect of these parameters on protein adsorption (Tab. VII-1). 
Comparable amounts of approximately 60-65 mg/m
2
 silicone or heat-treated silicone were finally 
deposited yielding a layer thickness of 60-70 nm. The bound layer was rigid in nature as 
indicated by rigidity quotients of ΔΓ/Δf = 0.04-0.05. A thicker silicone layer of 170 nm resulting 
from a higher coated amount of approximately 160 mg/m
2
 silicone was slightly less rigid 
(ΔΓ/Δf = 0.07) and was therefore not considered in further studies. The coated layer thickness 
was exemplarily confirmed in 3D-LSM (Tab. VII-1, Fig. VII-2c, Fig. VII-2d), which revealed 
thinner layers of 40-50 nm. For 3D-LSM analysis, a low 10 x magnification was employed, 
which has been previously shown to underestimate the layer thickness by 5-20 % [89] (see 
chapter III). Overall, both coatings were found to be comparable in terms of coated mass, layer 
thickness and rigidity. 
Tab. VII-1. Optimization of frequency shift (Δf), coated mass (Δm), rigidity quotient (ΔΓ/Δf), and layer thickness 
based on calculations according to Sauerbrey (Eq. VII-1) after spin-coating QCM chips with model spray-on and 
model bake-on silicone. Grey panels indicate coating solutions and characteristics used for further experiments. 
Sample description 
Concentration 
silicone solution 
Δf [Hz] Δm [mg/m
2
] ΔΓ/Δf 
Layer thickness [nm] 
QCM 3D-LSM 
Spray-on coating 
3.5 % -3695.7 ± 95.6 162.2 ± 4.2 0.07 ± 0.01 167.2 ± 4.3 - 
1.75 % -1478.7 ± 131.8 64.9 ± 5.8 0.05 ± 0.02 66.9 ± 6.0 50 ± 9 
Bake-on coating 
1.75 % -889.7 ± 20.1 39.0 ± 0.9 0.04 ± 0.02 40.2 ± 0.9 - 
2.5 % -1313.7 ± 81.1 57.6 ± 3.6 0.04 ± 0.03 59.4 ± 3.7 42 ± 11 
 
The morphology of both silicone surfaces was similar exhibiting a relatively smooth structure 
with circular, brighter yellowish marks in particular on the model spray-on silicone surface. The 
surface coverage at the center and each side of the quartz chip was homogeneous (Fig. VII-2a, 
Fig. VII-2b). Note that the yellow color is due to the gold surface on the quartz chip. The surface 
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additionally revealed micro-scratches, which are also present on untreated chip surfaces 
[101,102] or may be partially introduced during chip cleaning with cotton swabs. Atomic force 
and scanning electron micrographs of the untreated gold surface showed pyramid-like gold 
structures and nm-scale airborne-contaminants [101,102] that may preferentially adhere silicone 
during spin-coating and thus give rise to the circular structures observed in 3D-LSM. 
a. 
 
b. 
 
c. 
 
d. 
 
Fig. VII-2. Visual appearance of model (a) spray-on and (b) bake-on silicone surfaces in optical microscopy at the 
center and each side of the coated QCM chip. Exemplary micrographs of the (c) spray-on and (d) bake-on coating 
used for the determination of the coated layer thickness by 3D-LSM analysis as the difference in the average height 
between the chip surface and the silicone layer.  
Studies indicate that proteins readily adsorb to hydrophobic surfaces governed by hydrophobic 
interactions and the entropy gain upon dehydration of the hydrophobic surface, counter ion 
release and loss of ordered conformational structure within the protein molecule [38,103]. To 
understand the influence of surface hydrophobicity on protein adsorption, water contact angles on 
both silicone coatings were determined. The model spray-on and bake-on silicone coatings were 
highly hydrophobic with contact angles of 78.1 ± 1.3° and 91.9 ± 1.2°, respectively (Fig. VII-3, 
Tab. VII-2). 
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a. b. 
 
Fig. VII-3. Contact angle images of water on QCM chips after spin-coating with (a) model spray-on and (b) model 
bake-on silicone. 
Tab. VII-2. Measured contact angles of water and values for the dispersive and polar components of the surface free 
energy after spin-coating QCM chips with model spray-on and bake-on silicone. 
Measurement parameter Spray-on coating Bake-on coating 
Contact angle water (four different chip positions) 78.1 ± 1.3° 91.9 ± 1.2° 
Surface free energy γ [mN/m] 39.9 ± 0.6 29.4 ± 0.3 
Dispersive component γd [mN/m] 34.9 ± 0.2 (87 %) 27.4 ± 0.1 (93 %) 
Polar component γp [mN/m] 5.0 ± 0.3 (13 %) 2.0 ± 0.3 (7 %) 
 
For vials siliconized with Dow Corning Medical Fluid 360 without additional heat treatment, 
Mathes found a comparable contact angle of 78° [90] while bake-on siliconized cartridges 
exhibited a higher contact angle of 103 ± 2° (see chapter V). Previous studies suggested a 
decrease in the low molecular weight fraction of silicone below 5,000 g/mol, an increase in the 
fraction between 500 g/mol and 15,000 g/mol and no substantial formation of molecules with 
more than 50,000 g/mol upon bake-on. It can be argued, that lower molecular weight fractions 
migrate into micro-inhomogeneities on the sorbent surface due to a greater mobility and thereby 
lead to a disorientation of the applied, hydrophobic layer [104,105]. This may result in a slightly 
lower contact angle for untreated silicone oil (i.e., model spray-on) (for more comprehensive 
discussion please refer to chapter V). 
Contact angle measurements with different test liquids of known polar and disperse fractions (in 
this study water and diiodomethane) are widely used to calculate surface energetic properties 
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based on the Owens, Wendt, Rabel and Kaeble method. London dispersion forces arising from 
instantaneous dipoles due to a permanent electron density fluctuation within an atom and polar 
forces due to permanent dipole-dipole, dipole-induced and ion-dipole polarization as well as 
hydrogen bonding both sum up to the total surface free energy [106,107]. The surface free energy 
of the bake-on coating was determined to be less with 29.4 ± 0.3 mN/m compared to 
39.9 ± 0.6 mN/m found for the spray-on coating (Tab. VII-2). The bake-on coating showed a 
dispersive interaction energy of 93 % compared to 87 % for the spray-on coating in excess of the 
polar fraction and indicating a slightly stronger hydrophobicity and weaker polar contributions 
(e.g., due to dipole-dipole interaction with water [107]). In literature, comparable surface free 
energies for silicone oil, siliconized vials and silicone rubber were reported with 20-22 mN/m up 
to 45 mN/m and 91-97 % dispersive contributions [90,108–110]. In consequence, the model 
spray-on and bake-on silicone coatings were considered as suitable surrogates for spray-on and 
bake-on siliconized glass surfaces in therapeutic drug product containers. Interestingly, the bake-
on silicone coating was slightly more hydrophobic with higher dispersive force contributions. 
Furthermore, the surface IEP and surface charge at defined pH dictate the electrostatic 
interactions proteins may encounter upon adsorption. Starting at approximately 8 mV at pH 1.5, 
the ζ-potential of silicone droplets in highly purified water (model spray-on) decreased to zero ζ-
potential at the IEP of 3.9 ± 0.0 and reached -38 mV at pH 12.5 (Fig. VII-4). The ζ-potential 
determined for silicone emulsions containing heat-treated silicone droplets (model bake-on) with 
a slightly lower IEP of 2.9 ± 0.5 was in good agreement with the data obtained for pure silicone 
droplets. 
 
Fig. VII-4. The ζ-potential of droplets of pure silicone (model spray-on) and heat-treated silicone oil (model bake-on) 
in highly purified water versus pH. 
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Electric charge in aqueous solution results from selective adsorption of hydrogen and hydroxide 
ions at the shear plane between the surrounding solution and a layer of surface bound ions at the 
neural silicone surface [111]. In the case of strongly acidic or alkaline solution, charge may also 
be introduced by partial hydrolysis of the siloxane backbone and dissociation of the resulting 
silanol groups [112]. The IEPs were well in line with reported values for siliconized glass powder 
and slides of 3.4-3.6 [51]. Other studies suggest a higher IEP for silicone droplets in aqueous 
media and silicone rubber ranging from 4.5-5.5 [113–115], which may be due to different sample 
materials and measurements techniques. Overall, ζ-potential measurements indicated similar 
surface charges in the pH range of 1.5-12.5 for both coatings investigated in QCM. 
Consequently, the model spray-on and bake-on coating are expected to exhibit negative ζ-
potentials of approximately -20 mV to -40 mV at the tested pH values of pH 6, pH 8 and pH 10. 
3.2 THE ADSORPTION OF MAB TO MODEL SPRAY-ON AND BAKE-ON 
SILICONE SURFACES AS A FUNCTION OF PH STUDIED BY QCM  
 ADSORBED AMOUNT AS A FUNTION OF PH 3.2.1
The influence of pH on the adsorption of mAb to model spray-on and bake-on silicone surfaces 
was investigated in QCM.  
 
Fig. VII-5. Effect of pH on mAb adsorption (2 mg/mL) to model spray-on silicone surfaces in histidine buffer at 
consistent ionic strength of 50 mM as determined by QCM. Adsorbed mass was corrected for liquid-induced 
frequency and damping contributions according to Kanazawa (Ø - ΔΓ/Δf could not be quantified (≤ 0)). Statistical 
significance for bars is shown with * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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For spray-on silicone surfaces, the highest surface concentration with 6.8 ± 0.2 mg/m
2
 was found 
at pH 8 close to the mAb´s IEP at pH 8.0-8.5 [116] (Fig. VII-5). At pH 6, mAb still markedly 
adsorbed with 4.0 ± 0.6 mg/m
2
. The most pronounced drop in adsorption to 1.3 ± 0.3 mg/m
2
 was 
observed at pH 10. 
As described above the spray-on silicone surface was rather hydrophobic with contact angles of 
78.1 ± 1.3°, but also exhibited a substantial negative charge of about -20 mV to -40 mV at the 
tested pH values. Consequently, adsorption resulted from interplay of hydrophobic and 
electrostatic forces.  
At pH 8 close to the IEP, the mAb molecules carried least net charge, thus adsorption to the 
negatively charged silicone surface was suggested to be mainly driven by hydrophobic 
interactions. Furthermore, least inter-protein repulsion was expected close to the IEP, which 
enables closer packaging of the mAb molecules [117].  
At pH 6 the silicone surface and mAb were oppositely charged with strong electrostatic attractive 
forces triggering adsorption while electrostatic repulsion amongst the mAb molecules themselves 
makes close packaging unfavorable. Thus, a decreased adsorption at pH 6 compared to pH 8 was 
anticipated.  
At pH 10, where both the silicone surface and the mAb molecules were negatively charged, 
surface repulsion of the protein as well as amongst the mAb molecules themselves impeded 
adsorption. Nonetheless, adsorption to silicone surfaces was described even under 
electrostatically unfavorable conditions due to strong hydrophobic interactions as main driving 
force [118,119]. Even though the mAb carried net negative charge, charges are spatially 
distributed on the protein surface. Thus, local positively charged patches may exist, that still drive 
adsorption to the negatively charged silicone surface [120]. Additionally, incorporation of ions in 
the inner region of the adsorbed layer was described to mitigate high charge densities in the 
contact region [38]. This might further enable adsorption even under electrostatically unfavorable 
conditions.  
The adsorption of mAb to baked-on silicone surfaces also revealed a similar pH-dependent 
profile with higher maxima of 8.7 ± 1.6 mg/m
2
 at pH 8 and 7.0 ± 0.6 mg/m
2
 at pH 6. The 
adsorbed mass at pH 10 remained low with 1.2 ± 0.7 mg/m
2
 (Fig. VII-6). 
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Fig. VII-6. Effect of pH on mAb adsorption (2 mg/mL) to model bake-on silicone surfaces in histidine buffer at 
consistent ionic strength of 50 mM as determined by QCM. Adsorbed mass was corrected for liquid-induced 
frequency and damping contributions according to Kanazawa. Statistical significance for bars is shown with 
** p ≤ 0.01.  
A wide range of adsorbed amounts from approximately 1 mg/m
2
 to 10 mg/m
2
 has been described 
in literature obviously depending on buffer composition, measurement technique, surface 
characteristics as well as the protein under investigation [37,52]. In QCM, a pronounced 
adsorption maximum of approximately 7 mg/m
2
 close to the IEP was described for a Fc-fusion 
protein on untreated silicone surfaces compared to approximately 3 mg/m
2
 at pH values away 
from the IEP [119]. This is in agreement with what is generally observed for protein adsorption 
on hydrophobic surfaces with highest adsorbed amounts around the IEP [103,117]. On baked-on 
siliconized vials, two adsorption maxima with 5-7 mg/m
2
 (depending on ionic strength) were 
suggested for IgG at pH 5-6 and close to the IEP of 7.8 [51], which was similarly observed in this 
study. However, the adsorption of albumin on baked-on silicone surfaces was found to be rather 
pH-independent [121].  
The present study was performed on electrostatically comparable surfaces. Thus, different 
electrostatic attractive forces were less likely responsible for the higher adsorption at pH 6 on 
baked-on silicone surfaces compared to spray-on silicone surfaces. Rather, a change in 
hydrophobicity may be considered since slightly higher contact angles with stronger dispersive 
components were observed (Tab. VII-2, Fig. VII-3). Mathes found a linear dependence of IgG1 
adsorption on the surface polarity (expressed as γp/γ) with higher adsorbed amounts on 
hydrophobic surfaces [90]. Similar results were described by Warkentin et al. and Elwing et al. 
for mAb and γ-globulin adsorption to methylated silicon surfaces with increasing contact angles 
[122,123]. Ortega reported a 20 % higher IgG adsorption with an increase in contact angle from 
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78° to 94° [124]. Stronger hydrophobic interactions may thus have led to the increase in 
adsorption on baked-on silicone surfaces at pH 6 and pH 8 and additionally may have 
compensated electrostatic repulsive forces between the oppositely charged mAb molecules 
occupying the sorbent surface at pH 6 [117].  
 MAB ORIENTATION AND PROTEIN LAYER THICKNESS 3.2.2
A straightforward approach to determine the approximate orientation of mAb on the silicone 
surface is to compare the adsorbed mass in QCM with the theoretical monolayer coverage based 
on generally accepted models in literature assuming close packaging and RSA (Tab. VII-3).  
Tab. VII-3. Comparison between the theoretical protein monolayer coverage for end-on, side-on and flat-on 
adsorption assuming close packaging and RSA models. 
Orientation Adsorbed dimensions [nm] Surface contact area [nm
2
]
 a
 
Monolayer coverage [mg/m
2
] 
b
 
Close packaging RSA 
End-on 
c
 14×4.5 63 4.0 2.2 
Side-on 10×4.5 45 5.6 3.1 
Flat-on 14×10 140 1.8 1.0 
a Surface contact area was based on adsorption of aligned squares comparable to [58,125].  
b Theoretical monolayer coverage was calculated using the Avogadro`s number with 6×1023/mol, the molecular weight of 
approximately 150 kDa [126] and for RSA a jamming limit of 0.562 for aligned squares [26]. 
c End-on orientation holds for both Fab-up and Fab-down adsorption. 
 
As expected, the RSA surface exclusion model led to surface densities well below close-
packaging. Assuming no or only minor structural rearrangements, the experimental results in this 
work of 1.2 mg/m
2
 to 8.7 mg/m
2
 (Fig. VII-5, Fig. VII-6) do not allow an assignment of one 
particular protein orientation at the interface.  
A surface coverage higher than expected for a closely packed layer may likely be attributed to the 
co-existence of a second or more adlayers as previously suggested [87,97,127–129]. A second 
layer may also refer to systems with spread molecules interspersed with some intact molecules, 
which have insufficient free surface left for structural arrangement [130]. It is also possible that 
some clustering of the mAb occurs on the sorbent surface [129,131]. In QCM, it is additionally 
important to consider that the measured adsorbed mass corresponds to the protein layer and 
associated water, e.g., in the protein hydration shell or capillary-like water between the adsorbed 
molecules. Generally 1.7-2.7× higher adsorbed amounts were reported for QCM compared to 
other techniques (e.g., in situ ellipsometry, optical waveguide lightmode spectroscopy) [53,58]. 
The adsorbed amounts may thus still correspond to monolayer coverage.  
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To obtain additional information about structural and orientational arrangements on the surface, 
the adsorbed protein layer thickness was calculated based on an average protein density of 
1.35 g/cm
3 
[92] and compared to the approximate dimensions of IgG with 10×14×4.5 nm
3
 [132]. 
Assuming monolayer coverage, the relatively high adsorbed amounts suggest a closely packed 
layer of either end-on or side-on adsorbed species extending approximately 10 nm and 14 nm in 
solution, respectively (Fig. VII-7). Close to the IEP, a more contracted, end-on conformation is 
likely with Fab-fragments that lie close together with adsorbed amounts up to 5.5 mg/m
2
 as 
reported by Buijs et al. [131]. It has been previously found that on hydrophobic surfaces, the 
mAb molecule is preferentially adsorbed in an end-on orientation [131,133].  
However, the determined layer thickness between 0.9 nm and 6.5 nm in this study (Fig. VII-5, 
Fig. VII-6) was systematically lower than 10 nm and 14 nm as anticipated for end-on and side-on 
adsorption, respectively. This may be attributed to surface induced spreading [58,134], which 
particularly explains the rather questionable adsorbed layers thinner than the shortest axis of the 
molecule.  
Alternatively, flat-on adsorption has been reported for CH3-terminated surfaces and surfaces 
where electrostatic interactions are weak [135,136]. Flat-on adsorbed mAb extending 
approximately 5 nm in solution would roughly correspond to the calculated layer thickness, but it 
is rather unlikely due to the relatively high adsorbed amounts.  
 
Fig. VII-7. Schematic drawing of some orientations of adsorbed mAb in aqueous media modified from 
[130,131,137]. 
In addition, it has to be taken into account that the density of the adsorbed layer depends on 
protein size, experimental conditions (e.g., layer water content) and surface characteristics [130]. 
Malmsten et al. found a comparable layer thickness for IgG of approximately 17-18 nm on both 
silica and methylated silica corresponding with different low adsorbed amounts of 1.2 ± 0.1 mg 
and 3.0 ± 0.2 mg, respectively [133]. Therefore, calculation of the layer thickness may be 
inherently misleading while in turn, predicted orientations associated with the surface coverage 
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results do not account for surface induced structural changes. It was not within the scope of the 
current experiments to probe the loss of the structural component, thus it could not be 
unambiguously clarified whether alterations of the protein´s structure contributed to the surface 
coverage at the different pH values. 
 ADSORPTION REVERSIBILITY UPON DILUTION 3.2.3
The fraction of mAb reversibly associated was between 44 % and 74 % for spray-on silicone 
layers upon rinsing with buffer, while for baked-on silicone layers the adsorption was apparently 
irreversible (Fig. VII-5, Fig. VII-6).  
In protein adsorption studies, the concepts of reversibility and reconformation are often closely 
connected, but still not fully understood [16,36,37]. A simple explanation involves that “soft” 
proteins adapt its shape and assemble hydrophobic peptide moieties to interact with hydrophobic 
surface patches resulting in a loss of ordered structure and concomitant conformation entropy 
gain [38,103]. A perturbed protein structure was shown for IgG adsorption on hydrophobic 
polytetrafluoroethylene surfaces with a decrease in β-sheet and β-turn content, whereas α-helices 
and random coils were increased [62]. Upon adsorption the Fc-fragment remained unperturbed 
whereas the Fab-fragment denatured due to a higher hydrophobicity [138]. Disruption of the 
native structure was also reported for several other proteins upon adsorption on hydrophobic 
surfaces [103,139–141].  
Thereby, in particular on hydrophobic surfaces, protein adsorption was often found to be 
irreversible [119] or partially reversible by dilution [22,73,127]. This may indicate that two 
conformational populations are adsorbed to the surface with one being more loosely attached, 
which can be removed by rinsing [142]. The desorbed fraction may also be linked to molecules 
adsorbed above monolayer coverage that are not directly associated to the surfaces [127,143].  
In the literature, the fraction of protein irreversibly adsorbed to hydrophobic surfaces was 
generally higher than to hydrophilic surfaces [117,144,145], which may explain the observed 
discrepancies in adsorption reversibility for spray-on and bake-on silicone surfaces in this study.  
Although desorption experiments with buffer revealed a (partially) irreversible adsorption, a 
dynamic equilibrium with molecules arriving and displacing adsorbed species at the interface has 
been suggested by Lundström et al. [25]. and Norde et al. [103] (see 3.4.2). 
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 VISCOELASTIC PROPERTIES OF THE ADSORBED PROTEIN LAYER 3.2.4
QCM with dissipation monitoring can be employed to investigate the viscoelastic properties of 
the adsorbed protein layer. The highest rigidity quotient for mAb adsorption on spray-on silicone 
layers was ΔΓ/Δf = 0.08 (Fig. VII-5) indicating a rather rigid layer. On baked-on silicone layers 
higher ΔΓ/Δf up to 0.29 were observed (Fig. VII-6) (exceptional high value at pH 10, see below). 
The less rigid layer on baked-on silicone layers may be explained by both the higher surface load 
and/or a larger amount of coupled water. A linear correlation was found in literature between the 
measured dissipation and the total water content of the layer [130]. Considering the irregular Y-
shape of mAb, this was well expected since such a film is relatively porous and hence associates 
more water [58].  
There was no clear trend whether the rigidity increased or decreased upon buffer rinse, i.e., 
desorption. A higher rigidity and a concomitant lower surface coverage after rinsing as observed 
for spray-on silicone surfaces may be consistent with a more rigidly attached, dense layer after 
surface-induced spreading since the spread molecules closely fill up the free surface [97]. It can 
be further argued, that with lower surface coverage interfacial relaxation from an end-on to a flat-
on orientation by rollover increased rigidity [22]. These effects are most likely cooperative while 
their relative contributions cannot be precisely quantified. The quantitatively different rigidity 
behavior on bake-on silicone surfaces where the surface coverage remained high after desorption 
pointed towards a different mechanism. At present, we do not have a clear explanation for this 
behavior.  
The exceptionally large rigidity quotients > 1 at low surface coverage at pH 10 indicated a highly 
fluidic layer (Fig. VII-6). Dixit et al. reported a ΔR/Δf = 0.68 Ω/Hz for a purely viscous coupling 
of sucrose solutions [119], which equals ΔΓ/Δf = 6.6 (calculation based on Eq. VII-4). Thus, the 
rigidity values observed at pH 10 could be indicative for loosely attached mAb molecules due to 
electrostatic repulsion from the negatively charged surface.  
The reported negative ΔΓ/Δf values as a consequence of negative damping drifts were more 
difficult to interpret. They may derive from interfacial slip between the silicone layer and the 
adsorbed protein molecules or the quartz surface, respectively, which reduces the coupling of the 
layer and/or liquid to the crystal [87,146].  
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3.3 THE ADSORPTION OF MAB-ATTO 633 TO MODEL SPRAY-ON 
SILICONE SURFACES AS A FUNCTION OF PH STUDIED BY QCM 
In this study, Atto 633 was covalently labeled to mAb to enable analysis in FACS (see 3.4). The 
main obstacle to be clarified was how the fluorescent label affected the adsorption behavior of the 
protein. In particular, the effect on the adsorption of mAb-Atto 633 to spray-on silicone surfaces 
was investigated in QCM at different pH values and consistent ionic strength of 50 mM.  
Compared to unlabeled mAb (Fig. VII-5), higher amounts of approximately 9 mg/m
2
 labeled 
mAb-Atto 633 adsorbed at both pH 6 and pH 8 (Fig. VII-8). At pH 10 the adsorption level 
dropped sharply to 0.8 ± 0.7 mg/m
2
 similar to the adsorption of unlabeled mAb. In contrast to the 
adsorption of mAb to model spray-on silicone surfaces with a reversibly adsorbed fraction of 44-
74 %, mAb-Atto 633 did not desorb upon rinsing with buffer. 
 
Fig. VII-8. Effect of pH on mAb-Atto 633 adsorption (2 mg/mL) to model spray-on silicone surfaces in histidine 
buffer at consistent ionic strength of 50 mM as determined by QCM. Adsorbed mass was corrected for liquid-
induced frequency and damping contributions according to Kanazawa (Ø - ΔΓ/Δf  could not be quantified (≤ 0)). 
Statistical significance for bars is shown with *** p ≤ 0.001. 
Changed charge properties of the labeled proteins [147] as compared to the unlabeled species as 
well as the hydrophobicity of the fluorescent label itself [148,149] are properties, which could 
impact the adsorption behavior of the dye-mAb conjugate.  
For adsorption experiments on hydrophobic silicone surfaces, the hydrophobicity of the labeled 
species is probably the most important factor. HIC analysis revealed a heterogeneously labeled 
population with unlabeled mAb being present up to approximately 61-63 % (Fig. VII-9). The 
labeled species were not clearly separated due to their high degree of heterogeneity. Two 
prominent peaks could be exemplarily assigned to species with approximately one and two 
attached Atto-633 molecules based on the UV signal intensity in HIC at 280 nm and 633 nm (see 
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2.5.1). The DOL of 1.3 ± 0.1 as determined spectroscopically thus averaged the unlabeled main 
peak and the different labeled fractions.  
 
Fig. VII-9.  Effect of Atto 633-labeling on the elution profile of mAb in HIC. Elution was monitored with UV 
detection at λ = 280 nm (protein absorption) and λ = 629 nm (Atto 633 absorption). Exemplary DOLs are given at 
specific time points calculated according to the recommended procedure for labeling [104]. 
The ε-amino groups of lysine residues and the N-terminal α-amino group are the primary sites 
used for amine-directed labeling and drug conjugation. Thus, the high degree of heterogeneity 
suggests species labeled at different lysine residues in addition to different labeling degrees 
[150,151]. Studies investigating the amine-directed conjugation for antibody-drug conjugates 
described that both the light and heavy chain have been modified [151]. For modified 
trastuzumab, an actual substitution ranging from 1 to 7 payloads was found at an average drug 
antibody ratio (DAR) of 3.5 [152]. Furthermore 50 % unconjugated mAb and a DAR of 4-6 were 
reported for modified gemtuzumab resulting in an average DAR of 2-3 [153].  
Thus, Atto 633 labeling yielded a rather typical heterogeneous distribution of amine-labeled 
species. More importantly, these results clearly showed, that Atto 633-labeled mAb exhibited a 
substantially higher hydrophobicity compared to unlabeled mAb. As a consequence, mAb-Atto 
633 adsorbed to a higher extent and less reversible to hydrophobic silicone surfaces. Similarly, on 
hydrophobic surfaces, a higher protein hydrophobicity corresponded with a higher surface 
coverage when two different mAbs were investigated [127].  
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3.4 THE ADSORPTION OF MAB-ATTO-633 TO MODEL SPRAY-ON 
SILICONE SURFACES STUDIED BY FACS 
 IMPACT OF UNSPECIFIC SILICONE INTERACTIONS 3.4.1
FACS has emerged as a powerful technique to differentiate silicone droplets, proteinaceous 
particles and protein-coated silicone droplets using combinations of fluorescently-labeled 
proteins (e.g., Alexa Fluor 647), or non-covalently binding dyes such as SYPRO Orange [71], 
Bis-ANS and DCVJ [72] and stained silicone oil (e.g., Bodipy 493/503) [70]. The utility of 
FACS to identify heterogeneous silicone droplets with adsorbed proteins particularly offers an 
interesting approach to monitor protein adsorption. In most cases, experiments with fluorescently 
labeled proteins are based on two crucial assumptions: i) that the fluorescent dye does not alter 
the physicochemical properties and adsorption behavior of the protein and ii) that the dye itself 
does not interact with the sorbent surface. Clearly, these generalized assumptions require further 
assessment since recent studies indicated that fluorescently-labeled mAbs exhibit different 
aggregation [154] and adsorption behaviors [155].  
Selecting an appropriate fluorescent dye in terms of a minimum change in relative protein charge, 
IEP and size [147], protein aggregation behavior [156] or hydrophobicity of the fluorescent probe 
itself [148,149] surely mitigates concerns arising from the presence of a fluorescent label. 
However, in this study the choice of the fluorescent label was limited. Bodipy 493/503 is a 
lipophilic, non-charged fluorophore well-known to track lipid trafficking, as membrane probe and 
as specific tracer for cellular lipid droplets in FACS [99,157]. In addition, it was successfully 
used to stain silicone droplets in earlier studies [158,159]. mAb was labeled with Atto 633, which 
is described as pH-independent, cationic, moderately hydrophilic dye [98]. A combination of 
both dyes was thus considered reasonable and allowed a multicolor approach in FACS with 
minimum spectral spill-over in the emission filters (< 1.4 %) [100]. To mitigate label-induced 
alterations in the mAb properties, we used a relatively low DOL of 1.3 ± 0.1 compared to a DOL 
of 7-8 applied for IgG in former FACS studies [158,159].  
Contributions to the fluorescence detected in FACS could be divided into four categories arising 
from i) the adsorbed mAb, ii) unspecific Atto 633-to-silicone, iii) dye-to-dye and iv) mAb-to-
Bodipy 493/503 interactions. A mixture of Bodipy 493/503-stained or non-stained silicone 
emulsion, Atto-633-labeled mAb and free Atto 633 dye was consequently examined in order to 
investigate these different fluorescence contributions (Fig. VII-11, Fig. VII-10). 
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a. 
 
b. 
 
c. 
 
d. 
 
Fig. VII-10. Representative FACS dot plots of SSC versus FSC; and the fluorescence detected at 660/20 nm (i.e., 
Atto 633 fluorescence) versus 530/30 nm (i.e., Bodipy 493/503 fluorescence) for samples containing (a) 0.2 mg/mL 
non-stained silicone emulsion, (b) 0.2 mg/mL Bodipy 493/503-stained silicone emulsion, (c) a mixture of 0.2 mg/mL 
non-stained silicone emulsion and 0.05 mg/mL mAb-Atto 633 and (d) a mixture of 0.2 mg/mL Bodipy 493/503-
stained silicone oil and 0.05 mg/mL mAb-Atto 633 in 20 mM histidine buffer, pH 6. Arrows indicate an increase in 
the corresponding fluorescence due to labeling mAb with Atto 633 and silicone staining with Bodipy 493/503, 
respectively. 
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Fig. VII-11. Fluorescence contributions from mAb adsorption to silicone as well as unspecific Atto 633-to-silicone, 
dye-to-dye and mAb-to-Bodipy 493/503 interactions. Samples contained 0.2 mg/mL Bodipy 493/503-stained or non-
stained silicone emulsion in 20 mM histidine buffer, pH 6, a final protein concentration of 0.05 mg/mL mAb-Atto 
633 or equimolar concentrations of free Atto 633. In FACS, Atto 633 was excited with a 633 nm red laser and the 
mean fluorescence was detected with a detector band of 660/20 nm. For the excitation of Bodipy 493/503, a 488 nm 
blue laser was used followed by detection with a 530/30 nm detector band. 
While non-stained silicone oil emulsion showed a minimum fluorescence < 40 for both 
fluorescence filters, staining silicone oil with Bodipy 493/503 caused an increase in the 
corresponding Bodipy 493/503 fluorescence to 700 (Fig. VII-10a and Fig. VII-10b, Fig. VII-11 
left panel). The addition of Atto 633-labeled mAb increased the corresponding Atto 633 
fluorescence at a similar ratio to 12,500 and 12,900, respectively, in samples containing non-
stained or stained silicone emulsion (Fig. VII-10c and Fig. VII-10d, Fig. VII-11 middle panel). 
This indicated an adsorption of mAb primarily attributed to mAb-to-silicone interactions rather 
than a substantial binding affinity of mAb-to-Bodipy 493/503 or dye-to-dye interactions. 
Interestingly, experiments with free Atto 633 dye suggested a binding to silicone oil but to a 
markedly lesser extent, associated with an increase in the corresponding Atto 633 fluorescence to 
2600 (Fig. VII-11 right panel). The Atto 633 fluorescence signal after addition of free dye was 
rather comparable in non-stained and Bodipy 493/503-stained silicone emulsion thus excluding 
additional dye-to-dye interactions.  
Hydrophobic dyes such as Bodipy 630/650 were found to non-specifically bind to the protein 
interior through hydrophobic interactions [149]. The influence of this should, however, be 
negligible within the scope of this study. Nonetheless, the first obstacles using fluorescently-
labeled protein for adsorption experiments were clear from these results since Atto 633 dye itself 
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partially associated with silicone oil. Similarly, free Cy5 dye was found to substantially interact 
with sorbent surfaces such as CH3-silane, polystyrene and polydimethylsiloxane [76]. 
We further tested, if choosing a suitable concentration range may mitigate fluorescence 
contributions from the Atto 633 dye alone. The influence of different mAb-Atto 633 
concentrations ranging from 0.01 mg/mL to 1 mg/mL and equivalent concentrations of free Atto 
633 based on a DOL of 1.3 ± 0.1 is depicted in Fig. VII-12.  
 
Fig. VII-12. Concentration dependent mean fluorescence of mAb-Atto 633 at 0.01-1 mg/mL or equimolar 
concentrations of free Atto 633. Samples contained 0.2 mg/mL Bodipy 495/503-stained silicone emulsion in 20 mM 
histidine buffer, pH 6.  
For Atto 633-labeled mAb, surface saturation was reached at around 0.5 mg/mL. The curve 
characteristics coincided with a Langmuir adsorption isotherm [18,19]. However, the application 
of the Langmuir model with its implication of dynamic equilibrium and adsorption reversibility, 
is not necessarily justified by the agreement of the data [20]. Surface saturation may also be 
understood using the more relevant RSA model in which proteins readily adsorb to form an 
inefficiently packed layer with undefined gaps. The probability to find an available adsorption 
site decreases faster with increasing surface coverage [26]. However, the free Atto 633 dye 
exhibited a similar saturation plateau, but with an initially less steep slope. Due to the small size 
of the Atto 633 dye (535 Da [91]) relative to the overall size of the protein (~ 150 kDa [126]) and 
the corresponding much smaller footprint occupied upon adsorption, it is unlikely that both 
species achieved saturation coverage at equivalent concentrations. Instead, the stagnating 
fluorescence in addition to the indicated overshoot of fluorescence at 0.5 mg/mL mab-Atto 633 
compared to 1 mg/mL may be attributed to intermolecular concentration quenching as with 
higher concentration the fluorophores come in close proximity [160,161]. The plateau may thus 
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derive from competition between an increase in the number of fluorophores at the interface and 
the concomitant decrease in fluorescence quantum yield.  
The steeper slope for mAb-Atto 633 adsorption pointed to a greater surface affinity compared to 
the free Atto 633 dye, most probably due to long-range electrostatic attractive forces at pH 6, 
which trigger the transport of the positively charged mAb-Atto (IEP = 8-8.5 [116]) to the 
negatively charged silicone surface (IEP = 3.9). 
Overall, an easy set-up was established to assess the fluorescence contributions from unspecific 
Atto 633-to-silicone interactions. On the basis of these results, adsorption studies in FACS are 
recommended to be performed in a concentration range of 0.01-0.1 mg/mL mAb-Atto 633.  
 REVERSIBILITY OF MAB-ATTO 633 ADSORPTION UPON DILUTION, 3.4.2
EXCHANGE WITH UNLABELED MAB AND ADDITION OF 
POLYSORBATE 20 
Conceptually, reversibility testing of mAb adsorption to silicone oil in this work can be divided 
into three categories. i) reversibility upon buffer rinse, ii) exchange against dissolved proteins and 
iii) replacement of protein by surfactant.  
As depicted above for QCM experiments, mAb-Atto-633 adsorbed irreversible to model spray-on 
silicone surfaces upon dilution (Fig. VII-8) compared to unlabeled mAb (Fig. VII-5) most likely 
attributed to an increased hydrophobicity of the labeled species (Fig. VII-9).  
The first experiment in FACS involved an exchange study between unlabeled mAb and Atto 633-
labeled mAb to further probe discrepancies in the adsorption reversibility of both species. After a 
defined adsorption period of 2 h, which is sufficient for surface saturation of mAb-Atto 633 
(supporting information Fig. S VII-3), a ten-fold excess of unlabeled mAb was added and the 
mean Atto 633 fluorescence was monitored over a 6 h time period (Fig. VII-13a). The Atto 633 
fluorescence remained rather constant indicating that mAb-Atto 633 was not displaced by 
unlabeled mAb. In contrast, in experiments that were performed in reverse order, mAb-Atto 633 
steadily displaced the unlabeled mAb from the silicone surface since the Atto 633 fluorescence 
increased over time (Fig. VII-13b). Thus, a stronger surface binding of Atto 633-labeled mAb as 
compared to unlabeled mAb was indicated in FACS.  
Quartz Crystal Microbalance and Flow Cytometry to Characterize Protein Adsorption to Silicone Surfaces 
197 
a. 
 
b. 
 
Fig. VII-13. Sequential adsorption assay for mAb and mAb-Atto 633 onto 0.2 mg/mL Bodipy 493/503 stained 
silicone emulsion in 20 mM histidine buffer, pH 6. (a) mAb-Atto 633 was incubated for 2 h followed by adding an 
excess of mAb in a ratio of 1:10. (b) Experiments were performed in reverse order, incubating mAb first followed by 
an excess addition of mAb-Atto 633.  
For adsorption experiments on hydrophobic silicone surfaces, the hydrophobicity of the labeled 
species is a highly important factor (see 3.3), but also a difference in protein charge may play a 
role. At the tested pH 6, the silicone surface and protein carried opposite electrostatic charge. 
Note that, Atto NHS-ester primarily attack the highly polar primary amino groups of lysine, 
which are usually positively charged at pH 6 (pKa = 10.4 for lysine [162]). The conjugation 
reaction thus leads to the loss of a positive charge while, simultaneously, a positive charge is 
introduced due to the cationic Atto-label [98]. Thus, the influence of charge should be nullified 
and less strong than a change in hydrophobicity [74,148].  
Upon addition of a surfactant, the adsorption of mAb-Atto 633 was clearly reduced in mixed 
samples containing polysorbate 20 in concentrations as low as 0.005 % (m/v) (Fig. VII-14).  
In therapeutic protein formulations, the addition of nonionic surfactants has shown to prevent 
adsorption induced protein monomer loss [13,49,158,159] and different mechanism have been 
proposed [163,164]. Sequential and competitive protein adsorption experiments on hydrophobic 
surfaces primarily pointed at an interfacial competition mechanism with the low molecular 
surfactant arriving faster at the interface [165,166]. A protein repellent detergent layer is formed, 
which sterically prevents proteins from adsorption similar to polyethylene glycol-modified 
surfaces [167]. Initially adsorbed proteins may be also displaced by surfactant molecules in a 
later stage [168,169]. A direct association of nonionic surfactants to hydrophobic protein sites 
was described in some cases, thereby shielding these hydrophobic protein sites and mitigating 
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interfacial protein adsorption or protein aggregation [170,171]. However, a few studies on IgG 
suggest a negligibly weak protein-surfactant binding [172].  
 
Fig. VII-14. mAb-Atto 633 (0.05 mg/mL) adsorption to 0.2 mg/mL Bodipy 493/503 stained silicone emulsion in 
histidine buffer, pH 6, 50 mM, as a function of polysorbate 20 concentration ranging from 0.005 %  (w/v) to 
0.04 %  (w/v). The mixtures were allowed to adsorb for 2 h before FACS analysis. 
For Atto 633-labeled mAb, maximum adsorption suppression was achieved close to the critical 
micelle concentration (CMC) of polysorbate 20 at around 0.005-0.006 % [173–175]. In the 
literature, comparable results were observed for polysorbate 20, polysorbate 80 and poloxamer 
188 with adsorption minima for albumin and mAb onto hydrophobic surfaces close to the CMC 
[118,176]. It was suggested that surfactant monomers are the competing species. This makes a 
most effective surfactant concentration close to the CMC, where the concentration of monomer in 
the bulk is high, conceivable. The extent of adsorption depression depends on the protein, 
surfactant and surface properties among others factors, thus no general trend could be observed.  
Overall, labeling induced a substantially altered reversibility profile for both dilution with buffer 
in QCM (see 3.3) and exchange against unlabeled species in FACS. The adsorption of Atto 633-
labeled mAb was still inhibited by polysorbate 20. Both QCM and FACS thus demonstrated a 
high potential to study adsorption reversibility, but the complex nature of fluorescence-based 
adsorption studies was clearly highlighted. It is thus noteworthy that results derived from 
mechanistic adsorption studies based on single molecule tracking, but also FACS, may be 
essentially perturbed by the altered adsorption behavior of labeled protein species. 
 THE ADSORPTION OF MAB-ATTO 633 TO MODEL SPRAY-ON 3.4.3
SILICONE SURFACES AS A FUNCTION OF PH STUDIED BY FACS 
As described above (see 3.3), the adsorption of mAb-Atto 633 was investigated in QCM as a 
function of pH and at consistent ionic strength of 50 mM. mAb-Atto 633 markedly adsorbed at 
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pH 6 and pH 8 to a comparable extent, while at pH 10 the adsorption level dropped sharply. 
FACS was capable to qualitatively reflect this pH-dependent adsorption, but the pH effect was 
less pronounced (Fig. VII-15). In addition, FACS adsorption results may be affected by the 
composition of the sheath fluid that was not matched in these experiments.  
 
Fig. VII-15. Effect of pH on mAb-Atto 633 (0.05 mg/mL) adsorption to 0.2 mg/mL Bodipy 493/503-stained silicone 
emulsion in histidine buffer at consistent ionic strength of 50 mM (* p ≤ 0.05). The samples were allowed to adsorb 
for 2 h before FACS analysis. 
For comparison, a protein sample without silicone emulsion was particle-free in the detected size 
range as no signals in the scatter plots were observed (lower size range covered in FSC was 
approximately 1.5 µm, supporting information Fig. S VII-4). Consequently, the particles detected 
were attributed to silicone droplets with adsorbed mAb. Additional sample information can be 
derived from the number of detected events, i.e., particles, and from FSC as a measure for 
particle size. No additional particles (e.g., protein aggregates) were introduced compared to the 
initial silicone emulsion since the mean number of detected events ranged between 260 and 350 
(supporting information Fig. VII-5a). Also, the mean FSC was consistent with 3100-3600 for all 
samples (supporting information Fig. VII-5b), thereby indicating no substantial change in the size 
of droplet species, e.g., due to coalescence of silicone droplets, which has been previously 
reported for relatively highly concentrated silicone emulsions (0.5-1 %) [70]. In contrast, low 
silicone levels of 0.2 mg/mL (0.02 %) were employed in this study. In preliminary experiments, 
this concentration was identified to yield lowest reasonable particle counts in FACS.  
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4 CONCLUSION 
The choice of methods to study protein adsorption at the solid-liquid or liquid-liquid interface is 
large and ever-increasing. In this study, QCM and FACS were utilized to detect and characterize 
the adsorption of a model mAb to silicone surfaces.  
For QCM experiments, quartz chips were coated with silicone oil and heat-treated silicone to 
mimic the different silicone surfaces in drug product containers that are present after spray-on 
and bake-on siliconization, respectively. A spin-coating method was established to yield 
comparable rigid, homogeneous coatings with approximately 60-70 mg/m
2
 and a layer thickness 
of 40-50 nm in QCM. The model bake-on silicone coating was slightly more hydrophobic with 
contact angles of 91.9 ± 1.2° and 91 % dispersive components compared to the spray-on coating 
with a contact angle of 78.1 ± 1.3° and 87 % dispersive components. ζ-potential measurements of 
silicone droplets indicated similar negative surface charges of approximately -20 mV to -40 mV 
for both coatings at the tested pH 6, pH 8 and pH 10. 
Adsorption experiments were performed with mAb in histidine buffer at three different pH values 
(i.e., charge of the protein) and consistent ionic strength of 50 mM to investigate driving forces 
that trigger adsorption to hydrophobic silicone surfaces. On spray-on siliconized surfaces, the 
highest surface concentration for mAb with 6.8 ± 0.2 mg/m
2
 was found at pH 8 close to the 
mAb´s IEP at pH 8.0-8.5 [116] and lower adsorbed amounts if shifting away from the IEP. The 
adsorption of mAb to baked-on silicone surfaces exhibited a higher maximum of 8.7 ± 1.6 mg/m
2
 
at pH 8, but also a second adsorption maximum with 7.0 ± 0.6 mg/m
2
 was observed at pH 6. 
Overall, the adsorbed masses ranging between 1.2 mg/m
2
 and 8.7 mg/m
2
 entirely covered the 
predicted range for closely-packed and RSA adsorption models implying a diversity of molecular 
orientation on the surface when assuming no or only minor structural changes. However, the 
calculated layer thickness did not necessarily corroborate the surface coverage results, which may 
be attributed to surface-induced spreading. More than monolayer coverage could be assigned to 
additional adlayers or surface clustering, but might also be an inherent artefact of the QCM 
technique. QCM was reported to yield generally higher adsorbed amounts than other techniques 
due to layer entrapped water. On baked-on silicone surfaces, the adsorption of mAb was 
apparently irreversible upon rinsing with buffer while on spray-on silicone surfaces between 44-
74 % were reversibly associated. Overall, our results showed that the adsorption of mAb was 
noticeably influenced by surface hydrophobicity.  
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Atto 633-labeled mAb exhibited a higher hydrophobicity as compared to unlabeled mAb and as a 
consequence a different adsorption profile in QCM. The adsorption to model spray-on silicone 
surfaces was increased up to approximately 9 mg/m
2
 and irreversible compared to unlabeled 
mAb. In FACS, we have additionally demonstrated that mAb-Atto 633 was not exchanged 
against unlabeled mAb, but adsorption of mAb-Atto 633 was clearly reduced by the addition of 
polysorbate 20 in concentrations as low as 0.005 % (m/v). Adsorption was also partially driven 
by unspecific Atto 633-to-silicone interactions as confirmed in a set of control experiments in 
FACS. Both QCM and FACS revealed a similar pH dependent effect on the mAb-Atto 633 
adsorption, but the pH effect was less pronounced in FACS.  
Thus, based on our results the hydrophobicity of both the surface and adsorbed species markedly 
affected the adsorption properties. The use of fluorescently labeled proteins for adsorption studies 
has to be selected with care and the effect of the label needs to be clarified. We therefore suggest 
that the unlabeled and labeled species are comparatively evaluated, e.g., in terms of i) adsorbed 
mass, ii) adsorption reversibility towards rinsing with buffer, exchange against unlabeled species 
and surfactants, iii) non-specific binding of the dye to the investigated surface within the 
investigated concentration range, and iv) physicochemical properties such as hydrophobicity, 
charge, size and IEP. The experimental set-up in this study largely covered these suggestions, but 
only with high experimental effort. Thus, for further adsorption experiments particularly on 
hydrophobic surfaces, the hydrophobicity of the labeled species appeared to be a valuable 
indicator for a changed adsorption behavior. Another approach could thus aim to specifically tune 
fluorescence labeling with regard to a low DOL, and more importantly, fluorescence labels that 
induce no or minor alterations in the protein´s hydrophobicity. 
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5 SUPPORTING INFORMATION 
 
Fig. S VII-1. Effect of mAb concentration ranging from 0.1 mg/mL to 4 mg/mL on frequency shifts in QCM upon 
adsorption to spray-on silicone surfaces in 20 mM histidine buffer, pH 6. 
 
Fig. S VII-2. Exemplary physical stability of the spray-on silicone coating. The coating was exposed to highly 
purified water followed by histidine buffer of different pH and consistent ionic strength of 50 mM and then water, all 
at flow rate of 60 µL/min until frequency and damping signals were stable for 10 min with ± 1 Hz and ± 10 Hz, 
respectively. Similarly, the silicone coating was exposed to 10 mM phosphate buffer containing 145 mM NaCl and 
0.05 % (w/v) SDS (pH 7.2) between two runs of highly purified water. Frequency shifts between both water runs 
were used for modeling the mass of detached silicone coating according to Sauerbrey (Eq. VII-1). 
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Fig. S VII-3. Mean fluorescence of mAb-Atto 633 (0.05 mg/mL) as a function of incubation time in samples 
containing 0.2 mg/mL Bodipy 495/503-stained silicone emulsion in 20 mM histidine buffer, pH 6.  
 
Fig. S VII-4. Representative FACS dot plot of SSC versus FSC for silica standards in 20 mM histidine, pH 6. 
 
a.
 
b. 
 
Fig. S VII-5. Effect of pH on the detected events and FSC in FACS for samples containing mAb-Atto 633 
(0.05 mg/mL) and 0.2 mg/mL Bodipy 493/503-stained silicone emulsion in histidine buffer of different pH and 
consistent ionic strength of 50 mM (n = 3). Average for Bodipy 493/503-stained silicone emulsion (n = 14) was 
derived as average from all experiments during the course of the FACS study. 
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6 ABBREVIATIONS  
Atto 633 NHS-ester Atto 633 N-hydroxylsuccinimidyl-ester 
Bodipy 493/503 4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene 
CMC Critical micelle concentration 
3D-LSM 3D-laser scanning microscopy 
DOL Degree of labeling 
DAR Drug antibody ratio 
FACS Fluorescence activated cell sorting 
FSC Forward scatter 
HIC Hydrophobic interaction chromatography 
IEP Isoelectric point  
mAb Monoclonal antibody 
QCM Quartz crystal microbalance 
RSA Random sequential adsorption 
SDS Sodium dodecyl sulfate 
SSC Side scatter 
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VIII SUMMARY OF THE THESIS 
During the development of drug/device combination products comprising syringes or cartridges 
as primary packaging components, siliconization of the interior glass barrel is an essential step to 
enable device functionality with adequate piston extrusion performance. Bake-on siliconization is 
a complex, multi-step process with a set of parameters to be precisely regulated. In addition to 
functionality, compatibility of the formulation with the siliconized container surface is equally 
important and needs to be assessed, in particular for sensitive protein therapeutics. Both aspects 
were presented in the general introduction (chapter I).  
Adequate siliconization balances both sufficient silicone for lubricity and limited silicone levels 
to mitigate an impact on drug product, e.g., due to migrating silicone droplets. This challenge is 
met by bake-on siliconization processes applying low silicone levels and resulting in thin silicone 
layers, which, however, cannot be easily characterized by standard methods. Therefore, in 
chapter III, Fourier transform infrared spectroscopy (FTIR) after a multi-step solvent extraction 
was established to quantify baked-on silicone levels as low as 4 µg/cartridge barrel (limit of 
quantification = 18 µg/mL). FTIR showed a good linear response (R
2
 = 0.994-0.999) and an 
excellent sensitivity (limit of detection < 1 µg/mL). Additionally, 3D-laser scanning microscopy 
(3D-LSM) was introduced as a novel technique to visualize the baked-on silicone at such low 
levels and to determine the layer thickness down to 10 nm. 3D-LSM was further developed to 
characterize the silicone distribution along the cartridge barrel. Both methods were able to 
overcome the current limitations of other standard techniques to characterize such thin baked-on 
silicone layers and thus enabled further optimization of the bake-on siliconization process. 
The bake-on siliconization process comprises two steps, namely spraying diluted silicone 
emulsion into the interior cartridge barrel followed by baking at elevated temperature. An 
optimized spray process using a pilot scale siliconization unit was designed in chapter IV 
supported by the methods developed in chapter III. A spray quantity of 4 mg showed best 
atomization behavior and led to relatively thin, homogeneous silicone layers compared to a spray 
quantity of 16 mg and 29 mg. These higher spray quantities led to runlets and thus 
inhomogeneous silicone build-ups at the flared cartridge edge. A long time for pump dosing was 
beneficial for the atomization of higher spray quantities, whereas a high spray pressure did not 
result in an improvement. Adequate baked-on silicone levels ranging from 10 µg to 
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100 µg/cartridge barrel and layer thicknesses from 10 nm to 50 nm were targeted by adjusting the 
emulsion concentration while an optimized spray quantity of 4 mg was maintained. Initially, a 
low baked-on silicone level of approximately 10 µg/cartridge barrel was sufficient for adequate 
extrusion forces below 10 N. However, for optimal extrusion performance throughout long-term 
storage, a baked-on silicone level of 30 µg/cartridge barrel is advisable for extrusion forces below 
15 N. The spray nozzle position had a fundamental impact on the silicone distribution since it 
determined the matching area of the spray cone and the cartridge barrel. A spray nozzle position 
of 20 mm below the cartridge flange resulted in thicker silicone layers at the cartridge flange, 
which may be beneficial for break-loose of the piston during injection. A reduced set of methods 
and the identification of key spray parameters further allowed a fast optimization approach for a 
second, different nozzle design. The fundamental process understanding was a prerequisite to 
enable a fully controlled spray-on process. Overall, the optimized process yielded sufficient, but 
limited baked-on silicone levels, a specifically tuned silicone distribution and adequate 
functionality. 
Chapter V aimed to clarify the impact of the bake-on process in the heat-tunnel on the silicone 
layer characteristics. A baked-on silicone level of 13 ± 3 µg/cartridge barrel provided adequate 
functionality at considered standard burn-in conditions of 316 °C for 12 min. Burn-in times equal 
to or longer than 1 h cannot be recommended due to an increase in gliding forces above 15 N. 
Thus, long interruptions of the bake-on process need to be avoided at such low baked-on silicone 
levels. Alternatively, a baked-on silicone level of approximately 80 µg/cartridge barrel should be 
preferred to enable burn-in times up to 2 h. In thermogravimetric analysis, silicone showed an 
onset of the main weight loss at 313 ± 5 °C, which correlated well with the decrease in the baked-
on silicone level between 250 °C and 316 °C and a decrease in the layer thickness at 316 °C 
compared to 200 °C. The average molecular weight of the silicone polymer remained unchanged 
at approximately 23,000 g/mol independent of the burn-in temperatures between 200 °C and 
350 °C. However, at higher temperatures of 316 °C and 350 °C, the molecular weight distribution 
showed an increased fraction between 5,000-15,000 g/mol as depolymerization products and 
fractions below 5,000 g/mol were removed. Cyclic low molecular weight species of less 
than 500 g/mol were not found in the baked-on silicone layer. In addition, emulsion stabilizers 
were either quantitatively removed upon bake-on (parabens, propylene glycol) or remained in the 
baked-on silicone layer only in small traces (polysorbate 20, Triton X-100). A toxicological 
effect or an adverse impact on the drug product associated with low molecular weight species or 
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stabilizer residues were thus not considered to be of concern. During bake-on in a heat-oven as an 
experimental model, sufficient air exchange was required to mimic the time and temperature-
dependent siliconization process in the heat-tunnel. Air-exchange likely prevented saturation 
effects within the heat-oven and contributed to the removal of silicone decomposition products. 
Interestingly, for optimal spreading and uniform silicone layers, temperatures as high as 300 °C 
may be essential despite the concomitant decrease in the baked-on silicone level. Contact angle 
analysis suggested a thin silicone film remaining on the glass surface most likely due to covalent 
siloxane bonds between silicone and the glass surface although extraction was performed under 
harsh conditions. Overall, the performed experiments provided valuable insight into the thermal 
decomposition of silicone. The silicone layer characteristics were comprehensively studied to 
identify an adequate processing window for robust bake-on siliconization processes. 
Adequate piston extrusion performance governs the lower silicone level while higher silicone 
levels might compromise drug product quality, e.g., due to a higher number of silicone droplets in 
solution. Therefore, the impact of two practically relevant baked-on silicone levels (13 ± 3 µg 
and 94 ± 6 µg/cartridge barrel, i.e., 4 mg of a 0.6 % (w/w) and 3.5 % (w/w) silicone emulsion), 
on the formation of silicone droplets and protein particles in formulation containing surfactant 
was assessed in chapter VI. Agitation resulted in silicone migration whereas expelling alone or 
in addition to agitation did not enhance silicone migration in placebo. A therapeutic protein 
formulation containing a model monoclonal antibody (mAb) at a concentration of 2 mg/mL and 
33 mg/mL and additionally 0.04 % (m/v) polysorbate 20 was therefore assessed after agitation 
with and without headspace. The different baked-on silicone levels had no impact on the 
submicron particle size range in nanoparticle tracking analysis and the monomeric mAb in 
dynamic light scattering. The number of particles in the size range of 0.2-5 µm in resonant mass 
measurement and ≥ 1 µm in micro-flow imaging and light obscuration increased with higher 
baked-on silicone levels. Particles were identified as silicone droplets and the particle numbers 
were comparable in placebo and solutions containing mAb at 2 mg/mL or 33 mg/mL. Cartridges 
that were filled with headspace showed higher numbers of silicone droplets mobilized by bulk 
fluid shear forces due to the movement of the air bubble as compared to cartridges filled without 
headspace. Still, the optimized bake-on siliconization process in combination with adequate 
silicone levels resulted in considerably lower particles as compared to literature. Overall, the 
particle numbers were well below the limits of current pharmacopeias and were thus of no 
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concern for product quality. It was further demonstrated that the different baked-on silicone 
levels and migrated silicone droplets did not induce protein particle formation.  
In this study, the number of silicone droplets was reasonable low due to an optimized bake-on 
siliconization process. However, since proteins may interact with surfaces, adsorption to the 
silicone oil-water interface is also thought to occur and could be critical for the specified drug 
product concentration. In any case, adsorption studies are recommended to ensure drug product 
quality and provide adsorption mechanisms. Chapter VII thus aimed to evaluate quartz crystal 
microbalance (QCM) and fluorescence activated cell sorting (FACS) as novel methods to 
characterize protein adsorption to silicone surfaces. In QCM, sprayed-on and baked-on silicone 
layers were successfully modeled by spin-coating quartz chips with silicone oil and heat-treated 
silicone oil, respectively. Maximum adsorption on sprayed-on silicone surfaces was found around 
the protein´s isoelectric point at pH 8 with 6.8 ± 0.2 mg/m
2
. At the isoelectric point, protein 
molecules carry least net charge, which results in minimized inter-protein repulsion and thus 
enables close packaging. In comparison, adsorption to the slightly more hydrophobic baked-on 
silicone surface was increased with a broader maximum between pH 6 (7.0 ± 0.6 mg/m
2
) and 
pH 8 (8.7 ± 1.6 mg/m
2
) and less reversible upon rinsing with buffer. The literature suggests 
greater adsorption to hydrophobic surfaces and by more hydrophobic proteins. The latter was 
confirmed by adsorption studies using Atto 633-labeled mAb, which exhibited a significantly 
higher hydrophobicity and higher adsorbed amounts with 8.9-9.2 mg/m
2
 at pH 6 and pH 8. In 
contrary to the unlabeled mAb, the adsorption of mAb-Atto 633 was irreversible upon rinsing 
with buffer in QCM and exchange with unlabeled mAb in FACS. The pH effect on the adsorption 
of mAb-Atto 633 was similarly observed in QCM and FACS, but it was less clear presented in 
FACS. Polysorbate 20 at a concentration as low as 0.005 % (w/v) efficiently prevented mAb-Atto 
633 from adsorption. Overall, the hydrophobicity of both the sorbent surface and adsorbed 
species thus dominated the adsorption behavior. Labeling provided an interesting approach to 
artificially modulate the protein´s hydrophobicity and investigate the associated impact on 
adsorption. However, these results also clearly demonstrated that the effect of the label needs to 
be clarified before undertaking experiments where labeled proteins are applied as surrogates for 
the unlabeled species. 
In summary, this work highlighted challenges, which are encountered during the development of 
protein therapeutics in siliconized drug/device combination products. An exemplary bake-on 
siliconization process was systematically optimized by applying novel analytical tools. The 
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described experiments shall encourage further investigation and development of robust and fully 
controlled siliconization processes. They further underscored the complexity of developing a 
suitable bake-on siliconization process. Currently, there has been a considerable interest into the 
assessment of particles from many academic and industrial researchers, particularly for those 
particles smaller than 10 µm. For bake-on siliconized cartridges filled with therapeutic protein 
formulations containing surfactant, silicone droplet and protein particle formation was of no 
concern for drug product quality. Protein adsorption was efficiently mitigated by the addition of 
surfactant. Overall, this work provided a substantial contribution to rational formulation and 
packaging development for protein therapeutics.  
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ABBREVIATIONS 
FACS Fluorescence activated cell sorting 
FTIR Fourier transform infrared (spectroscopy) 
3D-LSM 3D-laser scanning microscopy  
mAb Monoclonal antibody 
PFS Pre-filled syringe 
QCM Quartz crystal microbalance 
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